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Abstract 
Hyaluronan (HA) is a highly abundant anionic polysaccharide found throughout 
mammalian connective tissues. Unlike other glycosaminoglycans, HA is non-sulfated 
and its alternating chemical structure is invariable. Despite its simplicity, HA is 
involved in the extracellular matrix organization and many other aspects of cell 
behaviour. Using HA as a model polymer, we took inspiration to design and synthesize 
glycopolymers based on HA and self-assembling HA-binding peptides.  
Glycopolymers provide an alternative to conventional polysaccharides by offering the 
possibility to display sugars across the polymer at defined densities, while providing 
a robust polymer backbone rather than the glycosidic bonds, potentially forming more 
stable biomaterials with similar biological activity. The synthesis of alternating, homo 
and statistical HA neoglycopolymers was achieved via reversible addition 
fragmentation chain transfer (RAFT) polymerisation. The monosaccharides are 
grafted onto the polymers backbone by post-polymerisation click reactions to achieve 
the desired glycopolymers. These glycopolymers share some properties of native HA, 
such as water solubility and negative charge. Binding studies showed the ability of 
these glycopolymers to interact with HA-binding peptides and proteins, whilst not 
presenting any cytotoxicity behaviour. This approach provides control over the type 
and variation of saccharides, not be possible using natural HA, suggesting their 
potential use in mechanistic studies to understand HA binding processes. 
Peptides, on the other hand, have received increasing interest as potential biomaterials 
due to their inherent biocompatibility and biodegradability. Peptides can be 
engineered to drive their self-assembly into defined nanostructures, such as micelles 
and fibers. By designing HA-binding peptides with self-assembling properties, their 
combination with natural HA resulted in the formation of supramolecular hydrogels 
or membranes. Whilst the synthesis of large molecules like proteins is still a challenge, 
peptide synthesis is relatively simple and their self-assembly can result in 
nanomaterials with structures and functions resembling proteins.  
The synthetic molecules described in this thesis can be used as probes to better 
understand the role and binding of HA as well as reveal new applications. 
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Glycosaminoglycans (GAGs) are a family of polysaccharides highly abundant in 
animal tissues. The GAG family is composed of five polysaccharides (Figure 1.1): 
chondroitin sulfate (CS), dermatan sulfate (DS), heparan sulfate (HS), keratan sulfate 
(KS), and hyaluronic acid (HA). These polysaccharides are linear, highly charged, 
with a repetitive alternating unit. This unit consists of a disaccharide made of an amino 
sugar, such as N-acetylgalactosamine (GalNAc) or N-acetyl glucosamine (GlcNAc), 
linked to a uronic acid such as glucuronic acid (GlcA) or iduronic acid (IdoA). In the 
case of KS, a hexose monosaccharide of galactose (Gal) is used rather than a hexuronic 
acid1.  
 
Figure 1.1 The various disaccharide structures of the GAGs repeat disaccharide. 
These polysaccharides differ in their degree of sulfonation, even within the same 
polysaccharide. For example, HS has different degrees of sulfonation. The sulfonation 
position varies among each GAG as well as the heteroatom which is sulfonated. The 
sulfonated GAGs have the ability to bind covalently to core proteins to form 
proteoglycans (PGs) as listed in Table 1.1. These PGs can be found predominantly 
either in the extracellular matrix (ECM) or on the cell surface, representing a large 
group of glycoproteins found in the body2. 
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Table 1.1. List of proteoglycans and their localisation in human tissues2-3. 
GAG-PG Proteoglycan Localization Tissue Distribution 
HS-PG 
Perlecan ECM basement membranes, other ECM, cartilage 
Agrin ECM basement membranes, brain and neuromuscular junctions 
Collagen XVIII ECM basement membranes, longest isoform more widespread 
Syndecan 1-4 MB most nucleated cells 
Glypican 1-6 MB epithelial and mesenchymal cells, brain 
Betaglycan MB fibroblasts 
Serglycin IG mast cells, other leukocytes, endothelial cells 
CS-PG 
(DS-PG) 
Aggrecan ECM cartilage, brain 
Versican ECM pericellular and interstitial ECM; blood vessels; brain, leukocytes 
Neurocan ECM brain 
Brevican ECM brain-perineuronal nets 
Decorin ECM connective tissue cells 
Biglycan MB/ECM connective tissue cells, macrophages 
Phosphacan MB brain 
Thrombomodulin MB endothelial cells, but also a variety of nonvascular cells 
CD44 MB widely distributed including lymphocytes 
NG2 MB some stem cells, glial progenitors, vascular mural cells, melanocytes 
KS-PG 
Lumican ECM widely distributed 
Keratocan ECM widely distributed but sulfated only in the cornea 
Fibromodulin ECM widely distributed 
Mimecan ECM widely distributed but sulfated only in the cornea 
SV2 MB synaptic vesicles 
Aggrecan ECM cartilage, brain 
ECM: Extracellular Matrix; MB: Membrane-Bound; IG: Intracellular Granule. 
HA is the only non-sulfonated GAG and it does not form covalent bonds with proteins 
to produce PGs, like sulfonated GAGs. Instead, HA interacts with various HA-binding 
proteins (HABPs) such as those listed in Table 1.2.  
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Table 1.2. Natural HA-binding proteins (HABPs) also known as hyaladherins 
HABP  Localisation Roles  
TSG-6 4 ECM Cell-matrix interaction regulator during inflammation and tumorigenesis 
TLR4 5 MB Inflammatory Response 
CD386 MB Mediation of cell binding to HA 
CD447 MB Mediation of cell binding to HA 
LYVE-18 MB Lymphatic endothelial cell marker for HA degradation 
Link Protein9-11 ECM G1 HA-binding domain of Aggrecan, Versican and Neurocan 
HAS12 MB HA synthesis 
HYAL12 MB HA degradation 
RHAMM13-14 SP, MB Cell migration and proliferation signaling and inflammation cascade 
ECM; Extracellular Matrix, MB; Membrane-Bound, SP; Soluble Protien. 
 
1.1.2. Biosynthesis and Sulfonation 
1.1.2.1. Biosynthesis 
CS, DS and HS are synthesised in the endoplasmic reticulum or the Golgi 
compartments15-16. They are formed sequentially on a tetrasaccharide of GlcAβ1– 
3Galβ1–3Galβ1–4Xylβ1–O-Ser (Scheme 1.1a) known as the GAG-protein linker. The 
serine residue is used to anchor the GAG-protein linker covalently to the core protein 
whilst the polysaccharide is systematically built up from the corresponding uridine 
diphosphate (UDP) saccharide donors, producing structures up to 70 kDa in weight17. 
The formation of CS is triggered by the first addition of GalNAc via GalNAc 
transferase I (GalNAcT-I) after which point the saccharides of CS are added 
sequentially by GlcA transferase II (GlcAT-II) and GalNAc transferase II (GalNAcT-
II)15.  
Compared to CS, the formation of HS is triggered by the first addition of GlcNAc, 
rather than GalNAc onto the GAG-protein linker. Once the pentasaccharide is formed, 
the HS synthases of Exostosin-like (EXT) enzymes; EXT1 and EXT2 catalyse the 
addition of GlcA and GlcNAc respectively18-19. Using a C5-epimerase, the GlcA 
adjacent to a GlcNAc of the HS chains can be converted to IdoA. This conversion, 
however, does not convert all the GlcA to IdoA and therefore generates HS possessing 
both hexuronic acid epimers, leading to different disaccharide units within the HS. 
DS and CS are epimers of one another, with the two-compounds differing in the 
position of the acid group. These two are formed by the use of C5 isomerisation of the 
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GlcA on CS to IdoA, but, again, this epimerisation is not quantitative so within DS, 
chain regions of the original CS chain remain17, 20. 
  
Scheme 1.1. Schematic of the GAG-protein linker (A) from which CS and HS are formed depending on the first 
saccharide added to the GAG-protein linker, followed by the epimerization of CS to form DS. (B) The 3 linkers 
from which KS can be enzymatically polymerised upon21. 
In comparison, KS is synthesised by alternative routes as well as three different KS 
chains dependent on the localisation of the KS. KSI was discovered in the corneal 
tissue, whilst KSII was found in cartilage and KSIII found recently in the brain. There 
is a 10-fold difference in the amount of KSI in the cornea compared to KSII in cartilage 
with 2 to 4 orders of magnitude more than KS in any other tissue. Whilst KS itself is 
a linear molecule, the linker used during the biosynthesis is not (Scheme 1.1b), with 
the KS chain of KSI being produced as both a monoantennary or a biantennary 
oligosaccharide structure21. KS is formed in various lengths of the disaccharide by β-
1,4-galactosyltransferase (βGal-T1) and β-1,3-N-acetylglucosaminyltransferase 
(iGnT) enzymes responsible for the biosynthesis of KS. Once complete, the 
nonreducing ends of the KS chains are terminated with either a neuraminic acid, 
βGalNAc or αGal22. 
Whilst sulfonated GAGs are formed in the Golgi, HA is synthesised at the plasma 
membrane by HA synthases (HAS). These HASs are split into 3 subgroups: HAS1, 
HAS2 and HAS3. Whilst these share structural similarities (55-75%) they bind HA 
with different affinities leading to the synthesis of different size strands Large strands 
of 2000 kDa are formed by HAS1 and HAS2, whilst HAS3 forms smaller stands, 
between 100-1000 kDa using UDP saccharide donors of GlcA and GlcNAc. Upon 
synthesis, these strands are extruded into the extracellular space. 
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1.1.2.2. Sulfonation 
Sulfonation of GAGs is achieved through sulfotransferases using activated sulfate 3′-
phosphoadenyl-5′-phosphosulfate (PAPS) as the sulfonate donor. KS is sulfonated by 
GlcNAc 6-O-sulfotransferases23 and one Gal 6-O-sulfotransferase24 (Chst1) leading 
to sulfonate groups on both 6’ positions. However, in the cornea, the Gal residues of 
KS are only partially sulfonated21. Compared to KS, CS is a more complex molecule 
to sulfonate due to the various different products possible (Figure 1.2). The majority 
of the CS chains ends up 4-O-sulfation at the GalNAc by chondroitin 4-O-
sulfotransferase (C4ST) of which there are 3 (C4ST-1, C4ST-2 & C4ST-3)15, these 
lead to the formation of CS-A and CS-B (DS), which have previously undergone C-5 
epimerisation (Figure 1.2). A small set of CS has a 6-O-sulfation at the GalNAc by 
chondroitin 6-O-sulfotransferase (C6ST-1)24 to form CS-C. CS-C can undergo a 
second sulfonation pathway by uranyl 2-O-sulfotransferase (UST)25 to form CS-D. 
CS-A can also undergo a second sulfonation pathway by GalNAc 4-sulfate 6-O-
sulfotransferase (GalNAc4S-6ST) to form CS-E. 
 
Figure 1.2. Sulfonation pathway for CS and DS. Figure adapted from Hiroshi 201315 
HS also has multiple potential sites for sulfonation. However, the first of these 
sulfonation pathways is the N-deacetylation and N-sulfonation. This N-substitution is 
facilitated by N-deacetylase/N-sulfotransferase-1 (NDST), but this reaction again is 
not quantitative leading to regions rich in N-sulfonation HS. EXT-1 and EXT-2 levels 
have been shown to affect this NDST ability to sulfonate at the N-acetyl group19. This 
has an impact on the remaining sulfonation pathways as N-sulfonation-rich areas have 
been shown to lead to further sulfonation, whilst N-acetyl-rich areas show a lack of 
sulfonation26. The C5 of HS can also undergo epimerisation, leading to the 2-O-
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sulfation by a 2-O-sulfotransferase (2OST) for the majority of the IdoA units formed. 
The high degree of sulfonation allows HS to interact with multiple proteins such as 
growth factors. To this end, there are three 6-O-sulfotransferases (6OST1-3) and seven 
3-O-sulfotransferases leading to a total of ten O-sulfotransferases for HS. The rich 
number of sulfotransferases, as well the incomplete sulfonation and selectively of 
some enzymes to pre-existing sulfonations, lead to a large array of HS repeats18. 
 
1.1.3. Biological Roles and Function  
Whilst GAGs have more defined structures, compared to other biological molecules, 
such as the 4 base pairs that form DNA or the 20 amino acids of peptides and proteins, 
they play a large role in biological process including27: cell adhesion, proliferation and 
migration, through protein-carbohydrate interactions. The variations in saccharide 
epimers, the degree of sulfonation and the PGs bound to the GAG leads to a multitude 
of properties. 
 
1.1.3.1. Extracellular Matrix  
The ECM28 is a key non-cellular component found in tissues and organs acting as a 
physical scaffold for cells to proliferate, migrate and differentiate as well as fill the 
majority of the extracellaur space. The ECM is made up of various components and 
compositions depending on the type of tissue, but it is primarily made of water, 
polysaccharides, including elements of the GAG family, and proteins such as collagen 
and fibronectin. Through the interactions of HA and the Link Proteins the formation 
of the ECM is achieved by the “link” of large aggregates of PGs, such as aggrecan in 
cartilage (Figure 1.3) and Perlecan with a central HA core.  
 
Figure 1.3. Structure of aggrecan with the CS and KS attached to the core protein connected to HA through the 
link protein. Adapted from Dicker 201412 
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Through integrins, discoidin domain receptors (DDRs), cell surface PGs, and CD44, 
cells adhere to the ECM1. By varying the construct of the ECM different roles can be 
achieved for example a Perlecan based ECM plays a role in glomerular filtration in 
kidney glomerular29. Whereas association of PGs such as Decorin, Biglycan, Lumican 
with collagen fibres produces a ECM which is highly hydrated as well as mechanically 
stable, but collagen association with elastin in the ECM provides tissue with the ability 
to recoil. These matrices create an adaptive structure that can be remodelled by 
enzymes, physiological conditions or as part of a disease for example tumorigeneses 
which leads to the formation of fibrotic stroma from the ECM30. 
 
1.1.3.2. Inflammation and Wound Healing  
Upon damage in the body, the inflammatory system works to protect the body using a 
cascade of reactions to activate inflammatory or immune cells. Within the wound 
healing process, CS/DS and CSPG/DSPGs become hydrated to swell within the 
wound31 with more than 50% concentration of the GAG at the wound being DS, that 
activates growth factors (GF) resulting in early coagulation. Within the first two 
weeks, the upregulation of high molecular weight HA by fibroblasts seals the wound. 
The binding of HA to TNF-stimulated gene-6 (TSG-6) modulates inflammation by 
inhibiting neutrophil migration32 and uses a negative feedback loop to inhibit 
plasmin33. The binding of HA to CD44 leads to the build-up of leukocytes to sites of 
inflammation34. The other GAGs within the matrix, such as CS and DS, facilitate the 
polymerisation of collagen and the regulation of GF. HS has been shown to bind to 
GFs and control their release when necessary35, modulating the proangiogenic effects 
in the new tissue36. GAGs and other ECM components, such as fibrin, fibronectin and 
collagen, work together in tandem with cells to repair the injured tissue. HA and CS-
A play vital antioxidant roles to inhibit the Haber–Weiss reaction and Fenton reaction 
caused by oxidation stress37-38.  
 
1.1.3.3. Coagulation 
HS is a well-known anti-coagulator and is used as blood thinning supplements to treat 
a range of thrombotic disorders. HS binds primarily to antithrombin (AT) through a 
pentasaccharide (Figure 1.4). A dodecasaccharide, comprised of two pentamers linked 
by an IdoA and terminated at the non-reducing end by 4,5-unsaturated uronic acid, 
 Glycopolymers as Synthetic Analogues of Natural Glycosaminoglycans 
 8 
can also be used to bind to AT. In a HS chain, approximately 0.5-10% of the sequence 
has the corresponding AT pentasaccharide sequence39. 
 
Figure 1.4. Anticoagulation oligosaccharide binding sequences of (top) HS antithrombin binding pentasaccharide 
and (bottom) DS HCII binding hexasaccharide. 
DS has also been shown to inhibit coagulation by binding to heparin cofactor II (HCII) 
through a hexasaccharide (Figure 1.4), whilst only 5% of the DS sequence contains 
the pentasaccharide40. Though, compared to DS, HS binds with a 5 times higher 
affinity to HCII in comparison to DS. By binding to AT or HCII, thrombin and factor 
IXa and Xa are suppressed to prevent coagulation. These factors inhibit downstream 
coagulation cascade enzyme factors Xa and IXa inhibition (Figure 1.5) 
 
Figure 1.5. Activation pathways for anti-coagulation by HS and DS through AT and HCII binding. (*Activated). 
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1.1.3.4. Neuronal Growth 
GAGs are known to play a role in the neuronal pathway growth by directing the axon 
growth. Through neuronal promotion by interactions between the GAGs as well as 
laminin, an immunoglobin super family of cell adhesion. Whereas numerous numbers 
of glycoproteins, proteins and proteoglycans repel the growth of the axon. Through 
the use of both promoting and repelling molecules the axon through is guided towards 
the target41-42. From all the GAGS, CS and HS have been shown to be vital in axon 
growth, affecting the temporal and spatial distribution of the GAG around the growing 
axon. Downregulation and removal of CS during the development of axons leads to 
the uncontrolled growth of the axon into abnormal areas43. In a study by Schachner44, 
the downregulation of various CS factors was tested against the growth of motor 
axons. In this instance, the downregulation of CS-C caused no change in axon growth. 
However, the downregulation of CS-A and CS-B reduced/increased growth inferring 
that the sulfonation of CS is critical to axon growth. Additionally, mice lacking the 
HS 2-O-sulfotransferase (Hs2st) and HS 6-O-sulfotransferase 1 showed axon defects 
indicating that the sulfonation of HS is also important to the direction of the axon 
growth45. Whilst KS and DS have been shown to be involved in axon growth, the 
higher sulfonated GAGs have shown to be vital to control the growth of axons. 
GAGs have a large variety of biological roles that could be utilised to treat many 
diseases as well as be used as building blocks to develop new biomaterials. As 
described, there is a large amount of molecular machinery involved in the formation 
of the different GAGs. To form these GAGs through chemical synthesis would require 
protection and deprotection stages in order to form the even small GAG oligomers. 
Whilst automated synthesisers are commercially available to aid in the production of 
carbohydrates, they are unable to form carbohydrates with the efficiency seen in a 
peptide or a phosphonamidite synthesis, with a need still for the vast number of 
reactions to form the starting monosaccharides. 
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1.2. Glycosaminoglycan Mimics 
Glycopolymers provide a simpler alternative method to conventional carbohydrate 
synthesis. Glycopolymers are synthetic polymers containing carbohydrates. The 
synthesis of these is a growing sub-field of polymer chemistry, due to their potential 
biomedical applications, such as in neuronal regeneration and anticoagulation as well 
as to probe the binding affinity to carbohydrate-protein binding sites in lectins to 
trigger downstream effects. They bring together two key components: the sugar 
moieties, which are biologically active through the recognition by specific proteins, 
and a stable polymer backbone. The polymer backbone enables rapid polymerisation 
avoiding the formation of glycosidic bonds. Currently, polymers can be produced with 
high precision over polydispersity (Ð), the degree of polymerisation46-47 (DP) and 
sequence48-53 through controlled radical polymerisation methods, such as reversible 
addition fragmentation chain transfer (RAFT)54, atom-transfer radical-polymerisation 
(ATRP)55 and single-electron transfer living radical polymerisation (SET-LRP)56. The 
synthesis of glycopolymers has utilised click chemistry57 as regioselective and 
chemoselective reactions to link the saccharide unit to either a monomer, for pre-
polymerisation modification, or orthogonally in post-polymerisation58. With a large 
array of polymerisation methods, monomers and chemoselective reactions available, 
more complex glycopolymers are being designed and synthesised59-60. This ability to 
produce complex glycopolymers has made it possible to produce glycopolymers based 
on the more challenging structures of the GAGs. 
 
1.2.1. Chondroitin Sulfate Mimics 
A glycopolymer based on the CS-E repeating unit was produced by the Hsieh-Wilson 
group in 200861. After protection of the hydroxyls, the CS dimer was coupled to a 
cyclooctene monomer. After selective sulfonation of the 4’ and 6’ hydroxyls on the 
galactosamine ring, the monomer was polymerised via ring-opening metathesis 
polymerisation (ROMP) (Scheme 1.2). The group also showed the extension from the 
dimer to tetramer, which was also polymerised by ROMP. By tuning the mol% of the 
3rd generation Grubbs catalyst, the polymer could be grown to large molecular weights 
of 119,000 Da with a narrow Ð of 1.33. The model of ROMP can be applied to other 
CS-based monomers. As CS is involved the control of axon growth, these CS-based 
glycopolymers also showed increased control over axon growth with increasing DP. 
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In a follow-up study, the Hsieh-Wilson group produced the norbornene equivalent of 
the cyclooctene62.  
The use of norbornene increases ring rigidity after the polymerisation of the double 
bond, whereas cyclooctene produces degrees of freedom within the bonds after 
polymerisation, aiming to control the orientation of the glycopolymer. By this 
constrained system, CS glycopolymers were obtained with a Ð range of 1.17 - 1.05 
and molecular weights of 280,000 Da, approaching the molecular weights of CS in 
nature. The addition of biotin allowed the binding of the polymer chains on a 
streptavidin-coated plate. The CS-E disaccharide used was bound to CS-E selective 
fluorescently labelled antibody, with CS-C fluorescently labelled antibody showing 
no binding. The group also tested glial cell-derived neurotrophic factor (GDNF), 
which also showed selectivity for the areas upon the plates with the glycopolymer 
bound. The assays highlighted the importance of sulfonation since the non-sulfonated 
variant of the glycopolymer showed no binding towards any of the antibodies or 
proteins. These two examples from the Hsieh-Wilson group provided a synthetic route 
to a CS-E mimic as well as a pathway to form other CS mimics. 
 
Scheme 1.2 CS glycopolymer formed by ROMP from (a) cyclooctene showing control over neurite outgrowth 
when increasing the degree of polymerisation and the length of the oligosaccharide. (b) Norbornene-based CS 
glycopolymer with biotin label attached for surface immobilization and measurement of the fluorescent output of 
labelled antibodies. Reagents and conditions: (i) 1:5 MeOH: ClCH2CH2Cl, 55 OC, 24h, Ru-Grubbs Catalyst, 1.0 
% (mol %). Scheme adapted from ref. 61-62.  
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An alternative route devised by the Song-Gill group63 used a peptide as the backbone, 
rather than an alkyne derivative. By using a proline or lysine bearing an azide group, 
the disaccharides alkynes synthesied could be “clicked” onto the peptide backbone. 
By changing the amino acid residues, the work were able to control the secondary 
structure to play with backbone flexibility plus the placement and number of sugars 
along the helix (Figure 1.6). This was determined by surface plasmon resonance (SPR) 
to study the change in response in the system dependent on the secondary structure. 
The use of a peptide compared to a polymer monomer gives control over the 
localisation of saccharides, an advantage over the ROMP method to produce 
homopolymers and statistical polymers. The stepwise addition of a peptide-based 
synthesis leads to control of the sequence to make specific variations of the CS mimic. 
Nerve growth factor (NGF) is an important GF involved in neuron growth; using the 
various glycopeptides, the binding to NGF was studied63. The CS-peptide mimics 
showed increased NGF binding as a result of the secondary structure, with the linear 
CS peptide showing a stronger KD than that of the alpha helix peptide (KD = 0.146 
mM and KD = 3.57 mM, respectively). 
 
Figure 1.6. Polypeptide-based CS glycopolymer using azide proline (1) and (2) lysine with the ability to change 
the density of the glycopolymer leading to change in response seen in the SPR binding to NGF. Figure adapted 
from ref63. 
A recent example of CS glycopolymers was published by the Rojo group who reported 
a disaccharide based on CS-E as a glycodendrimer rather than a linear glycopolymer64. 
The glycodendrimers were used to explore the interaction with the growth factor 
midkine involved in neural growth processes. Increasing the disaccharide valency, 
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from 1 to 3, 4 6 units of the disaccharides of CS-E, showed a decreasing half maximal 
inhibitory concentration (IC50) with increasing valency seen between 4 and 6 (Figure 
1.7).  
 
Figure 1.7. Glycodendrimers of CS (1-3) compared to dimer (19) to study the inhibition of midkine by flow 
cytometry. Figure adapted from ref. 64 
Due to the increase in flexibility of the alkyl core, compared with a benzene core 
arrangement imposed by this dendritic core, an increase in IC50 between 1 and 2 μM 
was observed, showing a higher relative inhibitory potency (RIP) of 26 compared with 
5. However, when increasing the number of disaccharide units in the case of 3, the 
RIP increases to 42 showing that, for midkine, the arrangement of the disaccharides is 
important to binding as well as the multivalent effect increasing potency.  
 
1.2.2. Heparin/Heparan Sulfate Mimics 
Early examples of heparin mimics looked at simplifying the structure of the saccharide 
to a simple sulfonated compound such as polystyrene sulfonate and polyvinyl 
sulfonate65. However, these examples resulted in delayed clot formation and reduced 
complement activation. In recent years, the field has moved towards glycopolymers, 
rather than simple sulfonate compounds.  
An early example of a glycopolymer inspired by HS came in 2004 from the Chaikof 
group66. Using fully sulfonated GlcNAc and lactose bound to an acrylate, cyanoxyl-
mediated free-radical copolymerisation with acrylamide was undertaken. It was an 
early example of an acrylamide polymerisation based on GAGs. The polymerisation 
showed good control over Ð (1.13 - 1.49), which increased to 1.57 as the polymer 
molecular weight increased above 100 kDa. The lactose-based polymer showed a 
larger range of Ð (1.16 – 1.67), but this can be attributed to the greater weight average 
molecular weight (Mw) of lactose causing a greater difference between chains. It was 
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an early example of an HS mimic due to the ability to bind to fibroblast growth factor 
(FGF), protect FGF from tyrosine digestion and its coagulation properties. 
The Grainger group67 applied a sulfonated mannose onto a glass surface. By binding 
an initiator group onto the surface; ATRP could be undertaken (Scheme 1.3A). Using 
a mannose-based glycomonomer as the feedstock glycopolymer, brushes could be 
grown from the surface. After deprotection of the acetyl groups, the hydroxyls were 
sulfonated using 0.2 M SO3.py solution in anhydrous pyridine, as confirmed by X-ray 
photoelectron spectroscopy (XPS) and elemental analysis67. The anticoagulation 
showed that post sulfonation increased the clotting time, but these times were affected 
by the difference in the surface energies. 
The same principle of glycopolymer formation followed by sulfonation was also used 
to form a glycomonomer of mannose, glucose, glucosamine and lactose bearing two 
secondary amines, which reacted with a diisocyanate to form a step-growth polymer68. 
Again, the decision for a sulfonation pre-polymerisation led to uncontrolled 
sulfonation. The sulfonation was confirmed by Fourier transform infrared (FT-IR) for 
the S=O peaks at 1220, 999 and 931 cm−1, with experimental analysis producing an 
average sulfonation of 3.68 – 6.88 of the hydroxides per glycomonomer/disaccharide 
units. These polymers were tested for their thrombin time (TT), reptilase time, 
prothrombin time (PT), and activated partial thromboplastin time (aPTT). Each case 
showed delays in coagulation time, whilst the non-sulfonated precursors showing no 
effect on the coagulation time. The best results were obtained for the mannose and 
lactose derivatives. 
A follow-up study by N. Ayres69 used the lactose based polymer with different 
diisocyanates units in the polymer backbone, causing an increase in the coagulation 
time. From here, the second generation of step-growth polymers was produced using 
linkers such as toluene 2,4-diisocyanate (TDI), isophorone diisocyanate (IPDI) and 
methylene bis (4-cyclohexyl isocyanate) (HMDI). Greater activity was observed from 
the second generation, due to the semi-flexibility of the polymer. It was also shown 
that the degree of sulfonation linearly affects the anticoagulation time. With a strong 
correlation on the degree of sulfonation to the coagulation time, then perhaps a 
controllable method of sulfonation is more suitable (Scheme 1.3B). 
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Scheme 1.3. Synthesis of heparin mimics by (a) ATRP of glycomonomer on a glass surface or by (b) step growth 
polymerisation using diamine glycomonomer-diisocyanates chemistry to form a polyurea backbone. Scheme 
adapted from ref.67-68. 
Building on the work undertaken with CS, the Hsieh-Wilson group formed heparin 
glycopolymers70-71 on the same principle of ROMP to polymerise the dimer. The 
complex protection of the disaccharide allowed the final sulfonation to be controlled 
compared to previous examples of sulfonation of HS mimics (Scheme 1.4). By 
selective deprotection of the hydroxyl, specific locations on the disaccharide could be 
sulfonated. From here, different sulfonated glycopolymers could be produced and 
tested to probe the effects of the sulfonation.  
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Scheme 1.4. Sulfonation pathway for heparin disaccharide71. Reagents and conditions: (a) 1,3-propanedithiol, 
DIPEA, MeOH, 87%; (b) K2CO3, MeOH (c) H2NNH2·H2O, AcOH, Py (d) SO3·Py, Et3N, Py, 55 °C (e) Ac2O, 
Et3N, MeOH (f) (H2IMes)(Py)2(Cl)2Ru=CHPh, DCE, MeOH (g) (i) TMSOK, TBAI, THF (ii) Pd(OH)2/charcoal, 
H2 (1 atm), phosphate buffer (pH 7.4), MeOH 
This concept of controlled sulfonation of the HS mimic was taken further in the 
formation of a heparanase inhibitor. Heparanase cleaves GlcAβ(1,4)GlcNS bonds but 
also has a recognition site for the disaccharide GlcNS(6s)α(1,4)GlcA adjacent to the 
cleavage site. By producing a glycopolymer that contained this disaccharide moiety 
without the critical GlcAβ(1,4)GlcNS bond, a glycopolymer could be used as an 
inhibitor. The Nguyen group72-73 took the tunability of the synthesis further by 
simplifying this synthesis pathway by incorporating click chemistry into the formation 
of the glycomonomers. In doing this, the system can be easily modified as the click 
reactions can tolerate the other functional groups as they are chemo and regioselective. 
In the example from the Nguyen group, the use of the copper azide-alkyne 
cycloaddition (CuAAc) was employed to create two glycomonomers based on a single 
carbohydrate synthesis. In general, the carbohydrate synthesis is the most labour-
intensive aspect of the formation of a glycomonomer. By creating one azide bearing 
disaccharide, multiple glycomonomers could be produced (Scheme 1.5). In these 
studies, the addition of a biantennary compound was shown to be more effective than 
a monoantennary for a glycomonomer. The polymerisation of the biantennary by 
ROMP showed an increase in DP and lead to a lower IC50 value.  
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Scheme 1.5. Neoglycopolymers of HS as (a) monoantennary, (b) biantennary and (c) disaccharide monomer 
bottlebrush formed by CuAAC from a single azide. Reagents and conditions: (i) CuI, DBU, DMF, 50 °C (ii) PPh3. 
An alternative approach was reported by the Stupp group74 to form an HS mimic. This 
was achieved by designing peptide amphiphiles (PA) with sulfonated sugars at the N-
terminus of the peptide by CuAAC. These PAs were designed to self-assemble into 
nanofibers displaying HS sugars on their surface (Figure 1.8). Growth factors were 
then utilised to compare the binding of HS and the glycopeptide nanofiber as well as 
looking at GF signalling. This approach showed an alternative to the formation of long 
peptides by allowing the peptides to self-assemble into nanofibers and presenting 
multiple copies of HS sugars rather than producing vast oligomers. 
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Figure 1.8. Cryo-TEM image (left) of nanofibers from the glycopeptide (HS-PA) with a structural representation 
of the PA; the binding comparison study (right) of HS and HS-PA with the GFs (HS-binding proteins). 
Over the past 20 years, the synthesis of HS mimics has shifted from using sulfonated 
groups to using the more native sulfonated monosaccharides with improved results. 
With growing control over the sulfonation of the saccharides, further enhancing the 
properties of these mimics, a next generation of fully mimicking HS glycopolymers is 
expected in the near future. 
 
1.2.3. Dermatan Sulfate & Keratan Sulfate 
Within the scope of glycopolymers, little has been undertaken with the remaining 
sulfonated GAGs of KS and DS. DS has yet to be produced using a glycopolymer, but 
DS and HS are epimers. In contrast, carbohydrate chemistry has already produced 
synthetic pathways for the formation of DS75-76 and KS77-78 oligomers. The non-
sulfonated repeat of KS, N-acetyllactosamine, has been developed as a 
glycopolymer79-80 as well as fully sulfonated analogues81. The fully sulfonated 
glycopolymer showed anticoagulant properties whilst adding a sialic acid unit to N-
acetyllactosamine creates inhibitors against influenza viruses. However, the selective 
single sulfonation of the 6’-GlcNAc of N-acetyllactosamine has yet not been 
produced. 
 
1.2.4. Hyaluronic Acid 
HA is produced as a mega Dalton polymer, which current glycopolymers cannot 
match. Although glycopolymers cannot match natural HA’s size, it has been shown 
that HA’s main receptor CD44 requires a minimum of 8 units of monosaccharide for 
binding82. The Chaikof group produced an HA dimer83 which bore an alkene onto 
which a norbornene could be attached84. Using ROMP as described by the Kessling 
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group85, the HA dimer could be polymerised to give a 9 kDa Mw polymer with a Ð of 
1.17 (Scheme 1.6). Rather than forming glycopolymers of HA, in recent years the 
work has moved towards the production of glycoclusters. Using the same disaccharide 
monomer as used by Chaikof, in tandem with olefin metathesis83, Schiff-base86-87 and 
click chemistry88-90 a variety of glycoclusters with increasing number of disaccharide 
units upon them have been produced.  
The HA-disaccharide has been incorporated into a glycopeptide by the Lönnberg 
group91 through the formation of an aldehyde from the alkene. Binding this aldehyde 
to a phosphonamidite building block by Schiff base chemistry produces a molecule 
which can be incorporated into the peptide, to add different numbers of these HA 
phosphonamidites. The study showed the glycoclusters are affected by the length 
rather than the density of HA disaccharides.  
 
Scheme 1.6. Synthesis of HA-based glycopolymer and glycoclusters from HA-disaccharide. Reagents and 
conditions: (a) MeOH, 25 °C, 3 h, then add NaCNBH3, 25 °C, 15 h (b) NaCNBH4, MeOH (c) DTAB (1 eq.), 
Grubbs Catalyst (5 mol%), (CH2)2Cl2, H2O, 60 °C, 5 h. 
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An increase in the number of HA dimers on the sequence showed no effect on the up-
take by HCE cells as observed by flow cytometry. This led to further studies to use 
longer tetrasaccharides of HA rather than dimers88, 90. A final example of the formation 
of an HA glycomonomer was shown by the Codée group, who produced oligomers of 
HA in both solutions and upon solid support92. The solution phase example included 
the formation of a trimer, pentamer and heptamer bearing an azide at the reducing end 
of the carbohydrate. The azide was used to “click” these oligomers onto the polymer 
or to a polymerisable group, similarly seen by the Nguyen group (Scheme 1.5), 
whereas the solid support synthesis used a designed Grubbs 2nd catalyst on a cleavable 
support (Scheme 1.7).  
 
Scheme 1.7. Formation of HA oligomer on Grubbs catalyst cleavable resin. Reagents and conditions: Grubbs 
second-generation catalyst, trichloroacetamide, DCM, 3 h (d) i. HF/Et3N, THF, 30 min; ii. 0.5 M KOH, THF, 4 
days; iii. Ac2O, THF/H2O. 
From this review on GAG-based glycopolymers, there is potential to form complex 
synthetic GAGs with control over the sulfonation. This control has been led to various 
applications being explored, such as neural growth, coagulation and enzyme 
inhibitors. Since CS and HS have a wider variety of applications, compared to DS and 
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GAGs, a correlation between the degree of sulfonation and properties is evident like 
for example anti-coagulation properties. With both KS and DS only containing one 
sulfonate, they present a synthetic challenge to ensure mono-sulfonation of the 
disaccharide. Although non-sulfonated, HA owns specific biological and physical 
properties. However, having the largest molecular weight of all the GAGs, work has 
been focused more on the synthesis of glycoclusters of HA or as end group 
modification of polymers to add biocompatibility. The formation of an HA 
glycopolymers has been restricted to the ROMP as described by Chaikof84. However, 
several of the examples reported previously could easily be modified to form 
glycopolymers based on HA.  
From the literature, the examples for CS and HS glycopolymers offer good candidates 
for biomimetic materials of the natural GAGs, which can be used as a platform to build 
new biomaterials. In several of these cases, the formation of a disaccharide, followed 
by the polymerisation of that disaccharide has produced comparable properties to 
those of natural GAGs without the requirement for extensive chemical synthesis. To 
date, there are examples from the literature62, 71-72 showing glycopolymers that can be 
tunable and rival the properties of natural GAGs as therapeutics.  
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1.3. Aims and Objectives 
From all the GAGs, this work is focused on HA, the structurally simplest and non-
sulfonated GAG. Although not forming covalent linkages with proteins, HA is yet 
involved in a plethora of biological processes. Whilst few examples of HA-based 
glycopolymers and glycoclusters have been described in this section, many of them 
have not shown their biological activity with groups stating “the biological evaluation 
of these compounds is ongoing”83-84, 86-87. By contrast, the biological activity of CS 
(Scheme 1.2) and HS (Scheme 1.5) glycopolymers has been shown. This could be due 
to the fact that HA biological activity is more challenging to be assessed. In our 
studies, we aim to look into this gap in knowledge by using novel approaches to 
synthesise HA glycopolymers. 
The previous examples of GAG-based glycopolymers have used the disaccharide 
pendants from the polymer backbone. The formation of a glycosidic bond requires 
multiple steps in order to achieve this producing an inefficient synthesis for the 
formation of glycopolymers. Compared with previous examples, the design approach 
used in this work is based on HA glycopolymers whereby the saccharides alternate 
across the polymer backbone through individual saccharides on individual monomers. 
We attempted both pre- and post-polymerisation modification to achieve the desired 
glycopolymers. Through click chemistry, various monosaccharides functionalised 
with a click moiety can be synthesised to produce multiple glycopolymers from a 
single parent polymer. This approach will provide a simple method to produce 
multiple glycopolymers from a single synthesis pathway. In order to achieve 
monosaccharide alternation across the polymer chain, we exploited alternating 
polymers in order to mimic the sugar pattern in HA (Scheme 1.8). By having 
monosaccharides rather than a disaccharide on display from the polymer, both 
saccharides will be involved in the binding, instead of the beta-saccharide on the 
disaccharide from the polymer. 
Since HA only forms non-covalent interactions with peptides and proteins we studied 
the binding sequences of these HA binders for their self-assembly with HA. By adding 
structural cues to the peptides, the secondary structures and self-assembly can be 
controlled to design higher ordered structures such as micelles and fibres. 
 Glycopolymers as Synthetic Analogues of Natural Glycosaminoglycans 
 23 
 
Scheme 1.8. The previous design concept for HA (left) with pendant disaccharide84 and (right) our design concept 
using an alternating polymer with HA monosaccharides. 
In summary, the aims of this thesis are: 
• Synthesise HA-based glycopolymers using alternating polymers 
• Compare the properties of the synthetic analogues with natural HA  
• Use HA-binding peptides and HA glycopolymers to investigate their binding 
and better understand the interactions of HA with its binding partners 
• Utilise the glycopolymers to investigate binding to several lectins to determine 
potential monosaccharide ligand binders leading to a better understanding of 
these receptors 
• Explore HA-binding peptides for binding and self-assembly with HA to create 
new biomaterials for potential applications such as wound healing, drug 
delivery or scaffold for cellular growth.  
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1.4. Carbohydrate Chemistry 
Polysaccharides are synthetically challenging to form in comparison to other 
biological molecules such as peptides or proteins. Whilst peptide synthesis pathways 
allow the formation of well-defined peptide structures, carbohydrates are much more 
complex. For a peptide, the formation of an amide bond requires the reaction between 
an amine and carboxylic acid, whilst the alternate carboxylic acid and amine are 
protected. In contrast, a saccharide is divided into two ends, the reducing and the non-
reducing end (Figure 1.9). The non-reducing end consists of 4 positions around the 
saccharide of the 2’, 3’, 4’ and 6’ hydroxyls, whilst the reducing end is the 1’ hydroxyl, 
also referred to as the anomeric centre. 
 
Figure 1.9. Example of a monosaccharide (glucose) highlighting the two ends of the saccharide with the reducing 
hydroxyl (purple) and the 4 non-reducing hydroxyls (red) along with highlighting the hemi-acetal group of the 
pyranose ring. 
The anomeric centre of the saccharide has the ability to ring open and ring close due 
to its proximity to the oxygen within the ring. With the ring-opened structure, the sugar 
exists as a reactive aldehyde, which in the presence of an acid catalyst can be attacked 
at C1 with the release of water. In this ring-opened form, the aldehyde is susceptible 
to nucleophilic attack by hydroxides, with an acid catalyst, as well as amines. This 
ring-opened form is short lived as the structure is more stable as a closed ring. The 5’ 
hydroxide is able to reclose the ring to form back the pyranose ring. However, attack 
by the 4’ hydroxide can lead to the furanose form. Whilst the furanose ring is stable, 
the pyranose is more favourable due to strain in a 5-membered ring. For this reason, 
many saccharides appear as the 6-membered ring rather than the 5-membered ring. 
 
Scheme 1.9. A schematic depicting the ring-opening and closing of saccharides (glucose in this example) between 
the pyranose 6-membered ring form and the furanose 5-membered ring form. 
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1.4.1. Anomeric Effect 
In the ring open form, the aldehyde has the freedom to move and therefore can invert 
between an axial (α) or equatorial (β) position. Due to the freedom of rotation, many 
reactions at the anomeric centre produce an anomeric mixture of saccharides.  
There are three competing factors within the anomeric effect, those are sterics, dipole 
induction and orbital overlap (Scheme 1.10). 
Sterics within the saccharide ring is caused by the axial position. These hydrogens are 
held in close proximity causing a steric repulsion. This is not seen between the 
equatorial positions due to the space around the functional groups. These steric effects 
are increased if large bulkier groups, such as hydroxide, point down axially. From a 
steric stand-point, the lower energy conformation is achieved if the bulkier group at 
the anomeric centre is in equatorial positions.  
 
Scheme 1.10. Anomeric effect 3 factors: 1,3,5 sterics (A), dipole moments (B) and orbital overlap (C). 
In comparison, the dipole induction of the monosaccharide between the ring oxygen 
and the 1’ hydroxide is more stable in an axial position. By placing the hydroxide in 
an axial position, the dipoles oppose one-another making the entire molecule dipole 
neutral. This effect is enhanced with more electronegative substituents, such as the 
introduction of a chloride at the C1 position. The chloride will exist 96:4 ratio 
favouring the axial position, despite having a large ionic radius93. The dipole of a 
molecule can be affected by the solvent. Having an increased dipole in the solvent 
leads to a reduction in anomeric specificity as the solvent negates the dipole within 
the monosaccharide94. 
Axial position is also favourable due to the orbital of C-O* and lone pair on the ring 
oxygen. When in the axial position, these align and therefore make it easier for the 
formation of a resonance structure in which the OR group has been removed from the 
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saccharide to form a C=O within the ring. This is one of the most widely accepted 
scenarios for the anomeric effect as the leaving group or nucleophile can now attach 
from either face of the sp2 centre. When forming a disaccharide, this anomeric effect 
has to be taken in account in order to form correct linkages. The orientations of these 
linkages can be critical to the function of the oligosaccharide. 
 
1.4.2. Glycosidic Bond Formation 
The glycosidic bond is the hemiacetal linkage between the reducing end and non-
reducing end of two monosaccharides. The complexity of forming a glycosidic bond 
is caused by the ability of those four hydroxyls at the non-reducing end to form a bond 
with the reducing end. If left uncontrolled, dendrimer type structures would form. In 
nature, enzymes control the introduction of a monosaccharide to the growing 
polysaccharide leading to regioselectivity of the glycosidic bond, whilst in chemical 
synthesis, selective protection and deprotection reactions are required in order to 
prepare the donor and receptor monosaccharide to form the desired glycosidic bond. 
An additional consideration for the formation of the glycosidic bond is the low 
reactivity of the non-reducing hydroxyl towards the anomeric hydroxyl. To this end, 
monosaccharides used in biosynthesis are tagged with a UDP in order to activate the 
anomeric position towards substitution. Carbohydrate chemists instead use leaving 
groups to allow the hydroxide of the incoming monosaccharide to bond. The formation 
of one glycosidic bond requires a large number of synthetic steps and this 
methodology can be used to form simple linear carbohydrate structures such as 
amylose (⍺ 1-4 linked glucose) or cellulose (β 1-4 linked glucose). However, to form 
more complex polysaccharides with ⍺ or β anomers, different linkages and branching, 
conventional carbohydrate synthesis lags behind the enzyme pathways employed by 
nature. Despite potential automation using phosphonamidite or amide condensation, 
there is still a vast amount of preparation steps before a machine is able to couple the 
monosaccharides. 
Utilising the reducing end, functionality can be grafted to the saccharide. This 
functional handle allows the monosaccharide to be attached onto a polymer backbone 
or a monomer, that can later be polymerised. This represents two of the three methods 
by which a glycopolymer can be formed. The three approaches are: the formation of 
a glycomonomer, grafting the saccharide onto a polymer and the simultaneous grafting 
and polymerisation.  
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1.5. Polymerisation  
As described previously, several polymerisation methods can be used to produce 
glycopolymers, including free radical polymerisation (FRP), RAFT and ROMP.  
 
1.5.1. Ring-Opening Polymerisation 
Ring-opening polymerisation (ROP) is an ionic polymerisation and utilises a cyclic 
molecule which has either an alkene or a breakable bond, such as lactones, cyclic 
carbonate derivatives or a ring strained epoxide. ROP allows very specific polymers 
to be formed in terms of the backbone length and composition forming biodegradable 
backbones using renewable sources. 
 
1.5.1.1. Cationic/Anionic Ring-opening Polymerisation 
Cationic Ring-opening Polymerisation (CROP) and Anionic Ring-opening 
Polymerisation (AROP) utilise charged molecules as initiators. The charge is passed 
onto the propagating group, with the reaction being terminated by hydroxyl-containing 
compounds. Schubert introduced an oxazolone based glycomonomer95 which was 
used in CROP to produce the glycopolymer, with careful consideration of maintaining 
the temperature (Temp) below 100 ℃ to ensure the saccharides did not decompose. 
In a second example from the Hendrick group, cyclic carbonates with attached sugar 
moieties were formed. These polymers have the bonus of being biodegradable due to 
heteroatoms present within the polymer chains. The downside, in terms of 
glycopolymer formation, is that, due to the termination by hydroxyl-containing 
compounds, the saccharide OH groups require protection. 
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1.5.1.2. Ring-opening Metathesis Polymerisation 
By comparison, ROMP is a much more functional group tolerable. ROMP uses olefin 
derivatives along with a metal catalyst, such as Ruthenium (Ru) formed by Grubbs, 
with the polymerisation occurring through the metathesis of the double bond. The 
polymer grows out from the metal centre and is terminated by the addition of ethyl 
vinyl ether, which reacts with the metal-carbene species to remove the metal from the 
polymer. 
 
Scheme 1.12. Reaction pathway for the ROMP of an olefin. 
The reaction proceeds by strained olefins driven by the release of ring strain. However, 
they are reversible reactions, requiring optimisation. Due to the tolerance of these 
reactions, several examples exist for glycopolymers72-73, 84, 92, 96-97 as they do not 
require the protection of the hydroxyls, or in the case of the GAG mimics the 
protection of the SO3-, as shown by examples from the Kiessling group85, 98. 
 
1.5.2. Radical Polymerisation 
Free radical polymerisations are one of the most common types of polymerisation, 
with publications dating back to 1930’s99 showing early work with vinyl compounds 
such as, but not limited to, styrene. “Free” radical polymerisation was the first example 
of a radical method, with the “free” denoting the uncontrolled nature of this reaction. 
The uncontrolled nature makes this technique very rapid but leads to undesirable side 
reactions, including branching, disproportionation and a large distribution of 
molecular weights contributing to a large Ð. Despite being an uncontrolled method, it 
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polystyrene with relative ease. The process of free radical polymerisation is broken 
down into 3 stages: initiation, propagation (Figure 1.10) and termination (Figure 1.11). 
  
Figure 1.10. Radical mechanism for the initiation and propagation of generic polymer initiated with AIBN. 
The initial process of initiation produces the free radical, which can be used in the 
polymerisation. This radical can be produced in many different types of reactions, 
such as thermal decomposition of compounds like peroxides or azo-based compounds 
photolysis using compounds such as azo compounds, metal alkyls and metal iodides; 
and redox reactions using a metal to reduce H2O2 to HO- and HO radical. In these 
types of reactions, alkene compounds are used as the radical produced will attack the 
terminus end of the alkene. Homolytic cleavage of the alkene produces a new bond 
and transfers the radical onto the monomer producing the propagation species. The 
polymerisation will move into the propagation phase of the polymerisation, where the 
propagating chains will continue to add monomers until either the monomer feedstock 
is consumed, or the reaction is terminated. 
The termination of free radical polymerisation can occur by 2 major pathways (Figure 
1.11). As the feedstock of monomer decreases, the probability of two polymer chains 
to combine from a single chain increases and this process is known as recombination. 
Alternatively, disportionation can occur. This is where a hydrogen is abstracted from 
an opposing polymer causing the polymer to terminate with a hydrogen, whilst the 
opposing polymer forms an alkene from the termination of the radical electron and 
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Figure 1.11. Major termination pathways of recombination (top) and disportionation (bottom). 
Alternative termination pathways are available, including initiator terminated 
polymer. By adding additional initiator to the polymerisation towards the end of the 
polymerisation, recombination between the living chain and the initiator occurs to cap 
both ends of the polymer with the initiator. Termination of the polymer can also be 
achieved by exposing the polymerisation to air or a hydrogen source. The oxygen in 
the air forms a peroxide at the omega terminus of the polymer, which is more stable 
to radical species, therefore, slowing the rate of propagation. Whilst in the presence of 
a hydrogen source in the living polymerisation causes the polymers to be terminated 
with a hydrogen. 
The free radical polymerisation is a very fast and efficient method to produce a 
polymer, but it still remains uncontrollable, leading to a large variety of polymer 
Number Average Molecular Weigh (Mn) being produced and thus a large Ð. Because 
of this, controlled polymerisation techniques have been developed in order to control 
the growth of these polymers and reduce the Ð of these systems to obtain polymers 
with a Ð closer to 1.0. 
 
1.5.3. Controlled Radical Polymerisation 
1.5.3.1. Reversible Addition-Fragmentation Chain Transfer 
Reversible Addition-Fragmentation Chain Transfer or RAFT was pioneered by 
Graeme Moad and Ezio Rizzardo showed a method in which the growth rate of 
polymers could be controlled to reduce the Ð (Figure 1.12) 100. The free radical process 
has no control over the propagation of the free radical after initiation. This leads to a 
normal distribution of molecular weights of the polymers over a prolonged reaction 
time. RAFT polymerisation is a controlled radical polymerisation (CRP), which 
utilises compounds, such as trithiocarbonates, dithiocarbamates and dithiobenzoates, 
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Figure 1.12. Free radical polymerisation (grey) compared to RAFT polymerisation (blue) of vinylbenzyl chloride. 
Slowing the rate of propagation is achieved by trapping the radical and releasing 
another chain to propagate. This reversible addition to and from the chain transfer 
agent (CTA) ensures the polymerisation is being controlled by limiting the number of 
active free radical species available.  
The broad range of RAFT groups now available allows the propagation rate to be 
tailored to suit the needs of the polymer, as well as the conditions in which the RAFT 
is to be used (e.g. aqueous or organic solvent systems). The RAFT group has 3 major 
components shown as A, X and Z in Figure 1.13.  
 
Figure 1.13. RAFT mechanism showing the association of one living radical chain R and leading to the reversible 
release of another living radical chain R’.  
The C=X bond, where A and X are either O or S, should be reactive towards the 
propagating species so that R. and X form a homolytic bond leading to the formation 
of the intermediate, where the stability of the intermediate is governed by Z. The Z 
groups found on the RAFT agent stabilise the radicals and can be tuned by addition to 
specific radicals. This modifies the fragmentation rates, so the association and 
dissociation of either polymer chain are in steady state. 
If Z is too electron withdrawing, this leads to stable intermediate species causing the 
polymerisation to terminate at the adduct (rate association >> rate dissociation). 
Conversely, if the Z is too electron donating, then the reaction will proceed free 
radically as the polymers will bind but, will almost instantaneously dissociate (rate 
association<< rate dissociation). The third component of the RAFT agent, A-R,’ has 
to be weak enough so that it breaks to release R’. Initially, R’ becomes the initiating 
species, but as the reaction proceeds, this becomes the propagating polymer species. 
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The reversibility of the RAFT group allows the number of propagating species to be 
limited. When the reaction has been terminated, the polymer will be found with the 
RAFT agent and the omega end of the polymer. Table 1.3 is taken from Sigma 
Aldrich101, shows the various ranges of RAFT agents commercially available and their 
ability to regulate the polymerisations. 
Table 1.3. RAFT agents performance against common classes of monomers101. 
RAFT Agent St A Am MA MAm VE VA 
 
- - - - - +++ +++ 
 
+++ +++ +++ - - - - 
 
++ + - +++ +++ - - 
 
++ + + +++ +++ - - 
 
+++ ++ ++ +++ +++ - - 
 
+++ ++ ++ +++ +++ - - 
 
+++ +++ +++ + + - - 
St = Styrene’s, A = Acrylates, Am = Acrylamides, MA = Methacrylate, MAm = Methacrylamides, VE = Vinyl 
ester, VA = Vinyl amides  
Whilst there are several commercially available RAFT groups, these are compounds 
containing trithiocarbonates, due to the wide range of monomers which can be 
polymerised (Scheme 1.13) using this class of RAFT agent. Trithiocarbonates can be 
formed with relative ease from thiol-containing reagents to produce a vast range of 
RAFT agents and tailored towards the polymerisation required. This approach requires 
controls of the Z group, as well as the initiating group (I) released by the RAFT group 
upon the first cycle of its use to ensure the alpha end of all the propagating polymer 
chain possess the same structure. 
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RAFT polymerisation is a popular method due to its ability to tolerate several 
functional groups including halides. RAFT can also be cleaved off, modified or used 
as a macroinitiator to extend the chain to the desired length or to include secondary 
blocks to add functionality to the polymer. 
 
1.5.3.2. Atom-transfer radical-polymerization 
Discovered in 1995, ATRP is another CRP technique which works on the principle of 
reversible-deactivation of the radical polymerisation. The principle of ATRP is the 
rate between the formation of the active and deactivated species. Metals such as 
copper, rhenium and iron are used as a catalyst together with a complexing ligand. 
An ATRP polymerisation (Scheme 1.14) is initiated without the requirement of a 
radical initiator, such as an azido compound, which would break down under ultra-
violet (UV) or thermal decomposition, but instead utilises a halide source with a weak 
C-X bond. This halide source allows the metal catalyst to extract the halide to initiate 
the reaction. The rate of initiation is dependent on the halide source, the degree of 
substitution and the radical stabilising group (Figure 1.14).  
 
Figure 1.14. Initiation rates of ATRP effected by the R group, the substitution and the halide. 
The extraction of the halide by the metal can occur as the metal complex is able to 
expand its coordination’s to allow the Mt-X bond to form, causing a reduction in the 
metal’s oxidation state. The now activated species is able to facilitate polymerisation. 
The polymerisation is controlled by the living polymers ability to extract the halide 
back from the metal to form the deactivated species. The reaction rate is heavily 
towards the deactivated species. As the monomer is consumed, the Ð improves as the 
rate of Kdeact becomes larger. However, with it comes an increased probability of 
chain-chain termination by the combination of two living species, causing high 
molecular weight shoulders to appear 
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Scheme 1.14. Schematic for the polymerisation of a monomer (M) under ATRP control initiated by a halide source 
([I]-X) using a metal-ligand complex (Mtn/L) to produce a halide terminated polymer (Pn-X) or to form a 
biopolymer terminated species (Pn-Pn). 
This ability to switch between the activated and deactivated species controls the 
number of polymerising chains at any given time. This, like the RAFT agent, allows 
the reaction to produce narrow Ð’s, with the rate of reaction rate of atom transfer 
radical polymerisation (kATRP) determined by Equation 1.1. 𝑘3456 = 𝑘89: 𝑘;<89:=  Equation 1.1 
. 
The use of halide sources as initiators for ATRP reactions opens up a large potential 
for end modification of the chains through the substitution of the halide with groups 
such as azides and amides, to allow for potential orthogonal reactions such as click 
reactions to form longer more complex chains. With the halide terminating the 
polymer, the polymer also becomes a macroinitiator, which with a fresh feedstock of 
monomer and catalyst can be chain extended to increase the molecular weight or to 
add different blocks of monomer to form block copolymers. 
 
1.5.3.3. Nitroxide-mediated polymerization 
Nitroxide-mediated polymerisation (NMP), like ATRP, is based on the dynamic 
equilibrium between an active propagating radical and a deactivated alkoxyamine 
(Figure 1.15A). It was first reported by the Harmer group102 in 1993 upon the 
polymerisation of styrene using benzoyl peroxide and 2,2,6,6-tetramethyl-1-
piperidynyl-N-oxy (TEMPO). From this first example, other NMP based radical 
species were produced (Figure 1.15B) with the design to prevent self-termination, 
initiation of new monomer and ß-hydrogen abstraction.  
Pn X Mtn/L Pn
M





[I] X Mtn/L+ [I]
M
+ X Mtn+1/L
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Figure 1.15. A general scheme for a dynamic equilibrium of NMP (A) as well as examples of NMP (B) based 
mediators  
Increased steric bulk on the adjacent carbons to the nitrogen leads to a reduction in the 
temperature required for monomers, such as butyl acrylate, to polymerise. However, 
increased steric bulk also leads to a reduction in deactivation. 
Advances in synthetic polymerization techniques in the past two decades allow 
absolute control over the polymerisation process. Currently, polymers can be 
produced with high precision over Ð, the degree of polymerisation46-47 (DP) and 
sequence48-53 through controlled radical polymerisation methods, such as RAFT54, 
ATRP55 and SET-LRP56. The synthesis of glycopolymers has utilised click 
chemistry57 through regioselective and chemoselective reactions to link the saccharide 
unit to either monomer, for pre-polymerisation modification or onto the polymer by 
post-polymerisation modification. 
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1.6. Click Chemistry 
In 2001, the concept of ‘click’ chemistry was born from Sharpless103, so called because 
of the ease at which these molecules ‘clicked’ together to form more complex 
structures. For a reaction to be classified as ‘Click’, Sharpless laid out rules for which 
they must adhere to:  
• modular and wide in scope; 
• highly efficient with high yields; 
• no or inoffensive by-products; 
• stereospecificity; 
• readily available starting materials and reagents; 
• no solvent or a benign solvent; 
• simple purification techniques (rather than chromatography). 
These rules now govern what is known as a ‘click’ reaction with examples shown in 
Table 1.4. However, several chemistries pre-2001, which claimed to be click 
chemistry failed to meet the criteria set out by Sharpless, including aldol chemistry. 
These click reactions have been extensively used in polymer chemistry to produce or 
add additional functionality to glycopolymers58, 104.  One of the most commonly used 
click reactions is CuAAC. 
Table 1.4. Examples of metal-free “click” chemistries 
Reagent A Reagent B Reaction Name 
Alkene Thiol Thiol-ene 
Alkyne Thiol Thiol-yne 
Alkene Diene Diels Alder 
Cyclooctene  Tetrazine  Hetero-Diels Alder 
Triazolinedione  Diene  Hetero-Diels Alder 
Dithioester Diene Hetero-Diels Alder 
Isonitriles Tetrazines [4+1] cycloadditions 
Alkene O2 Dihydroxylation 
Epoxide Nucleophile Epoxide Ring-opening 
 
1.6.1. Azide-Alkyne Cycloaddition 
The CuAAC is one of the most widely used approaches in click reactions. Whilst 
azides have to be handled with care, due to their explosive nature, they can be useful 
in facilitating the reduction of amines and the conjugation of alkynes. Azides and 
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alkynes, in most instances, require a metal catalyst in order to react together, as the 
azide is a poor 1,3-dipolar acceptor. Scheme 1.15 depicts the catalytic cycle for the 
[3+2] cycloaddition of the azide and alkyne over 5 steps. The first leads to the 
formation of the copper(I) acetylide complex, this causes the acidification of the 
terminus hydrogen leading to the deprotonation and the formation of the terminus 
acetylide. Following the formation of the acetylide, the azide binds to the copper 
which can then attack the alkyne from the opposing terminus. The sterics around the 
copper centres causes the heterocycles to be produced as the 1,4 isomers. In 
comparison, non-catalysed [3+2] cycloaddition of the azide and alkyne creates both 
1,4 and 1,5 isomers of the triazole105. The strained copper metallacycle formed is 
quickly converted to a Cu-triazolyl complex by the migration of nitrogen-Cu bond to 
the terminus carbon of the alkyne. The proton lost in the first is able to displace the 
copper freeing the triazole, thus allowing the catalyst to be regenerated.  
 
Scheme 1.15. Heterocycle of the CuAAC over 5 steps.  
The CuAAC is a popular reaction due to its tolerance to functional groups, as well as 
the vast number of solvents, copper source and ligands available for the reaction, 
allowing this reaction to be tailored to suit the condition and solvent system 
requirements (Table 1.5). CuAAC reaction has opened the door to the formation of 
several different more complex molecules which by other methods would require 
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primary concern with CuAAC when producing biologically active compounds is the 
need to remove toxic metals. This can lead to lengthy purification, which lowers the 
overall yield as copper exists at ppm levels after purification. 
Table 1.5. Examples of CuAAC reagents 
Copper Sources Ligands Solvents 
CuBr Na-Ascorbate Toluene 
CuSO4.5H2O Me6TREN DMSO 
CuI BiPip DMF 
CuCl n-Bu3N H2O 
CuSO4 EtNiPr2 t-BuOH 
Cu(II)OAc2 DMAP CH3OH 
Cu(CH3CN)4PF6 2,6-lutidine CHCl3 
CuCN DIPEA Hexane 
 
Recently, reactions have been developed to allow the formation of triazole without the 
need of Cu. Strain-promoted azide-alkyne [3+2] cycloaddition (SPAAC) reaction was 
developed in 2004 by Bertozzi{Baskin, 2007, Copper-free click chemistry for 
dynamic in vivo imaging}, which showed promise as a catalyst-free alternative to the 
CuAAC. The process employs cyclocetylene type compounds, due to the ring strain 
within the structure from the strained alkyne bond angles. The formation of the triazole 
is favourable as the ring strain is relieved. The rate of SPAAC reaction can be 
increased by making the alkyne electron deficient, thus dropping the LUMO bond of 
the alkyne. This is achieved by placing fluorine’s on the carbon adjacent to the alkyne 
(Figure 1.16), leading to an increased reaction rate from 1 to 38.1 M -1s-1. 
 
Figure 1.16. Cyclocetylene type compounds with increasing electron deficient alkyne, from left to right. 
Without Cu, SPAAC has been used widely for biological applications due to the 
biocompatibility of the reaction. This process has been used for biologically tagging 
molecules through methods such as surface binding compounds. This is achieved by 
using carbohydrates bearing azides to click to a difluorinated cyclooctyne (DIFO) with 
a fluorescent label.  
R RF FF
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1.6.2. Thiol Click Reactions 
Thiols are also functional groups which can be used in click reactions. Thiol-ene type 
reactions are very versatile, facilitating an anti-Markovnikov addition of a thiol onto 
an alkene. This reaction can be initiated by radical or UV induction to cleave the S-H 
bond. The thiol radical attacks the terminus of the alkene with the radical of the sulphur 
transferred onto a carbon which can then abstract a hydrogen from another thiol in 
order to initiate another thiol-ene reaction.  
 
Scheme 1.16. Radically induced Thiol-ene radical reaction mechanism with the initiation (i) followed by the 
propagation (ii) of the alkene and the chain transfer of the radical and abstraction of the hydrogen (iii) for the next 
thiol-ene reaction. 
Thiol-ene type reactions are used in the formation of glycopolymers to graft the sugars 
onto the polymers. Where an alkene is not used in the polymerisation (e.g. ROP) then 
it is free for the thiol-ene reaction. The Bradley group106 produced microarrays of 
different glycopolymer compositions by clicking thiol monosaccharides onto pendant 
alkenes in order to measure the fluorescent output of labelled lectins upon binding. An 
example by Schubert107 showed the challenges of polymerising an acrylamide bearing 
a pendant alkene by RAFT, but the remaining alkenes were able to undergo thiol-ene 
reactions. 
RAFT groups can be reduced with sodium borohydride (NaBH4) to produce a free 
thiol. This free thiol can be reacted with another to form a disulphide or through the 
thiol-ene reaction to add functionality to the omega terminus of the polymer108-110. The 
thiol-ene reaction can also work by using alkyne (Thiol-yne reaction) and this can lead 
to a double substitution of the alkyne by the thiol111-112. Thiol-ene reaction can also 
follow a Michael addition-type reaction if the alkyne is activated (e.g. in acrylates and 
maleimides). Thiol click reactions also extends to the para substitution of the 
pentafluorostyrene with the use of a base to form glycopolymers113.  
R SH R S R S R1
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1.6.3. Cycloaddition Reactions 
Whilst CuAAC is a [3+2] cycloaddition, other cycloaddition reactions also can be 
denoted as a “click’ reaction. The Diels-Alder reaction, which won the Nobel prize in 
1950, is considered a click reaction. The Diels-Alder works between a diene and 
alkene (dienophile) as a [4+2] cycloaddition similar to the CuAAc and is considered 
a concerted pericyclic reaction. This is a thermally activated reaction, but some 
reactions can undergo Diel-Alder reactions at room temperature. The reaction occurs 
between the highest occupied molecular orbital (HOMO) and the lowest unoccupied 
molecular orbital (LUMO) orbitals of the diene and dienophile. These reactions work 
more efficiently with the addition of electron withdrawing groups on the dienophile 
and electron donating groups on the diene to bring the molecular orbitals closer in 
energy.  
The Diels-Alder reaction has been incorporated into glycopolymer synthesis through 
the hetero-Diels Alder (HDA) reaction. Using an HDA reaction with the RAFT end 
group allow conjugation to the glycopolymer with other polymer chains or add 
addition functionality114-115.  
Due to the versatility of click reactions and the functional group tolerance, the focus 
shifts toward is it more efficient to modify before or after the polymerisation. There 
are two main methods by which glycopolymers can be formed: either by pre-
functionalisation of a monomer to form a glycomonomer, or grafting saccharides onto 
the pre-formed polymer. There is a third less common approach which is the 
simultaneous conjugation and polymerisation (Scheme 1.17). With the ability to 
functionalise the anomeric position with amine and oxygens readily, several examples 
of styrene116-120, vinyl121-126, acrylate114, 127-128 and acrylamide129-131 based 
glycomonomers can be synthesised. These glycomonomers are able to polymerise by 
both ATRP and RAFT, but examples also exist from CROP of a 2-oxazoline-based 
glycomonomer, as reported from Schubert95. 
Click chemistry has allowed the easier conjugation of saccharides with polymerisable 
groups to create new glycomonomers46, 122, 132-133. However, due to the high efficiency 
of click reactions, it has opened up the potential to post modify the polymer. There are 
several advantages and disadvantages (Table 1.6) of post-modification. One main 
advantage is the ability to form a library of glycopolymers from the same polymer by 
interchanging the saccharide clicked onto the backbone. This ability to graft the 
saccharides onto the polymer post-polymerisation has allowed synthetic pathways to 
form glycopolymers which do not require protection group chemistry. For example, 
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ROP cannot tolerate the hydroxyls of the monosaccharide. By using ROP, followed 
by a click reaction, the glycopolymers could be synthesised. The advantage of this is 
compared to the previous vinyl examples, ROP glycopolymer produced with a 
biodegradable backbone134-135. 
 
Scheme 1.17. The three strategies used to form glycopolymers either by the polymerisation of a glycomonomer or 
grafting onto a polymer backbone through methods such as click chemistry or by simultaneous grafting and 
polymerisation, where A and B are corresponding reactive groups. 
The final and less used approach is the simultaneous ’one pot’ approach whereby the 
grafting and polymerisation occur together. The major example of this is the 
simultaneous CuAAC and ATRP polymerisation136 since they both require CuI. These 
reactions are less common as they require more care in order to set up to two reactions 
orthogonally ensuring no cross-reactions are occurring51.  
Table 1.6. List of advantages and disadvantages of the pre and post modification of the polymer. 







Always known carbohydrate content 
Less reaction and purification steps 
Chain extension to form block copolymers or 
elongated polymers 
More suitable for large quantities of homo-
glycopolymers 
Direct glycopolymer synthesis without 
deprotection 
Polymerisation of known monomers 
Facilitated characterization 
More control over molar masses and Ð values 
Suitable for preparation of libraries from the same 
batch of polymer 
More convenient route for tailoring of properties 








Cumbersome synthesis and purification of 
glycopolymers 
Lower control over molar masses and Ðs 
More difficult to characterize 
Solubility compatibility issues between 
carbohydrate monomers, initiators and co-
monomers 
Lower randomization and different distances 
between sugar and copolymers 
Usage of expensive, new monomers 
Require sufficient reactivity of the backbone 
Limited to highly efficient reactions 
Usage of excess of carbohydrates 
Usually cumbersome synthesis of sugar 
derivatives 
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Of the two major routes, each has their advantages and disadvantages. However, it is 
dependent on the polymer backbone and other functional groups on the polymer as to 
the best synthetic pathway for the glycopolymer synthesised. With pros and cons for 
both methodologies, the large array of polymerisation methods, monomers and 
chemoselective reactions available enable the formation of more complex 
glycopolymers59-60. From these CRP and orthogonal click reactions, more complex 
polysaccharide analogues can be produced. Therefore, glycopolymer synthesis far 
surpasses nature’s toolbox which is restricted by the enzymatic pathways available. 
.  
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1.7. Peptides 
Glycopeptides have shown to be a new area of carbohydrate research, due to the 
stepwise growth of the peptide backbone. As peptides and proteins have shown to 
interact with GAGs, these can be used to look at potential applications of the 




Peptides can be defined as polymers formed from the 20 amino acids used in natural 
proteins linked together by amide bonds. Each amino acid has a central carbon, which 
in turn is bonded to single hydrogen, a carboxylic acid, an amine, as well as a side 
chain group, which varies, dependent on the amino acid. Of the 20 amino acids (Figure 
1.17), 19 are chiral with glycine (G) being the exception, due to the R group of G being 
a second hydrogen. In nature, the chiral amino acids exist in the L-form, whilst D-
forms of the amino acids exist, but these are non-natural. Using the 20 naturally 
occurring amino acids and non-natural amino acids, countless number of peptides can 
be synthesized. Once a peptide chain becomes longer than 50 amino acids, these 
become classified as polypeptides or proteins.  
The primary structure of peptides, defined by the sequence of the amino acids, leads 
to the formation of a secondary structure, such as alpha-helices and beta-sheet through 
intra/intermolecular hydrogen bonding. For larger proteins, the secondary structure 
can fold to form tertiary structures which through interactions with other tertiary units 
form quaternary structures. The folding and intra/intermolecular interactions are key 
to for protein function. However, small peptides are highly unlikely to form large 
complex structures as they do not possess a large number of amino acids required to 
create these tertiary structures.  
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Figure 1.17. Structures of the 20 naturally occurring L-amino acids with the side chain residues. 
 
1.7.2. Peptide Synthesis 
The synthesis of a peptide appears as a simple condensation reaction between the 
amine and the carboxylic acid. However, the formation of this amide is no simple feat. 
Within peptide synthesis two sets of protecting groups are used in order to control the 
stepwise growth of the peptide137. The side groups of the amino acids are protected by 
a variety of groups dependent on the type of peptide synthesis and structure of the side 
chains, these include groups such as tert-Butyloxycarbonyl (Boc), 2,2,4,6,7-
Pentamethyldihydro-benzofuran-5-sulfonyl (Pgb) and Trityl (Trt). These protecting 
groups inhibit the side chains from reacting causing branching or side reactions 
(Figure 1.17). These protecting groups are selected to be cleaved simultaneously in 
the final step as well as to be robust during the step-wise synthesis of the peptide. 
The other protection chemistry is utilised for the terminals of the peptides, which are 
selectively deprotected after removal of previous coupling reaction mixture. These 
protection groups are typically cleaved differently to those of the amino acids, for 
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therefore the side chain groups would be base stable, whilst labile in acids. Other 
examples of this include the use of Boc protecting groups. These group are deprotected 
by TFA, so therefore the side chains are typically benzylated as these groups are acid 
stable and require hydrogenation for deprotection. 
For the formation of the amide bond, whilst an amine can be used as a nucleophile; in 
the presence of an acid a simple proton exchange is typical. Therefore, there is no 
driving force to create an amide bond. Consequently, carboxylic acid group needs to 
be activated in order to be susceptible to nucleophilic attack by the amine.  The 
activation is facilitated by reagents typically hydroxylamine such as 3-
[Bis(dimethylamino)methyliumyl]-3H-benzotriazol-1-oxide hexafluoro-phosphate 
(HBTU), Oxyma and N-hxydroxybenzotriazole (HOBt) along with carbodiimides, for 
example, diisopropylcarbodiimide (DIC) and N,N'-dicyclohexylcarbodiimide (DCC). 
The combination of reagents produces an activated ester with the loss of a urea-based 
compound (Scheme 1.18). The amine can readily attack the activated ester to form the 
amide bond releasing hydroxylamine.  
 
Scheme 1.18. Mechanism of amide bond formation through the use of DIC and HOBt to form an activated ester 
where the amine of the peptide can attack. R = protecting group e.g. Fmoc, R1 = protected amino acid side chain, 
R2 = peptide chain. 
The process of forming a peptide was two main approach; solution phase synthesis 
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early 20th century by Crutius138 and Fischer139 . They achieved the formation of the 
peptide bond by the use of activated carbonyl species such as acyl chlorides and acyl 
azides140-141. These methods required the use of extractions to remove the unreacted 
amino acids and the by-products from the reactions. By the incorporation of 
benxzyloxycarbonyl at the N-terminus of the peptide, this lead to directional group of 
the peptide, where the peptide is grown from the C-terminal of the peptide. Once the 
synthesis is complete, with the use of hydrogen and a palladium catalyst the 
benxzyloxycarbonyl is cleaved to give a free the N-terminal. Whilst solution phase 
peptide synthesis is still used for large scale reactions on smaller scales solid phase 
peptide synthesis (SPPS) was become standard practice due to the ease at which the 
technique is employed. 
Solid supports are utilised to form peptides by a step-wise approach similar to that of 
solution phase but increasing the efficiency of the removal by-products and unreacted 
reagents by simple filtration142. These resins are formed of crossed linked polymers 
such as polystyrene with functional groups such as amines in examples such as rink 
amides and TantaGel, hydroxides examples such as Wang resins and chlorides such 
as the Merrifield Resin (Figure 1.18). By selecting the resin, the C-terminal can be 
selected for either a carboxylic acid or amide dependent on the use of the peptide. To 
note with the Wang resin several of these come preloaded with the first amino acids, 
this is due to the poor efficiency of the coupling to the resin. 
 
Figure 1.18. Examples of amide terminal producing resins (red) and carboxylic acid terminal producing resins 
(blue). Clockwise from top left: Rink Amide, TantaGel, Wang Resins and Merrifield Resin 
Merrifield143 developed in 1963 the solid phase peptide synthesis (SPPS) approach 
where the peptide is grown from a solid support. This support was a crosslinked 
polystyrene polymer copolymerised with vinylbenzyl chloride, where by the chloride 
could be used as an anchor to build the peptide from. The first amino acid is attached 
through the use of triethylammonium salt to create an ester linkage between the resin 
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esters and the use of dicyclohexylcarbodiimide using carbobenzoxy group protecting 
amine of which could be cleaved by HBr. This procedure revolutionised the synthesis 
of peptides as compared to solution phase synthesis as the by-products can be easily 
washed away with minimal purification between cycles. Since 1968 SPPS has been 
developed with new resins and employ more reactive chemical to refine the process 
(Scheme 1.19). This methodology allows the peptides to be produced through cycles 
of coupling and deprotection in a in a controlled step-wise approach.  
 
Scheme 1.19. Merrifield solid phase peptide synthesis cycle using HOBt/DIC coupling and piperidine (20% v/v in 
DMF) for the Fmoc deprotection with TFA cleavage to remove from the support. 
However, the downfall of this approach whilst it can be used to form peptides with 
high purity crudes and specificity for the sequence, this comes from the use of excess 
reagents, therefore in terms of atom economy is very wasteful and is why solution 
phase at large scale is still the industry standard. Once the desired sequence has been 
completed, the cleavage of the peptide can take place from the resin using acids such 
as trifluoroacetic acid (TFA). In this step, not only is the peptide cleaved from the 
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1.7.3. Peptide Design  
Peptides can be designed using a few different techniques, including screening 
algorithms of computation libraries or through computer modelling of an active site. 
Peptides can also be derived from natural proteins which have been sequenced. 
Examples for HA binding sequences can be obtained in Table 1.7.  
Table 1.7. HABPs and their corresponding HA-binding sequences. 
Protein Localisation Sequence Ref 



















Human GHAP ECM KVGKSPPVR 148 
TSG-6 ECM HREARSGKYK 4 
RHAMM = Receptor for Hyaluronan Mediated Motility, LP = Link Protein, CD44 = Cluster of Differentiation 44, 
HAS = Hyaluronan Synthase, Human GHAP = Glial Hyaluronate-Binding Protein, TSG-6 = Tumour necrosis 
factor-inducible gene 6. ECM; Extracellular Matrix, MB; Membrane-Bound, SP; Soluble Protein. 
 
1.7.3.1. Phage Display 
An alternative approach to rational peptide design is phage display, a high-throughput 
technique used to investigate peptide-target interactions. Phage libraries consist of 
bacteriophage, a virus that infects bacteria, which have been genetically modified to 
display a peptide as an N-terminus fusion to a viral coat protein. The first example 
was reported in 1985 with 24 clones149, and today random peptide libraries are 
commercially available containing 109 unique peptide sequences150. 
In order to identify target-binding peptides rounds of biopanning are undertaken 
(Scheme 1.20). The target is immobilised and incubated with the phage library. 
Unbound phages are removed by washing and bound phages are eluted, either using a 
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non-specific low pH elution buffer or by incubation with a known binder of the target 
molecule. Binding phage can then be amplified using bacteria and further panning can 
be carried out. Through these rounds of panning, target-specific binders are enriched, 
and non-specific binders removed. Once target specific binding is confirmed by 
enzyme-linked immunosorbent assay (ELISA) phage DNA can be isolated and 
sequenced to reveal the peptide sequence responsible for binding.  
 
Scheme 1.20. Schematic of the phage display process with the eventual successful sequences being sequenced. 
Scheme taken from ref150. 
These panning experiments can be carried out both in vivo and in vitro151; the majority 
of experiments in the literature have been carried out in vitro, however  the sequences 
identified do not always maintain their target-binding ability when investigated in 
vivo. Whilst in vivo panning is more costly the sequences isolated are more likely to 
retain their binding capacity in downstream applications, such as targeting specific 
tissues and drug delivery152-153.  
Phage display has been used to discover antibodies able to bind GAGs154-157, as well 
as peptide ligands with affinity to tissues and ECM components158. One of these 
peptides is known as Pep-1159. Pep-1, a 12-mer peptide (GAHWNFQALTVR), was 
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discovered in 2000 and binds to HA. In the phage display process, Pep-1 was 
negatively screened against CS to ensure the selectivity for HA over CS. Pep-1 has 
one of the highest affinities for HA with a KD = 1.64 µM and will compete with other 
HABPs. As a result, research has since been undertaken using Pep-1 to detect the 
localisation of HA in tissues160-161, to reduce inflammatory response162-163 and 
inhibition of receptor binding164-166.  
Phage display libraries are typically 7 and 12 mers in length, however, synthesis of 
peptides by manual or automated procedures can produce varying lengths of peptides 
as well as designing the peptide to contain multiple domains within them. 
 
1.7.3.2. Peptide Amphiphile 
Peptide self-assembly (SA) provides a route for the formation of complex 3D 
structures, which can begin to compete with the complex structures of proteins. By 
controlling the primary structure of the peptide, the folding of the peptide into alpha 
helical or beta-sheet conformations can be tailored. From the secondary structures, 
PAs can begin to control the stacking and interactions of those secondary structures. 
PAs have been designed to induce structural formation through the use of their 
amphiphilic nature, whereby the molecules possess a hydrophobic region, such as an 
alkyl “tail” chain, and a hydrophilic polar head group. This is a basic PA design that 
has been used to produce many different PA variations (Figure 1.19)167-170.  
 
Figure 1.19. Example of a PA design with the alkyl tail (black), β-sheet forming segment (red), charged domain 
(purple), a spacer (green) and the bioactive sequence (blue). 
This structural formulation breaks the peptide into four main sections: a hydrophobic 
tail, a charged domain, a spacer and a target sequence. The hydrophobic tail can be 
fatty acids with differing lengths of alkyl chains that can range from C10 to C16 
dependent on the solubility of the peptide. Sequences such as V3A3 are typically 
coupled adjacent to the tail to promote hydrogen bonding and β-sheet formation 
leading to cylindrical nanofibers instead of spherical micelles. The 4 residues closest 
to the core hydrophobic tail has been shown171 to be critical for the structure formation. 
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the formation of micelles and nanofibers is affected by the order and nature of the 
amino acids closest to the fatty acid tail. By replacing the beta-sheet forming domain 
with cysteines, upon increasing of the pH or adding reducing agents intramolecular 
chemical crosslinking can be formed through disulphide bonds168, 172 increasing the 
rigidity of the nanofibers compared to hydrogen bonding or charge-charge 
interactions. The charge domain ensures solubility of the peptide, whilst a spacer unit 
coupled before the target sequence allows the peptide to be displayed on the nanofiber 
surface. Through this PA design, multiple bioactive epitopes can be displayed. This 
approach can lead to a more stable assembly as well as response more effective 
binding through the multivalent presentation of bioactive signals. These two distinct 
sections in polarities within the structure allows for the formation of three-dimensional 
structures such as micelles and fibres (Scheme 1.21). 
 
Scheme 1.21. Schematic of a cross-section representation a micelle (left) and fibres (right).  
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1.8. Preface 
The thesis begins with an introduction to the work previously undertaken in the field 
of GAG-based glycopolymers, highlighting the gap on HA glycopolymers and 
justifying the need for the work presented in this thesis. Glycopolymer synthesis 
involves the use of techniques of polymer and carbohydrate chemistry, which have 
been covered in this part of the thesis. The synthesis of peptides is also described as 
peptides were used to exploit their binding to natural HA and HA glycopolymers. 
The experimental work begins with the modification of HA monosaccharides at the 
anomeric centre to produce a click monomer, which can be grafted onto monomer or 
a polymer. The work then shifts towards the production of peptides known to bind to 
HA. Through analysis of the binding sequence, termini modifications are undertaken 
in order to promote their self-assembly with natural HA and create new biomaterials. 
The final experimental chapter compares the physical and chemical properties of the 
glycopolymers with native HA, as well their binding to small peptides or to 
carbohydrate-binding proteins (lectins). By presenting the HA sugars in a controlled 
manner (in homoglycopolymers or alternating glycopolymers), these glycopolymers 
can be used as probes to elucidate the role of each HA sugar in relevant binding 
processes. 
In the final chapter, the results described in the preceding chapters are summarized, 
highlighting the main conclusions of the work and pointing out new directions for 
future work.  
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Chapter 2 Synthesis and Characterisation of Hyaluronan 
Glycopolymers 
2.1. Introduction 
HA is a carbohydrate of great interest due to its biocompatibility and biological 
functions. As such, HA has been researched for many biomedical applications1 in the 
areas of ophthalmology, orthopaedics, dermatology, drug delivery and biomaterials2-
3. From this relatively simple molecule, a record $5.32 billion4 was spent globally in 
2012 on HA-based products in areas such as health-care and cosmetics. Forecasts 
estimate $9.85 billion being spent globally by 2019, with the HA raw material market 
reaching $7.25 billion by 20245. Currently, ultrapure HA is extracted from natural 
sources6 such as rooster combs and bovine vitreous humour. However, due to the risk 
of cross-species transmission of diseases, HA is now being manufactured on a large 
scale from bacteria fermentation to make the method more scalable (Figure 2.1). 
 
Figure 2.1. Microbial fermentation using Streptococcus for producing HA. Image taken from Life Core7 
HA is readily broken down by a family of enzymes known as hyaluronidases 
(HYALs). These work together to break down the large mega Dalton polymer into 
small fragments by HYAL-2, which is then further hydrolysed by HYAL-1. The 
balance between the production of HA by HAS and degradation by HYALs enables 
HA homeostasis within the body. However, a shift towards increased degradation 
and/or a decrease in synthesis leads to pathological conditions such as osteoarthritis 
and cancer. By contrast, the inverse can also lead to diseases such as scleroderma8. 
Modern synthetic methods for the synthesis of carbohydrates to produce large 
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polysaccharides with precision control is challenging, time-consuming and resource 
demanding9.  
Glycopolymers provide a simpler alternative method to conventional carbohydrate 
synthesis. They bring together two key components; the biologically active sugars, 
which also provide water solubility, whereas the polymer backbone provides stability 
and control over the architecture. As previously shown, glycopolymers and 
glycoclusters of HA have been produced by first forming the HA repeating 
disaccharide (dimer) and then attaching this to a monomer, that after polymerisation 
yielded the HA glycopolymer10. The reactions to produce the disaccharide are elegant 
in their design, the disaccharide synthesis still requires multiple steps in order to 
produce them before conjugation to a monomer/polymer. Many reports in the 
literature suggest that the size of HA oligomers affect the interaction with receptors11. 
The architecture designed in the previously reported HA glycopolymers may not be 
ideal for interaction with receptors. The disaccharides on the glycopolymer will bind 
predominately through the terminus monosaccharide rather than the dimer. As the 
terminus monosaccharide is always the same, it raises the question about the 
availability of the internal monosaccharide for binding. This might be the reason why 
these publications did not report biological activities of the synthesised HA 
glycopolymers. Receptors such as CD44 require a minimum of 8 saccharides in order 
to bind 12. 
In this chapter, a different approach is proposed, which eliminates excessive 
carbohydrate chemistry with an example shown in Scheme 2.1 for the formation of a 
glycosidic bond between GlcA and GlcNAc. By utilising click chemistry, various 
monosaccharides can be grafted onto a parent monomer/polymer to produce a variety 
of glycopolymers. This approach is an effective method to produce a library of 
glycopolymers and reduces the number of steps required13-15. This clicking of 
monosaccharides onto monomers/polymers approach can also be applied to the 
synthesis of more complex alternating polymers. This alternative strategy allows the 
easy interchange of the monosaccharides onto the polymer, as well as forming a full 
alternating glycopolymer based on HA compared to the formation of disaccharides. 
The styrene-maleic anhydride copolymer system is well known to alternate16-19 with 
examples from the Lutz group20-23. The group has synthesised libraries of substituted 
styrene monomer and the maleic anhydride derivatives to look at the effect of the side 
chains upon the polymerisation. As a result, a block copolymer was produced, 
whereby a growing styrene polymer had sequentially additions of maleimides at set 
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time points to form a styrene polymer with sections of alternation with a maleimide 
derivative. These maleimides could be orthogonally and chemoselectively deprotected 
and monosaccharides were clicked onto post-polymerisation. 
 
Scheme 2.1 Formation of HA dimer by a 10 step synthesis from Chaikof10. Reagents and Conditions: (i) (a) TfN3, 
MeOH, DMAP, 25 °C, 18 h, (b) Ac2O, pyridine, 0 °C, 10 h, R, R1 = Ac; (ii) (a) H2NNH2·AcOH, DMF, 0–25 °C, 
45 min; (b) anhydrous K2CO3, CCl3CN, DCM, 25 °C, 48 h; (c) 4 Å mol. sieves, TMSOTf, 4-penten-1-ol, DCM, 0 
°C, 1 h, R = Ac, R1 = C(NH)CCl3  (iii) MeONa, MeOH, 0–25 °C, 6 h; (e) CSA, THF, C6H5CH(OMe)2, reflux, 6 
h; (iv) TMSOTf, DCM, 0–25 °C, 3.5 h; (v) (a) CH3COSH, 25 °C, 24 h;  (b) TFA–H2O (2:1), DCM, 0 °C, 1 h; (c) 
3 M NaOH, 9:1 MeOH–H2O, 25 °C, 2 h; (d) O3 (278 °C), then add Me2S, 278 °C–25 °C, 24 h. 
Although this polymer is an example of an alternating glycopolymer, it is not 
alternating with respect to the sugar, but in regard to the backbone (Scheme 2.2). The 
proposed approach relies on the functionalisation of both the styrene and the maleic 
anhydride, whereby selective orthogonal reactions allow different monosaccharides to 
be grafted onto the individual monomers to produce a fully alternating glycopolymer 
in respect to both the backbone and the monosaccharides. In doing so, and compared 
to previous HA glycopolymer versions, both monosaccharides will be displayed 
evenly across the polymer. In this methodology, the yield of the glycopolymers will 
not be limited by the disaccharide synthesis. The polymerisation can be tailored in 
length to ensure the presence of enough monosaccharides to bind receptors in a 
multivalent fashion.  
 
Scheme 2.2. Schematic representation of the previous work22 into to alternating glycopolymer showing the 
alternation blocks (AB) in between a homopolymer block (HB, section blue) compared with the design principle 
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In this chapter, RAFT polymerisations of styrene and maleic anhydride derivatives are 
utilised to form a fully alternating glycopolymer. We first looked at the production of 
the homopolymers to provide a simple platform on which to build upon. Examples of 
both pre- and post-polymerisation are accessed for the formation of the glycopolymer. 
The homo-glycopolymers are formed from a parent polymer, which has been 
converted to bare a click group orthogonally to the polymerisable alkene. This 
orthogonal group allow the formation of multiple glycopolymer variants by 
supplementing different monosaccharides in the click reaction.  
In the second half of the chapter, we build upon the homo-glycopolymer system to 
form a co-monomer system with a maleimide. With the diverse range of maleimides 
being discussed in the literature to polymerise with styrene21, 24, a maleimide was 
selected to produce a polymer with two different orthogonal groups. The alternating 
behaviour of polymers was characterised by following the semi-logarithmic kinetic 
plots for each monomer as well as analysing the obtained polymers via matrix-assisted 
laser desorption ionization time of flight (MALDI-ToF) mass spectrometry. By 
controlling the order in which these reactions are carried out, we can control the 
locations of the monosaccharides and a fully alternating glycopolymer can be 
produced, in respect to the backbone and the monosaccharides. The synthesis of other 
glycopolymers based on glucose (Glc), mannose (Man) and Gal was also attempted to 
act as controls in binding experiments described in chapter 4. 
  
 Synthesis and Characterisation of Hyaluronan Glycopolymers 
 66 
2.2. Results and Discussion 
2.2.1.1. Synthesis of Click Functionalised Monosaccharides 
To synthesise a glycopolymer, we must first consider the functionality of the 
monosaccharides being used. GlcA and GlcNAc sugars bare potential reactive sites 
(carboxylic acid and N-acetyl group, respectively) for chemical modification, but 
these functional groups are key in the HA binding process and therefore must remain 
unmodified. For example, the CH3 of 6-GlcNAc and 5-GlcA are known to be essential 
for the recognition by CD44 in the octasaccharide bound. Ideally, a universal method 
for the glycopolymer synthesis would be desirable, but several monosaccharides do 
not bare any functional group. However, all monosaccharides bear a common 
anomeric centre, which can be readily functionalised with a donor alcohol using an 
acid catalyst; this process is known as Fischer glycosidation. The use of H2SO4 
immobilized on silica reported by Mukhopadhyay25 provided an efficient 
methodology for Fischer glycosidation for several monosaccharides (Scheme 2.3). 
 
Scheme 2.3. Schematic representation of the functionalisation of monosaccharides via direct Fischer glycosidation. 
Propargyl alcohol was selected as the alcohol donor since the compound possesses an 
alkyne. This alkyne can be used later for CuAAC click reactions. Compared with other 
simpler monosaccharides, such as Glc and Man, GlcNAc required an increased ratio 
of the catalyst and prolonged reaction time, in order to produce substantial grafting of 
the alkyne onto the monosaccharide. This is caused by reduced solubility of GlcNAc 
in neat propargyl alcohol leading to low conversions26-27. The 1H nuclear magnetic 
resonance (NMR) of all four compounds showed the introduction of the terminus 
alkyne hydrogen at 3.0-2.8 ppm displaying weak triplets due to distance coupling 
between the terminus alkyne and the CH2 doublet seen at 4.3-4.4 ppm (Figure 2.2). 
All four compounds (1-4) were produced as an anomeric mixture. The prolonged 
reaction time and the sterics of the N-acetyl group of the GlcNAc led to a decrease in 
the anomeric ratio for 4 comparing to 1-3. This can be seen due to the dual peaks in 












Figure 2.2. 1H NMR spectrum at 400 MHz in D2O (top) of compound 2, showing the splitting of the propargyl 
group (A-B) and the anomeric hydrogen (C) and the anomeric ratio of products from direct Fischer glycosidation 
with H2SO4-Silica using propargyl alcohol as the donor (bottom) showing the anomer ratio of the product as 
determined by 1H NMR. 
Compared to GlcNAc, GlcA is more difficult to be functionalised at 1’ position due 
to the carboxylic acid at the 5’ position. The carboxylic acid leads to the formation of 
a stable bicyclic product rather than the anomeric substitution (Scheme 2.4). This is 
caused by the conversion of the pyranose 6-membered ring to a furanose 5-membered 
ring. This 5-membered ring formation is reversible but is made irreversible by the 
formation of a second 5-membered ring, resulted by the 3’ hydroxyl reacting with the 
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lactone was confirmed by X-ray crystallography analysis of the crystals formed 
compared with those reported in literature28.  
 
Scheme 2.4. Schematic representation of the by-product formation of Glucurono-6,3-lactone (5). 
To inhibit the lactone ring formation, the hydroxyl groups on the sugar were protected 
by acetylation. Previous work by the Murphy group29 in 2007 has shown the formation 
of an azide directly onto the sugar ring using (CH3)3SiN3 as a Lewis acid and SnCl4. 
The azide was produced as a minor product with the major product being another 
bicyclic lactone catalysed by the SnCl4 (Scheme 2.5). The Murphy group30 showed 
that in the absence of the (CH3)3SiN3, the SnCl4 catalyses the bicyclic lactone. 
Increasing the sugar to azide ratio, the yield of azide product was increased, but 
remained as the minor product behind the lactone. 
 
Scheme 2.5. Schematic representation of 1,2,3,4-tetra-O-acetyl-α-D-glucopyranuronate with (CH3)3SiN3 
producing the lactone by-product and the desired azide 
These results infer that the azidation reaction is either unfavourable, kinetically slow, 
or the azide source is being destroyed during the reaction leading to a decrease in the 
azide source. Reports in the literature31 showed that the protection of the carboxylic 
acid is required for the inhibition of the cyclisation. With the formation of methyl 
1,2,3,4-tetra-O-acetyl-α-D-glucopyranuronate using the (CH3)3SiN3 and SnCl4 
reaction, the azide product can be synthesised with no evidence of the lactone in the 
1H NMR. The methyl 1,2,3,4-tetra-O-acetyl-α-D-glucopyranuronate can undergo 
Fischer glycosidation using BF3.OEt2 as a Lewis acid catalyst to produce the alcohol-
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Scheme 2.6. Schematic representation of Methyl 1,2,3,4-tetra-O-acetyl-α-D-glucopyranuronate of the substitution 
of C1 acetyl group by (CH3)3SiN3 catalysed by SnCl4 and indirect Fischer glycosidation by alcohol donor catalysed 
by BF3.OEt2. 
This reaction could tolerate both propargyl alcohol as well as 2-azidoethanol to yield 
GlcA functionalised with both an alkyne and an azide. The deprotection of the 
protected GlcA derivatives was achieved by Zemplen deprotection using NaOMe in 
MeOH to remove the acetyl and methyl protecting groups. This reaction caused the 
sugars to darken over time becoming brown in colour. The 1H NMR showed the 
removal of the CH3 of the acetyl groups, as a shift upfield of the protons within the 
carbohydrate ring, with no evidence of degradation of the GlcA derivatives. This 
cannot be directly quantified due to the use of different deuterated solvents caused by 
a change in solubility of the monosaccharide through the indirect Fischer 
glycosidation. Using this indirect route, the ß anomer product was favoured, but by 
using the SnCl4 catalyst, compound 9 is seen exclusively as the ß anomer (Figure 2.3). 
With the monosaccharides bearing the click moieties being successfully synthesised, 
the corresponding polymer is required in order to perform the CuAAC to produce the 
glycopolymers. 
 
Figure 2.3. Products of functionalisation with (CH3)3SiN3 catalysed by SnCl4 and indirect Fischer glycosidation by 
alcohol donor catalysed by BF3.OEt2 forming both the alkyne (10) and azide derivative (11) showing the anomer 
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2.2.2. Glycopolymer Synthesis 
2.2.2.1.  Polymer Backbone Selection 
Since the premise of the work is to form an alternating glycopolymer based on the 
styrene-maleic anhydride system, functionalised monomers of styrene were evaluated. 
Two commercially available styrene candidates were selected; vinyl benzyl chloride 
(VBC) and pentafluorostyrene (PFS) (Figure 2.4). Both monomers have been shown 
to be suitable for modification to bare an azide group32-33 for CuAAC click reaction 
with the alkyne monosaccharides. The pendant group have also been substituted by 
other nucleophilic functional groups such as amines34-35 and thiols32, 36. RAFT was 
chosen over other CRP due to the tolerance of halides during the polymerisation. In 
contrast, ATRP and SET-LRP were unsuitable due to the chloride of VBC interfering 
with the polymerisation mechanism, leading to potential crosslinking37.  
 
Figure 2.4. Structure of VBC (left) and PFS (right) highlighting the potential sites (red) for nucleophilic 
substitution. 
The styrene derivatives were tested against styrene (St) as a control in both 
homopolymerisation and an alternating polymerisation system (Figure 2.5). Both 
monomers follow the trends seen by St, in which, the polymerisation under RAFT 
control is slow in the homopolymerisation. The high electron deficiency of the alkene 
in PFS leads to a conversion of 27%, which is half when compared with VBC at 54% 
over the same time period. However, the rate of polymerisation of both monomers 
increased when copolymerised with N-methyl maleimide.  
PFS provided a much more controlled polydispersity (Ð) in both scenarios, the rate of 
polymerisation for the homopolymer is incredibly slow, therefore inhibiting the DP. 
Since HA contains thousands of disaccharide units (up to the MDa range), obtaining 
a very long homopolymer chain of PFS would be difficult under the current conditions. 
From these results, VBC was seen as a better option to that of PFS. This raises the 
question whether to do pre- or post-modification in order to form the glycopolymer. 
As shown in (Table 1.6), there are merits to both modification routes for the formation 
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polymerisation approach. This would ensure that the polymer produced contains 100% 
of monosaccharides across the polymer backbone. 
 
Figure 2.5. Graphical representation of the conversion (Bar) and Ð (symbols) comparing VBC and PFS against a 
control of St. Polymerisation under RAFT for 13 hours at 70 ℃ with 100: 1: 0.2 ratio between the monomer, RAFT 
agent and initiator respectively.  
 
2.2.2.2. Formation of a Glycopolymer by Pre-polymerisation Modification 
Using VBC, the chloride can be readily substituted for an azide, with a peak at 2098 
cm-1 in the FT-IR indicative of an azide, on top of a shift seen from 4.61 to 4.33 ppm 
in the 1H NMR and 46.13 to 54.70 ppm in the 13C NMR for the adjacent CH2. 
Compared with examples described in the literature38, where the monosaccharide 4 
was acetylated before clicking, these were seen as unnecessary steps. By using a 
solvent mixture of 2:1 methanol: water, 4 and 11 could be solvated and “clicked” 
together using CuSO4.5H2O (0.1 M) and Na-ascorbate (1 M) as the copper source and 
ligand, respectively. The reaction was confirmed by 1H NMR which showed the 
addition of two triazole peaks at 8.04 and 8.00 ppm with a ratio of 60:40. The two 
singlets of proton K in Figure 2.6 arise due to the two isomers, which can form 1,4 or 
1,5. These isomers can also be seen in the splitting of the CH2 of the CH2 adjacent to 





























Figure 2.6. The synthetic pathway (top) for the formation of the glycomonomer (12) by Sn2 substitution of the 
chloride to azide followed by CuAAC with the corresponding 1H NMR spectrum at 400 MHz in D2O of 12 (bottom) 
showing the splitting of G, K and I due to anomers and triazole isomers. 
Following this, the corresponding maleimide derivative synthesis was attempted. N-
propargyl maleimide (PMI) was prepared by the ring opening and closing of the 
maleic anhydride with a propargylamine. The ring opening reaction was highly 
efficient in the formation of the corresponding acid 13. The product crystallised out to 
give a white solid which by 1H NMR shows the addition of the alkyne onto the 
maleimide through the ring opening; this ring opening can be seen due to the 
inequivalent hydrogen of the alkene. These hydrogens become equivalent again on the 
ring closing due to the symmetry of the cyclic ring (Figure 2.7). However, the reaction 































Figure 2.7. Scheme (top) for the formation of N-propargyl maleimide (14) through ring opened intermediate, 13 
and 1H NMR spectra at 400 MHz in CDCl3 (bottom) of glycomonomer between 6.0 – 7.0 ppm looking at the alkene 
bond on through the ring opening and ring closure reaction. 
The click reaction between 9 and 14 was attempted to form the glycomonomer (15) 
(Scheme 2.7). However, the reaction could never give clear evidence of the triazole 
peak on 1H NMR; steric interference of the monosaccharide 9 could have potentially 
caused this issue. Other examples within literature22, 39 use an azide extended from the 
carbohydrate by a small alkyl linker, so between 2-4 carbons long similar to compound 
11. 
 
Scheme 2.7. Schematic representation of the formation of glycomonomer (15) through the CuAAC of 9 and 14 to 
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With the inability to produce 15, 12 was tested for its ability to polymerise. The 
glycomonomer was tested under several different conditions (Table 2.1). The reaction 
was first tested with Maleic Anhydride (MAh) as a co-monomer since it was shown 
earlier that maleimides increase the rate of polymerisation, which was monitored by 
1H NMR and gel permeation chromatography (GPC). However, the reaction did not 
progress to polymerisation. To reduce steric hindrance, 12 was diluted in 
concentration with St in a mole ratio of 1:10, but the polymerisation again showed no 
conversion. It was also noted that during the reaction an inhibition of the 
polymerisation of styrene occurred when tested in different solvents, ratios, 
temperatures, as well as by free radical polymerisation, but the monomer failed to 
polymerise. 
Table 2.1. Summary of polymerisation of 12 with comonomer in various conditions. 
Entry 
Ratio 
Solvent Temp (ºC) 
12 St MAh CTA V601 
1 4 - 4 1 0.1 Dioxane 70 
2 4 - 4 1 0.1 Butanone 70 
3 11 89 - 1 0.5 Butanone 70 
4 1 9 - 1 0.5 Butanone 70 
5 94 8 - 1 0.1 Butanone 70 
6 80 10 - 1 0.1 DMF 100 
7 98 10 - - 1 DMF 100 
 
With several issues seen in glycomonomer synthesis due to solvent incompatibility, 
sterics and lack of polymerisation, we have focused on the second alternative route in 
glycopolymer synthesis, which is based on the synthesis of a functional backbone and 
followed by post-polymerisation grafting onto the polymer. Though this leads to a 
better control over the polymerisation kinetics, the grafting and substitution reaction 
would need to be quantitative.  
 
2.2.2.3. Formation of a Glycopolymer by Post-polymerisation Modification 
The polymerisation of VBC monomer under RAFT polymerisation was solvated in 
1,4-dioxane. The most common solvents in the literature40 for this type of 
polymerisation are toluene, anisole or dimethyl formaldehyde (DMF), these were 
excluded for two reasons. First, the boiling points of these solvents are >100 ℃, thus 
removing these solvents by evaporation to concentrate the sample before precipitation 
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is challenging. Secondly, these solvents have peaks within 1H NMR which would 
resonate at the same frequency as several of the functional groups of the polymer, 
therefore making it more challenging to determine monomer peaks from trace solvents 
- e.g. the overlap of the aromatic hydrogens of toluene and styrene between 7 – 8 ppm. 
As seen previously (Figure 2.5) the styrene polymerisation reached a maximum of 
55% conversion on average. Therefore, in order to target a polymer with a DP of 
approximately 50 repeats, it was necessary to work with twice the ratio of monomer 
to chain transfer agent (CTA) (i.e. 100: 1 rather than 50: 1) to consider the limitations 
of this polymerisation. The DP of 50 was selected so that the glycopolymers had an 
equivalent number of monosaccharides to that of a 20 kDa HA chain. The monomer 
was polymerised under RAFT conditions to produce a well-defined polymer with a 
low Ð on average below 1.2 (Table 2.2). 
 
Scheme 2.8. Schematic of the synthetic route for the homopolymerization of VBC to pVBC (P1) by RAFT 
polymerisation with V601 initiator at 70 ℃ in DMF. 
The poly(vinylbenzyl) chloride (pVBC) was converted to poly(vinylbenzyl) azide 
(pVBAz) using the same conditions as used for the VBC to Vinylbenzyl azide (VBAz) 
in the glycomonomer synthesis (Figure 2.6). On the addition of sodium azide to the 
polymer, a colour change was observed causing the solution to darken from yellow to 
orange. The GPC traces showed a consistent formation of a high molecular weight 
shoulder leading to a broadening of the Ð (Table 2.2). The peak molecular weight (Mp) 
was seen to be double of the high molecular weight shoulder compared to the major 
peak (Figure 2.8). This result inferred that coupling between two chains was occurring 
during this reaction facilitated by the sodium azide. To ensure quantitative conversion 
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Figure 2.8. GPC comparison of pVBC produced by RAFT polymerisation (blue) to functionalised to pVBAz (grey) 
at 50 ºC with peaks labelled with the Mp, showing the shoulder formed during the azidation of PVBC. 
However, on the reduction of the azide concentration, full conversion was still 
reached, with a reduction in the high molecular weight shoulder inferring a link 
between [NaN3] and the size of the shoulder. Switching the solvent to DMF from 
dimethyl sulfoxide (DMSO) ensured there was no effect from the solvent, as well as 
a change in a drop-in temperature. By dropping the temperature to 25 ºC over the same 
period of time, the reaction still showed quantitative yields of the Cl to N3 however, 
the Ð still remained broad. 
Table 2.2. Conversion of pVBC to pVBAz using NaN3. 
Entry Polymerisation [Cl]:[NaN3] Temp (ºC) Solvent 
Ð a 
pVBC pVBAz 
1 RAFT 5.7 50 DMSO 1.18 1.28 
2 RAFT 2.2 50 DMSO 1.18 1.28 
3 RAFT 4.9 50 DMF 1.09 1.34 
4 RAFT 4.9 25 DMSO 1.17 1.33 
5 RAFT 3.2 25 DMSO 1.17 1.30 
6 Free Radical 2.8 25 DMSO 1.95 1.76 
7 Free Radical 2.9 50 DMSO 1.95 1.80 
aDMF + 5 mM NH4BF4 eluent, calibrated with PS standards.  
The trithioester group of the RAFT agent has also been shown41 to be susceptible to 
attack by nucleophiles such as NaN3. Upon attack by a nucleophile, the trithioester 
decomposes to a free thiol. Within a basic environment, two adjacent thiols will react 
to form dithiol bridges. By producing the polymer free radically, followed by the 
azidation of the chloride, Ð is uncontrolled in these examples. However, what is 
evident is that on the addition of the NaN3 into the system, there is no broadening 
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overtime with a quantitative conversion of the Cl to azide (N3). Even at elevated 
temperatures (50 ºC), the GPC traces showed no distinct high molecular weight 
shoulder compared with the RAFT polymers (Figure 2.9). This evidence inferred the 
necessity to attempt the modification of the synthetic pathway to avoid this side 
reaction. The alternative routes were to polymerise the azide monomer in situ, or to 
cleave the RAFT end group.  
 
Figure 2.9. GPC traces of pVBC produced free radically (dark blue) but also converted to pVBAz at 25 ºC (light 
blue) and at 50 ºC (grey), with no evidence of the high molecular weight shoulder. 
First looking at the polymerisation of VBAz in the literature, examples were not 
evident for a direct polymerisation of VBAz but rather a polymerisation of VBC and 
conversion to pVBAz33. A review42 published in 1969 showed that at elevated 
temperatures an azide group can break down to form an amine, which if present within 
a polymerisation solution will play havoc with the polymerisation process. The amine 
will attack both the RAFT group and the alkenes present in the system, leading to an 
uncontrolled polymerisation together with crosslinking through the amine. The results 
of the polymerisation of VBAz (Table 2.3) showed a Ð > 2.  
Table 2.3. Polymerisation conditions for pVBAz for 5 hours at 70 ℃ 
Entry [St] [VBAz] Solvent 𝜌 a (%) Mn b (g mol-1) Ð b 
1 - 102 DMSO >99 4400 2.8 
2 - 50 DMF >99 6600 2.4 
3 40 10 DMF >99 7400 2.3 
[CTA]: [I] of 1: 0.2. a 1H NMR (400 MHz, d-DMSO). bDMF + 5 mM NH4BF4 eluent, calibrated with PS standards. 
The 1H NMR results show a conversion (𝜌) >99% which when comparing to previous 
styrene examples (Figure 2.5) infer that the alkene is being consumed by another route. 
When reducing the azide content to 20% of the monomer content in entry 3 of Table 
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2.3, the Ð & 𝜌 remained higher than expected for a styrene polymerisation. This result 
showed that even a small amount of azide in solution was detrimental to the 
polymerisation. The GPC traces infer degradation of the azide further, due to the 
multimodal peak shape of the distribution with a minimum of 3 clear distinct peaks 
compared with GPC trace of pVBAz produced by post modification of pVBC (Figure 
2.10A). The decomposition of the azide to an amine is confirmed by FT-IR. By post-
modification to pVBAz, there is a clear peak at 2109 cm-1 for the azide (Figure 2.10B), 
which is present in the monomer but not after polymerisation, with the evidence of an 
amine between 3100-3600 cm-1. 
 
Figure 2.10. Comparison of GPC traces (A) and the FT-IR spectra (B) of the direct polymerisation of VBAz (grey) 
to the polymerisation of VBC followed by azidation to pVBAz (blue). 
Since the polymerisation of pVBAz is an unsuitable pathway due to the decomposition 
of the azide, the alternative was to look at RAFT cleavage. A recent review41 from 
Thang showed several functionalisation approaches to remove the RAFT end group. 
Of these, three were screened as a potential solution; nucleophilic, radical induced 
with and without H source. Radical induced RAFT cleavage43 was attempted by the 
use of excess V601 to reinitiate the polymerisation. Due to the large excess of initiator 
radicals within the system, this would promote termination through radical-radical 
recombination between the propagating chain and initiator. The polymer would, 
therefore, be terminated with the initiator rather than the RAFT agent as the C-C bond 
formation would be irreversible. The removal of the RAFT end group was monitored 
by UV (the RAFT trithiocarbonate absorbs between 300 – 360 nm), as seen in the 
yellow colour of the RAFT polymer, which is lost upon cleavage (Figure 2.11). By 
radical induced RAFT cleavage, a small residual amount of RAFT end group can be 
seen in the UV trace of the product after two cycles of cleavage. 
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Figure 2.11. UV trace of pVBC before (blue) and after (grey) the RAFT cleavage with a colour change in the 
polymer seen upon partial cleavage of the RAFT agent (Insert).  
Examples of RAFT cleavage of styrene-based polymers45, 46 have been described in 
the literature. Many examples show incomplete cleavage due to the stability of the 
RAFT group on a styrenic polymer (Figure 2.12A). Supplementing the radical induced 
cleavage with a peroxide, such as Lauroyl Peroxide (LPO), was shown to be highly 
effective at RAFT removal from styrenic based polymers47. When carrying out the 
LPO supplemented RAFT cleavage it was shown by GPC UV trace at 308 nm with 
95% of the RAFT end group cleaved in a single cycle. However, the RI trace showed 
an increase in Ð again caused by a small high molecular weight shoulder. The purpose 
of the RAFT cleavage was to avoid the high molecule shoulder (Figure 2.12B). The 
shoulder caused by the NaN3 creating a disulphide bridge of the RAFT, rather than the 
unknown side reaction of the LPO. The reactions were continued as RAFT cleavage 
of a styrenic polymer was shown to be resource demanding for less than quantitative 
conversions (Table 2.4). 
Table 2.4. Results of RAFT Cleavage at 80 ºC in Dioxane. 
Entry [V601]: [LPO] 
Precursor Product 
Cleavage 
Mn, GPC a Ð a Mn, GPC a Ð a 
1 20: 0 11800 1.13 12500 1.12 97 % * 
2 20: 0 7200 1.18 7200 1.16 81 % 
3 20: 0 11600 1.14 12500 1.15 55 % 
4 20: 2 11600 1.14 12000 1.16 95 % 
* Process repeated twice to achieve 97%. a DMF + 5 mM NH4BF4 eluent, calibrated with PS standards.  
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Figure 2.12. LPO assisted radical RAFT cleavage monitored by UV at 308 nm (A) showing a decrease in the 
absorbance at 308 nm, whilst the RI (B) shows another high molecular weight shoulder formation during the LPO 
assisted RAFT cleavage. 
As a proof of concept, entry 1 from Table 1.4. was converted from chloride to the 
azide. The FT-IR spectrum showed the introduction of the azide bond at 2109 cm-1, 
but the GPC trace showed a small peak shift between the RAFT polymer and cleaved 
polymer, indicating successful azidation without the formation of a high molecular 
weight shoulder. Although this proves the potential for the RAFT cleavage for this 
reaction scheme, the synthesis is not sustainable for upscaling due to the large 
quantities of initiator consumed. With the azidation already causing a reduction in 
yields, an additional step caused undesirable loss of product and thus the efficiency of 
the overall synthesis.  
 
Figure 2.13. FT-IR spectra (A) showing the clear formation of the azide peak without the high molecular weight 
on the GPC trace (B) on conversion to pVBAz (grey) from the pVBC parent polymer after RAFT cleaved polymer 
(light blue) by radical induced RAFT cleavage. 
With the varying success of RAFT group cleavage and the proof that the RAFT end 
group was degrading to a thiol causing disulphide bridges, the reactions were 
continued as the disulphide bridges could be reduced at a later time, if required, 
without the loss of the azide. Reduction of the disulphide bridge in the presence of the 
azide would also lead to the reduction of the azide to an amine. The final step in the 
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production of the glycopolymer was to ‘click’ the alkyne sugar onto the backbone 
(Scheme 2.9).  
 
Scheme 2.9. Schematic of the synthetic route for the CuAAC reaction of P2 with a monosaccharide alkyne for 16 
hours at room temperature. 
The CuAAC system was changed for the post-modification compared with the pre-
modification due to 11 being partially soluble in methanol, whilst P2 is not. Because 
of this, the reaction could not take place in CuSO4.5H2O with Na-ascorbate. A 
selection of solvents was tested against all the components: Cu-catalyst, ligands as 
well as the monosaccharide alkynes and P2. It was found that DMSO and DMF were 
suitable candidates; however, DMF has a major peak at 8.0 ppm, the same resonance 
as the triazole of the glycopolymer, so DMF was therefore not used. Even though the 
monosaccharides and the polymer were soluble in DMSO, the copper (II) sulphate and 
Na-ascorbate were immiscible with DMSO. Therefore, a switch was made to Cu(I)Br 
and the ligand Me6TREN, which are both soluble in DMSO. The switch of solvents 
and reagents provided the correct conditions in which to undertake the click reaction.  
The resulting 1H NMR showed the addition of a triazole peak at 8.0 ppm for the single 
triazole. Referencing the triazole as 1, a ratio of 1:4:3 exists between the single 
hydrogen of the triazole, the four styrenic hydrogens between 6.0 – 7.2 ppm and the 
single hydrogen of the CH3 from them N-acetyl group at 1.60 ppm. This ratio suggests 
full conversion of the azide to the monosaccharide 11, this was also evident by the 
shift of the benzylic proton. This result is confirmed by FT-IR through the 
consumption of the azide peak at 2109 cm-1 (Figure 2.14).  
With the synthetic pathway ratified using 4 as the test monosaccharide with the parent 
polymer, P2, the other monosaccharides were converted into other glycopolymers 
(Table 2.5) using the same methodology. A statistical copolymer, P8, was produced 
by using equal quantities of 4 and 9. The 1H NMR showed a rough 50:50 average 
between the two monosaccharides, with the ratio being determined by the ratio of the 
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4: 1.5. This indicating 50% of the glycopolymer was GlcNAc compared to the styrene 
and triazole, therefore the remaining 50% is GlcA.  
 
 
Figure 2.14. An example of glycopolymer formed by CuAAC with P2 and 4 to form P6 with structural 
conformation by 1H NMR at 400 MHz in d-DMSO (top) showing the formation of the triazole and FT-IR (bottom) 
showing the reduction in N3 at 2109 cm-1 and the increase of the OH reigon. 
The clicking of protected sugars which were produced by indirect Fischer 
glycosidation was investigated. Although the click reaction was successful between 
P2 and acetylated form of compound 10, the acetylated glycopolymer produced was 
highly insoluble in methanol. These solvent mixtures proved to be ineffective in 
deprotecting the acetylated glycopolymers, so the monosaccharides produced by the 
indirect Fischer glycosidation were fully deprotected before the click reaction to avoid 
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Table 2.5. Summary of homopolymers synthesised by RAFT and click reactions. 
Entry Polymer 
Mn, (g mol—1) 
Ðb 
Theoa GPCb 
P2 pVBAz56 13400 13400 1.20 
P3 pVB-Glc56 32000 4400 1.07 
P4 pVB-Man56 32000 4400 1.08 
P5 pVB-Gal56 32000 4300 1.04 
P6 pVB-GlcNAc56 36000 6900 1.13 
P7 pVB-GlcA56 35000 6300 1.02 
P8 pVB-GlcA23-co-VB-GlcNAc23 35500 4100 1.04 
a 1H NMR (400 MHz, d-DMSO). bDMF + 5 mM NH4BF4 eluent, calibrated with PS standards. 
 
2.2.3. Synthesis of Alternating Glycopolymers 
2.2.3.1. Maleimide Synthesis 
The incorporation of a maleimide derivative into the polymerisation will take the 
homopolymer version to an alternating one. With the maleimide component, the 
choice is to either produce a click-based monomer or to modify MAh post-
polymerisation. Even though there are examples of post-modification, the MAh broke 
down during the polymerisation in the initial studies due to amine impurities in the 
solvents. The reactivity of the anhydride bond towards OH containing solvents led to 
ring opening of the MAh during precipitation. With the imide bond of the maleimide, 
whilst also susceptible, the probability is lower due to the lower reactivity of the 
unsaturated imide. The failure of the post-polymerisation modification of MAh comes 
due to the lack of a suitable point within the reaction scheme in which to form the 
imide (Scheme 2.10). The amine is able to break down both the chloride and the RAFT 
group, but the temperatures required would lead to the thermal decomposition of the 
azide or a monosaccharide. 
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Scheme 2.10. Schematic for the post-modification of MAh to an imide with the potential side reaction; substitution 
of chloride (A) and the thermal decomposition of azide (B) and monosaccharide (C). 
Due to the synthetic challenge of the post-modification of MAh, an N-substituted 
maleimide was used instead. Utilising the PMI, 14 (Figure 2.7) the copolymerisation 
with VBC was tested (Table 2.6) initially at low concentrations and at two different 
temperatures. This was due to the potency for a free alkyne to also undergo radical 
polymerisation. The Ð of entries showed fractional differences in the Ð but comparing 
the GPC traces at the two temperatures a cleaner peak was observed at 70 °C, as the 
GPC of the reaction run at 80 °C shows a much larger high molecular weight shoulder 
(Figure 2.15). This suggests the elevated temperatures promote the activation of the 
radical species on the alkyne.  
 
Figure 2.15. GPC traces of the copolymerisation at 70 ˚C (grey) and 80 ˚C (blue) of VBC and 14 at 70 ºC under 
RAFT conditions, showing increased high molecular weight shoulder with increased temperture. 
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The reaction was scaled up from 0.1 mmol to 1 mmol to produce a sufficient amount 
of polymer for further modifications, but when scaling-up crosslinking of the polymer 
was observed due to the formation of a gel-like substance. To try and produce the 
polymer at higher quantities, a batch experiment was run (Table 2.6 – Entry 4.1-10) 
to keep the concentration of the propargyl group at a minimum in the solution, in order 
to prevent crosslinking. The batch produced a wide range of Ð and Mn values for the 
same polymerisation and when combining the polymers followed by precipitation, the 
formation of a broad polymer Mn of 16,000 gmol-1 and a Ð of 1.74 was seen, exhibiting 
control over the polymerisation, but does not limit the high molecular weight shoulder 
of the alkyne polymerisation (Figure 2.16).  
 
Figure 2.16 GPC traces of the individual copolymerisation of VBC with 14 at 70 ºC under RAFT conditions at 10-
fold decrease in concentration, with the combined copolymersation after precipitation (offset black dotted).  
Reports in the literature24, 44-47 have previously shown that a free alkyne has the 
potential to be attacked by a radical in solution, but compared with the attack of the 
alkene by a radical, the homolytic bond breaking of pi bond of alkyne leaves one pi 
bond still intact. This pi bond is able to stabilise the radical. The polymer of acetylene 
type bond has been shown to be limited due to this stabilisation of the radical. The 
alkyne is a less reactive bond in PMI, it is a potential cross-linking molecule leading 
to broadening of the Ð. The radical on the alkyne, due to its stability, shows that as 
the reaction proceeds towards completion it also results to radical-radical coupling 
leading to coupling and termination of growing chains, which again will lead to a 
broadening of the Ð and irregularity of the polymers formed. Due to the peak 
broadening, the alkyne was protected with a trimethylsilane (TMS) group in order to 
inhibit the polymerisation of the alkyne, to be deprotected before the click reaction. 
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Table 2.6. The polymerisation of VBC and PMI under RAFT polymerisation in 1,4-Dioxane. 
Entry Scale (mmol) Temp (°C) [M]:[N] 
Mn (g mol-1) 
Ð b 
Theoa GPCb 
1 0.1 70 20:20 6100 16000 1.45 
2 0.1 80 20:20 6100 16500 1.47 
3 1 70 50:50 15000 Crosslinked 
4.1 0.1 70 17:20 2400 14700 1.68 
4.2 0.1 70 17:20 2400 14800 1.89 
4.3 0.1 70 17:20 2400 12100 1.57 
4.4 0.1 70 17:20 2400 13700 1.68 
4.5 0.1 70 17:20 2400 13100 1.63 
4.6 0.1 70 17:20 2400 14200 1.72 
4.7 0.1 70 17:20 2400 14300 1.83 
4.8 0.1 70 17:20 2400 13500 1.65 
4.9 0.1 70 17:20 2400 13200 1.58 
4.10 0.1 70 17:20 2400 14800 1.88 
a 1H NMR (400 MHz, d-DMSO), bDMF + 5 mM NH4BF4 eluent, calibrated with PS standards. 
Several options are available in order to produce 18, which can be seen in Scheme 
2.11. Initially, the pre-existing synthetic route for 14 (Figure 2.7) was extended to 
include protection of the terminus hydrogen with trimethylsilane chloride (TMS-Cl) 
(Route A). The reaction successfully produced 18, but due to the low yield of the ring 
opening and closing producing little starting material for the formation of 18 from 14, 
the reaction was reformulated so that the TMS was already present in the molecule, so 
the ring closing reaction was the final reaction (Route B). By forming the TMS 
protected propargylamine 16 and incorporating this into the ring opening and closing 
reactions, compound 18 could be successfully synthesised. Whilst 18 was produced 
with good purity, the yield over the 3-step reaction results in a costly and dangerous 
route, because of the use of n-BuLi and low efficiency of this approach. 
An alternative strategy was to form an N-methoxycarbonylmaleimide (19), which can 
readily form N-substituted maleimides by the nucleophilic attack of methyl 
chloroformate by maleimide. These species can react with amines to substitute the R 
group of the amine. While examples of PMI formation via route C, the reaction was 
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less efficient when using the TMS PMI for route D with lack of evidence supporting 
the formation of 18 by this route.  
 
Scheme 2.11. Scheme for the synthetic pathway to TMS PMI (15) via multiple synthetic routes. 
The Mitsunobu reaction (Route E) presented an alternative route to the synthesis of 
the maleimide 18 in a single step, with the use of TMS propargyl alcohol, which is 
commercially available, thus avoiding the use of n-butyl lithium (n-BuLi) and 
reducing the overall hazard in the formation 18.  
Table 2.7. Result for the formation of 18 by various different synthetic pathways. 
Reaction pathway No Steps Overall Yield 
A 3 14 % 
B 3 28 % 
C 3 6 % 
D 2 0 % 
E 1 33% 
F 1 0 % 
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Over a single step, it produces the highest yield for the formation of 18, compared 
with the multiple step routes A-D. Finally, route F was also attempted as a single step, 
but this reaction produced 0% conversion as the 1H NMR showed no shift in the CH2 
of the propargyl group, which if reacted would move downfield due to the addition of 
the heavily electron withdrawing maleimide group in a similar manner seen for the 1H 
NMR of route E.  
Using the synthetic route D, 18 was synthesised and after purification, by column 
chromatography (x 2), the product was be isolated as a mixture of isomers, which can 
be seen by the small secondary peaks of the alkene hydrogens and the CH2 adjacent 
to the amine on the 1H NMR (Figure 2.17A). The 1H NMR shows a slight upfield of 
the CH2 and TMS upon the addition to maleimide, whereas the maleimide CH shows 
only a small shift due to its distance from the centre of reaction. 
 
Figure 2.17. Compound 18 1H NMR spectra at 400 MHz in CDCl3 (A) of maleimide (grey), TMS propargyl alcohol 
(light blue) and the final product (18) (blue) with the FT-IR (B) of 18. 
The FT-IR shows the stretch of the alkyne, which is not visible in unprotected PMI 
(Figure 2.17B). This is due to an increased molecular weight on the terminus alkyne 
of the TMS compared to a single hydrogen, which effects the reduced mass Equation 
2.1 which links into FT-IR stretches.  
 µ = 	 𝑚@𝑚A𝑚@ +𝑚A Equation 2.1 
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2.2.3.2. Polymerisation of an Alternating Backbone 
 
Scheme 2.12. The Polymerisation of 18 with VBC by RAFT to form P9 at 80 ℃ for 5 hours in a ratio 50:25:1:0.2 
(18: VBC: RAFT: Initiator) in DMSO. 
Using 18 as the co-monomers in a styrene-maleic anhydride-based system, with VBC 
utilising RAFT polymerisation (Scheme 2.12), the kinetics of the copolymerisation 
system showed that the reaction was proceeding under control by RAFT (as shown by 
the Ð and Mn) over the course of the polymerisation (Figure 2.18). The Ð shows a 
drop off after 2 hours, this is due to the starting material of 18 in the GPC overlapping 
in retention for the first few measurements. This initial high Ð is due to the TMS-PMI 
which elutes from the GPC at the lower end of the styrene calibration window 
affecting the Ð until the polymer is large enough to elute with a clear resolution from 
the remaining monomer. 
 
Figure 2.18. Polymerisation of 18 and VBC monitoring the parameters of Ð and Mn over the initial 2 hours of the 
polymerisation with the theoretical Mn (dotted line). 
An alternating polymerisation can be determined by few methods including the Mayo-
Lewis equations, MALDI-ToF, 13C NMR and kinetics. The reactivity ratios of a co-
monomer system set by Mayo-Lewis48, Equation 2.2 to Equation 2.7 shows the potential 
reactions which can occur during the polymerisation with M1 and M2 being the two 
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𝑀@∗ + 𝑀@ EFFGH	𝑀@𝑀@∗ Equation 2.2 𝑀@∗ + 𝑀A EFIGH	𝑀@𝑀A∗ Equation 2.3 𝑀A∗ + 𝑀@ EIFGH	𝑀A𝑀@∗ Equation 2.4 𝑀A∗ + 𝑀A EIIGH	𝑀A𝑀A∗ Equation 2.5 𝑟@ = 	𝑘@@𝑘@A Equation 2.6 𝑟A = 	𝑘AA𝑘A@ Equation 2.7 
 
The reaction rate constant can be used to determine the reactivity ratios which 
determine how the polymer grows i.e.: 
• k11 > k12 and k22 > k21 (block polymer)  
• k11 = k12 and k22 = k21 (statistical copolymer) 
• k11 < k12 and k22 < k21 (alternating polymer) 
 
From these equations, it can be determined if the VBC and TMS PMI form an 
alternating polymer in the RAFT polymerisation condition. This is because the 
maleimide will not homopolymerise under RAFT conditions. However, it has been 
shown that maleimides will homopolymerise by other techniques, for example by 
nucleophilic initiated polymerisation with nucleophiles as amines49 and thiols50. 
Maleimides have been shown to accelerate the consumption of VBC compared with 
the homopolymerisation of VBC (Figure 2.19). Over prolonged periods, VBC will 
polymerise to a small extent, as shown in the previous section (2.2.2.3. ). From these 
results, it was shown that k11 << k12 and k22 < <k21, therefore forming a kinetic point 
and the polymer produced is an alternating polymer.  
The rates of polymerisation (Kpapp) of the monomers in the copolymerisation system 
also show alternation in behaviour. This is shown by the two monomers that are 
consumed at the same rate, as denoted by the dashed trend lines with equivalent 
gradients of 0.47 inferring they are incorporated into the polymer at the same rate. If 
these two were inequivalent, then this would indicate a random or block copolymer 
formation. This, along with the known inability of maleimide to homopolymerise, 
again infers the alternation of the polymer.  
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Figure 2.19. The kinetic plot of VBC (blue) and 18 (grey) in a homopolymerisation (shaded) and copolymerisation 
(hollow) system with corresponding trends line, where Kpapp is equivalent to the gradient. 
MALDI-TOF was used to test the alternation of the backbone to search for the repeat 
unit. From the MALDI-ToF mass spectroscopy (MS) spectrum (Figure 2.20) taken 
between the major peaks, a difference of 360 Da is detected. This is consistent with 
the sum of the masses of VBC and TMS PMI. There are several smaller peaks which 
are summarised in Table 2.8. From the previous literature about kinetics and MALDI-
ToF MS analysis, the system shows good alternation behaviour, with tolerance over 
the bulky side chains of the monomers. The polymerisation was precipitated in 
methanol, this led to ring opening of the PMI ring with the methanol to show an OMe 
adduct as a small impurity. The proceeding runs of this polymerisation was therefore 
precipitated in isopropanol as the hydroxyl is sterically hindered and therefore will 
reduce this ring-opening pathway. 
















TMS PMI VBC 
R2 = 0.998
Kp app = 0.47 ± 0.01 
R2 = 0.997
Kp app = 0.47 ± 0.01 
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Figure 2.20. Low-resolution MALDI-ToF of P3 (a) with a labelled zoom between 4900 – 5400 Da (b) showing the 
minor distributions (Table 2.8) within the repeat of 360 Da for the two monomers. 








A - 4972 4987 




C - 5126 5139 
D - (PVBC12-alt-TMS PMI14) 5182 5195 




F - 5335 5349 
G - (PVBC13-alt-TMS PMI13/TMS PMA+OMe) 5366 5380 
aDetermined by sum of the monomer mass plus either the RAFT agent or the Initiator bMALDI-ToF peaks. 
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2.2.3.3. Grafting of the Monosaccharides onto the Alternating Polymer 
With the polymerisation of the monomers being shown to produce a highly alternating 
backbone, the synthesis began to move towards the grafting of the sugars onto the 
polymer. The initial polymer product has two potential orders in which to graft the 
sugars upon. The TMS group can be cleaved by K2CO3 to give a free alkyne or, 
alternatively, the chloride can be substituted in the same manner which produced the 
homopolymers to form an azide. The chloride groups in the polymer are highly 
reactive species that can be easily substituted, whilst the TMS group is in comparison 
more stable, therefore the click synthesis onto the benzylic position was run first, 
followed by the grafting on the maleimide alkyne (Scheme 2.13). 
In a similar manner to the homopolymer system, the chloride was substituted with 
sodium azide. This again led to a broadening of the Ð due to the RAFT agent breaking 
down and forming disulphide bonds. The FT-IR showed the addition of an azide peak 
at 2096 cm-1, whilst maintaining the TMS group of the alkyne at 2184 cm-1 (Figure 
2.21).  
 
Figure 2.21. FT-IR spectra of P9 (blue), P10 (light blue), P11 (grey) followed by P12 (dark grey) highlighting the 
key groups of OH, alkyne, N3 and COOH as the alternating polymer is functionalised with GlcNAc and GlcA units. 
Graphs offset by 0.15 
The azide is then consumed during the 1,3-Huisgen cycloaddition, which was 
confirmed by the reduction of the peak at 2096 cm-1 with the survival of the TMS 
group seen in the IR and 1H NMR at 0.12 ppm. The IR also shows the retention of the 
OH groups within the polymer from the hydroxyls on the sugar post lyophilisation. 
The 1H NMR also indicates the addition of a triazole peak at 7.91 ppm, along with an 
introduction of sugar peaks between 4.0 – 5.0 ppm, as well as the N-acetyl group of 
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the reaction has gone to full conversion due to the shift in the benzylic CH2 and the 
formation of the triazole peak in the 1H NMR. 
 
Scheme 2.13. Synthesis of alternating glycopolymer (P12) to mimic the structure of hyaluronan through controlled 
CuAAC, deprotection and Sn2 reactions. 
With the confirmation of the first of the two monosaccharides, 4, successfully clicked 
onto the polymer, the TMS group could now be removed from the polymer to expose 
the free alkyne. During dialysis of P11, the water was supplemented with K2CO3. The 
method of dialysis removes the excess propargylated sugar, at the same time the 
K2CO3 within the first few cycles caused the cleavage of the TMS group from the 
maleimide. The polymer was then dialysed against pure water to reduce the salt 
content, which was later freeze-dried to give the polymer as an off-white powder. The 
FT-IR showed a removal of the peak at 2184 cm-1; this is due to the stretch of the 
hydrogen alkyne being unable to measure by this form of IR with the 1H NMR 
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Figure 2.22. 1H NMR spectra at 400 MHz in d-DMSO of P11 showing the first CuAAC success with TMS group 
still intact. 
With the alkyne group deprotected, the second of the 1,3-Huisgen cycloadditions can 
be run to attach the second sugar, 11. Using the same methodology as in the previous 
example, the click reaction was carried out producing in quantitative conversions an 
alternating glycopolymer based on HA structure. The FT-IR showed the broadening 
of the C=C region at 1672 cm-1 due to the introduction of a C=O of the carboxylic acid 
functional group on 11 (Figure 2.21). Since these two groups vibrate within the same 
region, this is seen by a widening of the band. 
Table 2.9. Summary of homopolymers synthesised by RAFT and click reactions. 
Entry Polymer 
Mn (g mol-1) 
Ðb 
Theoa GPCb 
P9 pVBC24-alt-TMS PMI24 12800 19500 1.57 
P10 pVBAz24-alt-TMS PMI24 19900 18300 2.40 
P11 pVB-GlcNAc24-alt-PMI24 27000 4800 1.02 
P12 pVB-GlcNAc24-alt-PMI-GlcA24 40000 5700 1.06 
a 1H NMR (400 MHz, d-DMSO). bDMF + 5 mM NH4BF4 eluent, calibrated with PS standards. 
The FT-IR reveals a qualitative increase in the OH peaks, whilst the 1H NMR shows 
more of a quantitative change (Figure 2.23). The ratio of 1: 4: 3 between the triazole: 
styrene: acetyl increases to 2: 4: 3 after the second click reaction. An increase is also 
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seen in the number of hydrogens associated with the region in the 1H NMR with the 
protons of the ring of the monosaccharide between 3.0 - 4.5 ppm. 
 
Figure 2.23. 1H NMR spectra at 400 MHz in D2O of P12 showing the second CuAAC success. 
The results from the FT-IR and the 1H NMR show the successful synthesis of the 
alternating glycopolymer. The GPC shows a change in hydrodynamic volume in DMF 
as on the addition of the sugar, a drop-in value output by the GPC decrease in both Mn 
and Ð on the addition of the sugars onto the polymer. 
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2.3. Conclusion 
To conclude, we have successfully produced a range of glycopolymers (homo and 
alternating) and characterised them by various methods, including 1H NMR, FT-IR 
and MALDI. We first looked into the production of glycomonomers, which in the 
styrene-based monomer was possible. However, these monomers were unable to 
polymerise under the several conditions tested. This led to the synthetic pathway to 
become a post-polymerisation modification rather than a pre-polymerisation 
modification. This post-modification provided a much better control of the polymers 
being produced, especially in the later alternating system, as the steric bulk of the 
sugars had the potential to disturb the polymerisation. Using post-polymerisation 
techniques, we were able to show the conversion of a homopolymer of VBC, P1 to a 
full glycopolymer, by the conversion to an azide based polymer P2 followed by 
CuAAC to produce a range of glycopolymers with various monosaccharide pendant 
groups.  
We selected the homopolymerisation synthetic pathway and incorporated a propargyl 
functionalised maleimide within the system, causing broadening of the Ð. This was 
improved by the addition of a TMS protecting group to inhibit the alkyne 
polymerisation. The incorporation of the TMS propargyl group was tested in many 
different reaction pathways in order to find the most suitable one. We showed the 
increase in steric upon the styrene-maleic anhydride based alternating system of VBC 
and 18 indicated no detrimental effects on the alternation of the polymer backbone 
when producing P9. Through the careful arrangement of the post-polymerisation 
modifications of the backbone, we could produce a fully alternating glycopolymer as 
shown by 1H NMR, MALDI and GPC. 
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2.4. Experimental  
2.4.1. Materials  
Vinylbenzyl chloride (VBC, ≥90% (GC), 0.05% 4-tert-butylcatechol and 0.05% 
nitroparaffin as stabilizer), N-acetyl-D-glucosamine (GlcNAc, >99%), D-Glucuronic 
Acid (GlcA, >98 %), sodium azide (NaN3, ≥99.5%), propargyl alcohol (99%), 
propargyl acrylate (98%), D-(+)-mannose (Man, ≥99%), D-(+)-galactose (Gal, 
≥99%), D-(+)-glucose (≥99%), sodium methoxide (CH3ONa, 25 wt.% in methanol), 
maleimide (99%), dichloromethane (DCM, >99%), methanol (CH3OH, >99.9%), 
acetic acid (AcOH, >99.9%), iodine (I2, >99.9%), sulphuric acid (H2SO4, 95-98%), 
ethyl acetate (EtOAc, 95%), sodium acetate (NaOAc, >99%), boron trifluoride-diethyl 
etherate (BF3OEt2, synthesis grade), dimethyl formaldehyde (DMF, >99.9%), 
iodomethane (MeI, copper stabilised, 99.5%) 2-bromoethanol (95%), 
Tetrabutylammonium bromide (NBu4Br, 98%), diethyl ether (Et2O, 1ppm BHT 
inhibitor, >99.7%, dimethyl sulfoxide (DMSO, anhydrous, >99.9%), 
Triphenylphosphine (PPh3, >95%), Tetrahydrofuran (THF, anhydrous, 99.9%), 
diisopropyl azodicarboxylate (DIAD, 98%) (6.1 mL, 30.9 mmol), 3-
(Trimethylsilyl)propargyl alcohol (99%), hexane (>95%), maleic anhydride (MAh, 
>95%), propargylamine (98%) and copper bromide (CuBr2, 99.9%) were purchased 
from Sigma Aldrich. Sodium thiosulfate (Na2S2O3), magnesium sulfate (MgSO4), 
sodium chloride (NaCl), sodium bicarbonate (NaHCO3), silica, potassium carbonate 
(K2CO3) and aluminium oxide (Al2O3) were purchased from VWR. All monomers 
were passed through basic Al2O3 before use in polymerisations. 1 kDa dialysis tubes 
was purchased from Spectrum Laboratories (California, USA).  
 
2.4.2. Instruments and Analysis 
2.4.2.1. Gel Permeation Chromatography (GPC).  
Size-exclusion chromatography measurements were conducted on an Agilent 1260 
infinity system operating in DMF with 5 mM NH4BF4 and equipped with 2 PLgel 5 
μm mixed-C columns (300 × 7.5 mm), a PLgel 5 mm guard column (50 × 7.5 mm), a 
differential refractive index (DRI) and a variable wavelength detector (VWD). The 
system was eluted with DMF at a flow rate of 1 mL min-1 and the DRI was calibrated 
with linear narrow polystyrene standards. 
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2.4.2.2. Nuclear Magnetic Resonance (NMR) Spectroscopy  
Spectra of the molecules were collected on a Bruker AV-III spectrometer at 400 MHz 
for 1H NMRs and at 101 MHz for 13C NMRs. CDCl3 was used as a solvent and the 
resonance signal at 7.26 ppm (1H) and 77.16 ppm (13C) served as a reference for the 
chemical shift δ of the spectra. 
 
2.4.2.3. Matrix Assisted Laser Deposition Ionisation Time of Flight (MALDI-ToF).   
The polymers were analysed on a Bruker Daltonics AuToFlex MALDI-ToF mass 
spectrometer equipped with a nitrogen laser at 337 nm and positive ion ToF detection. 
The samples were prepared in a 9:1:1 mixture from a solution of the matrix (30 
mg/mL), potassium trifluoroacetate (10 mg/mL) with the sample (10 mg/mL) 
dissolved in THF and 2 μL being deposited onto the stainless-steel target plate. Spectra 
were recorded in reflectron mode with the laser set at 20-30% power and the mass 
spectrometer was calibrated against polymers at mixture up to 6000 Da.  
 
2.4.3. Methods 
2.4.3.1. Monosaccharide functionalization  
2.4.3.1.1. General procedure of the synthesis of Prop-2-ynyl monosaccharides (1 - 4).  
The synthesis has been modified from a previously reported method51. The example 
given for 4. Briefly, GlcNAc (10.01 g, 45.3 mmol) was suspended in propargyl alcohol 
(25 mL, excess) which was heated to 65 ºC. H2SO4.Silica (1.30 g, 30 mg per mmol) 
was added and the reaction was stirred for 16 hours. The reaction mixture was added 
to a silica column with the propargyl alcohol eluted with DCM and then the product 
was eluted out with methanol (100 %). The product was reduced under reduced 
pressure with the resulting oil being suspended in water and lyophilized to produce a 
yellow powder. 
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2.4.3.1.2. Prop-2-ynl-D-glucopyranoside (1) 
 
1H NMR  
(CDCl3, 400 MHz) 
d: 5.11 (d, 0.4H, J = 3.8 Hz H-1), 4.67 (d, 0.6 H, J = 12 Hz, 
1H, H-1), 4.50 (t, J = 3.0 Hz, H-2), 4.36 (1H, q, J = 2.3 Hz 
CH≡CH), 4.25 (d, 0.6H, J = 2.4 Hz) 3.96–3.69 (3H, m, H-6, 
H-5) 3.55-3.29 (2H, m H-4, H-3), 2.93 (1H, dt, 11 Hz, J = 2.4 
Hz, CH≡CH). 
 
2.4.3.1.3. Prop-2-ynl-D-mannopyranoside (2) 
 
1H NMR  
(CDCl3, 400 MHz) 
d: 5.05 (d, 0.4H, J = 1.6 Hz H-1), 4.67 (d, 0.6 H, J = 12 Hz, 
1H, H-1), 4.50 (t, J = 3.0 Hz, H-2), 4.32 (1.4H, dd, J = 6.1 Hz, 
2.4 Hz CH≡CH), 4.25 (d, 0.6H, J = 2.4 Hz, CH≡CH) 3.96–
3.68 (5H, m, H-6, H-5, H-4, H-3), 2.94 (0.75 H, t, J = 2.4 Hz, 
CH≡CH) and 2.86 (0.75 H, t, J = 2.4 Hz, CH≡CH).  
 
2.4.3.1.4. Prop-2-ynl-D-galactucopyranoside (3) 
 
1H NMR  
(CDCl3, 400 MHz) 
d: 5.17 (dd, 0.75H, J = 15.6 Hz, 2.8 Hz H-1), 4.59 (d, 0.25 H, 
J =12 Hz, 1H, H-1), 4.36 (1.4H, dd, J = 2.4 Hz CH2≡CH), 
4.25 (d, 0.6H, J = 2.4 Hz, CH≡CH) 4.12–3.67 (5H, m, H-6, 
H-5, H-4, H-3), 2.93 (0.75 H, t, J = 2.4 Hz, CH≡CH) and 2.85 
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2.4.3.1.5. Prop-2-ynl 2-acetamido-2-deoxy-D-glucopyranoside (4) 
 
1H NMR  
(CDCl3, 400 MHz) 
d: 5.10 (d, 0.4H, J = 4 Hz H-1), 4.77 (d, 0.6 H, J = 12 Hz, 1H, 
H-1), 4.36 (1H, q, J = 14.0 Hz, 2 Hz CH≡CH), 3.98 (1H, t,  
H-2), 3.74 – 3.84 (3H, m, H-6, H-5), 3.50-3.63 (2H, m, H-4, 
H-3), 2.96 (1H, dt, J = 11 Hz, 2.4 Hz, CH≡CH), 2.09 (3H, s, 
NH(O)CH3). 
FT-IR (ATR): 3274 (br, OH), 2931 (w, C-H), 2118 (w, C≡C), 1650 (s, 
C=O).14, 1556, 1438,1417,1387, 1316, 1254 (w, C-O), 1099, 




GlcNAc (4.01 g, 18.13 mmol) was suspended in acetic anhydride (20 mL) followed 
by I2 (1.98 g) and stirred for 48 hours. DCM (50 mL) was added to the suspension and 
the solution was then added to ice, washed with Na2S2O3 (1 M, 100 mL) and the phases 
separated. The aqueous layer was washed with DCM (2 x 50 mL). The organic layers 
were combined, washed with NaHCO3. sat (50 mL) and then dried over MgSO4, 
filtered and reduced under reduced pressure. The oil produced was placed under high 
vac to give a white powder (6) (5.61g, 14.40 mmol, 80%). 
 
1H NMR  
(CDCl3, 400 MHz) 
5.70 (d, J = 8.7 Hz, 1H H-1), 5.60 (d, J = 9.3 Hz, 1H, NH), 
5.17 - 5.11 (m, 2H, H-2, H-5), 4.34 - 4.25 (m, 2H, H-4) 4.13 
(dd, 2.1 Hz, J = 10.4 Hz, CH2), 2.12 (s, 3H CH3), 2.10 (s, 3H 
CH3) 2.12 (s, 3H CH3), 2.05 (s, 3H CH3), 2.04 (s, 3H CH3), 
1.94 (s, 3H NCH3) 
FT-IR (ATR): 3434 (w, C-H), 1715 (s, C=O), 1672 (s, C=O), 1510, 1361, 


















2-Acetamido-1,3,4,6-tetra-O-acetyl-2-deoxy-glucopyranose (500 mg, 1.28 mmol) 
was suspended in anhydrous DCM (20 mL) and cooled to 0 ºC. BF3OEt2 (0.68 mL, 
5.27 mmol) was added dropwise and then stirred at 0 ºC for 30 minutes after which 
point propargyl alcohol (0.38 mL, 6.6 mmol) was added and heated to reflux. After 5 
hours, the solution was quenched with DCM (100 mL), washed with NaHCO3. sat (2 
x 100 mL), H2O (100 mL) followed by NaCl. sat (100 mL). The organic layer was 
dried over MgSO4 and reduced under vacuum to produce an oil. The oil was placed 
under high vacuum to form a white solid (231.8 mg, 0.6 mmol, 47%). 
 
1H NMR  
(CDCl3, 400 MHz) 
5.92 (s, 1H, NH), 5.33 - 5.20 (m, 2H, H-3, H-5) 5.04 (t, 1H, J 
= 8.3Hz, H-2), 4.85 (d, 1H, J = 8.3 Hz, H-1), 4.40 (t, 2H, J = 
1.9 Hz, CH2≡CH) 2.48 (t, 1H, J = 2.4Hz, CH2≡CH) 2.07, 2.03 
(s, 9H, Ac), 1.94 (s, 3H NCH3) 
FT-IR (ATR): 2950 (w, C-H), 1743 (s, C=O), 1664 (s, C=O), 1510, 1371, 




The synthesis has been modified from a previously reported method29. Briefly, GlcA 
(5.14 g) was added to a stirring solution of Ac2O (25 mL, 264 mmol) followed by the 
addition H2SO4 (conc. 5 drops) which was then heated to 65 ºC. Once the sugar was 
dissolved, more GlcA (5.09 g) was added (Total GlcA; 10.23 g, 52.7 mmol). The 
solution was stirred for an hour and then cooled to 25 ºC. H2O (75 mL) was added and 
then the product was extracted into DCM (3 x 50 mL). The organic layers were 
combined, dried over MgSO4 and reduced under reduced pressure and azeotroped 
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1H NMR  
(CDCl3, 400 MHz) 
6.43 (bs, 1H COOH), 5.78 (d, J = 7.5 Hz, 1H, H-1), 5.29 (m, 
2H, H-2, H-5), 5.12 (m, 1H, H-3), 4.24 (m, 2H, H-4), 2.10, 
2.03, 2.02, 2.01 (4s, 12H, OAc) 
FT-IR (ATR): 3303 (br, O-H), 2950 (w, C-H), 1756 (s, C=O), 1726 (s, C=O) 
1392, 1369, 1510, 1361, 1205 (C-O), 1122, 1045,1005, 892, 
657, 597, 565, 495  
 
2.4.3.1.9. Methyl 1,2,3,4-tetra-O-acetyl-α-D-glucopyranuronate 
 
The crude 1,2,3,4-tetra-O-acetyl-α-D-glucopyranuronate was dissolved in DMF (25 
mL) and reacted with NaHCO3 (8.9 g, 106 mmol) followed by the addition of MeI 
(8.2 mL, 132 mmol). The reaction was stirred for 16 hours at 25 ºC. and then quenched 
with H2O (200 mL). The product was extracted into EtOAc (3 x 200 mL). The organic 
layers were combined, dried over MgSO4 and concentrated under reduced pressure. 
The resulting oil was taken up in acetone and precipitated in water. The precipitate 
was filtered and dried under vacuum to give a white powder (12.74 g, 33.9 mmol, 64 
%). 
 
1H NMR  
(CDCl3, 400 MHz) 
5.76 (d, 1H, J = 7.7 Hz, H-1), 5.31 (t, 1H, J = 10.0 Hz, H-3), 
5.25 (t, J = 9.4 Hz, H-4), 5.14 (t, 1H, J = 8.9 Hz, H-2), 4.18 
(d, 1H, J = 9.5 Hz, H-5), 3.74 (s, 3H, OCH3), 2.11 (s, 3H, 
CH3), 2.03 (s, 6H, 2 x CH3), 2.02 (s, 3H, CH3). 
FT-IR (ATR): 2948 (w, C-H), 1749 (s, C=O), 1436, 1369, 1209 (s, C-O), 




The synthesis method has previously been reported52. Briefly, 2-bromoethanol (10 g, 
80 mmol) was suspended in H2O (20 mL) followed by the addition of NaN3 (9.53 g, 
144 mmol) and NBu4Br (590 mg). The reaction was stirred for 16 hours at 80 ºC. The 
reaction was cooled and extracted into Et2O (10 x 50 mL). The organic layers were 
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1H NMR  
(CDCl3, 400 MHz) 
3.73 (t, 2H, J = 4.5 Hz, CH2OH), 3.38 (t, 2H, J = 4.5 Hz, 
CH2N3). 
FT-IR (ATR): 3373 (br, O-H), 2935 (w, C-H), 2098 (s, N3), 1441, 1347 1283 
(w, C-O), 1060, 977, 877, 828, 631, 554, 503 
 
2.4.3.1.11. General procedure for the glycosidation by Lewis acid 
Methyl 1,2,3,4-tetra-O-acetyl-α-D-glucopyranuronate (1 equiv) and propargyl alcohol 
(4 equiv) was suspended in anhydrous DCM (25 mL). The reaction was cooled to 0 
ºC at which point BF3.OEt2 (2 equiv) was added. The reaction was stirred at 0 ºC for 
15 minutes and then allowed to warm to 25 ºC and stirred for 16 hours. The reaction 
was diluted with DCM and then washed with water (2 x 50 mL) and brine (50 mL). 
The organic layers were combined, dried over MgSO4 and reduced under reduced 
pressure. The oil was purified by flash chromatography, EtOAc: hexane (1:1). 
 
2.4.3.1.12. Methyl 2,3,4-tri-O-acetyl-1-propargyl-α-D-glucuronate (9) 
 
Methyl 1,2,3,4-tetra-O-acetyl-α-D-glucopyranuronate (5.06 g, 13.4 mmol) and 
propargyl alcohol (3.2 mL, 54.8 mmol) was suspended in anhydrous DCM (25 mL). 
The reaction was cooled to 0 ºC at which point BF3.OEt2 (3.3 mL, 25.3 mmol) was 
added producing an off-white solid (2.94 g, 7.90 mmol, 59%) 
 
1H NMR  
(CDCl3, 400 MHz) 
5.76 (d, 1H, J = 7.7 Hz, H-1), 5.49 (t, 1H, J = 10.0 Hz, H-3), 
5.28-5.10 (m, 3H, H-4, H-2), 4.82 (d, 1H, CH2C≡CH), 4.18 
(d, 1H, J = 9.5 Hz, H-5), 3.73 (s, 3H, OCH3), 2.63 (t, 2H, 
C≡CH) 2.11 (s, 3H, CH3), 2.03 (s, 6H, 2 x CH3), 2.02 (s, 3H, 
CH3). 
FT-IR (ATR): 3278 (w, C-H), 1743 (s, C=O), 1437, 1369, 1212, 938, 897, 
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2.4.3.1.13. Methyl (2-azidoethyl 2,3,4-tri-O-acetyl-β-D-glucopyranosid)uronate (10) 
 
Methyl 1,2,3,4-tetra-O-acetyl-α-D-glucopyranuronate (5.03 g, 13.4 mmol) and 2-
azidoethanol (2.6 mL, 52.6 mmol) was suspended in anhydrous DCM (25 mL). The 
reaction was cooled to 0 ºC at which point BF3.OEt2 (3.3 mL, 25.3 mmol) was added.  
 
1H NMR  
(CDCl3, 400 MHz) 
d 5.49 (t, 1H, J = 10.1 Hz, H-2), 5.21 (q, 2H, J = 9.4 Hz, H-3, 
H-4), 5.09 (dd, 1H, J = 8.4 Hz, 3.7 Hz, H-5), 4.63 (d, 0.4 Hz, 
J = 7.7 Hz, H-1), 4.38 (d, 0.4 Hz, J =10.2 Hz, H-1), 4.21 (t, 
2H, J = 5.1 Hz, CH2N3), 3.73 (s, 3H, OCH3), 3.45 (t, 2H, J = 
5.2 Hz, OCH2), 2.48 (m, 1H, CH)  2.02 (s, 3H, CH3), 2.01 (s, 
3H, CH3), 1.98 (s, 3H, CH3). 
FT-IR (ATR): 2957 (w, C-H), 2106 (s, N3), 1743 (s, C=O), 1438, 1370, 
1209, 1038, 936, 893, 599, 508 
 
2.4.3.1.14. Vinylbenzyl azide (11) 
 
VBC (9.8 mL, 65 mmol) was added dropwise to a solution of NaN3 (8.58 g, 130 mmol) 
in DMSO (100 mL) at 80 ºC and left to stir for 16 hours. The solution was cooled and 
diluted with ether (100 mL) and washed with H2O (3 x100 mL). The aqueous layers 
where collected and washed with ether (3 x 100 mL). All the organic layers where 
combined and dried over MgSO4, filtered then reduced under vacuum to give a yellow 
oil (8.84 g, 56 mmol, 86%) 
 
1H NMR  
(CDCl3, 400 MHz) 
d: 7.43 (d, 2H, J = 8.1 Hz, Ortho-CH), 7.28 (d, 2H, J = 8.1 
Hz, Meta-CH), 6.73 (dd, 2H, J = 16.8, 10.0 Hz, CH=CH2), 
5.77 (d, 1H, J = 16.8 Hz, trans-CH=CH2), 5.28 (d, 1H, J = 
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13C NMR 
(CDCl3, 133 MHz) 
137.82 (Para-CH), 136.38 (1C, CH=CH2), 134.95 (1C, C) 
128.59 (2C, Ortho-C), 126.78 (2C, Meta-C), 114.59 (1C, 
CH=CH2), 54.70 (1C, CH2N3) 
FT-IR (ATR) 3004 (CH), 2977 (CH), 2098 (N3), 1710 (C=C), 1678 (C=C), 






Vinylbenzyl azide (2.76 g, 17.74 mmol) and 1.4.3.5 - Prop-2-ynl 2-acetamido-2-
deoxy-D-glucopyranoside (3.00 g, 13.59 mmol) in methanol (10 mL) was purged in 
N2 for 30 minutes. The CuSO4.5H2O (0.15 g, 0.07 mmol) in H2O (2 mL) was added 
followed by Na-Ascorbate (0.23 g, 1.11 mmol) in H2O (3 mL); the reaction was sealed 
and stirred for 16 hours at 25 ºC. The reaction crude was reduced in reduced pressure 
and diluted in water (100 mL). The aqueous layer was washed with DCM (3 x 100 
mL) and the aqueous layer passed through Al2O3 (neutral). The solution was 
lyophilised forming an off-white powder (3.61 g, 8.79 mmol, 64 %). 
  
1H NMR  
(CDCl3, 400 MHz) 
d: 8.04 (s, 0.4 H, Triazole-CH), 8.00 (s, 0.6H, Triazole-CH), 
7.51 (d, 2H, J = 8.1 Hz, ortho-CH), 7.33 (t, 2H, J = 8.2 Hz, 
meta-CH), 6.78 (dd, 1H, J = 17.7 Hz, 11.0 Hz, CH=CH2), 
5.85 (d, 1H, J = 17.7 Hz, CH=CH2-trans), 5.59 (s, 2H, CH2), 
5.33 (d, 1H J = 11.0 Hz,  CH=CH2-cis), 4.85 (m, 1H, H-1), 
4.56 (d, 1H, J = 8.4 Hz, H-1), 3.42 – 3.86 (m, 6H, H-2, H-3, 
H-4, H-5, H-6), 1.85 (s, 1.7 H, CH3), 1.79 (s, 1.3H, CH3) 
FT-IR (ATR) 3291 (br, OH), 3086 (w, CH), 2928 (w, CH), 1615 (C=C), 
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1110, 1034, 947, 916, 827, 792, 715, 661, 610, 550, 526, 518, 
511 
 
2.4.3.1.16. (E)-4-oxo-4-(prop-2-yn-1-yl amino)but-2-enoic acid (13) 
 
MAh (10.0 g, 105 mmol) and propargylamine (6.5 mL, 103 mmol) were suspended in 
AcOH (50 mL) and stirred for 16 hours in the dark. The orange suspension was dried 
under reduced pressure to produce the intermediate yellow.  
 
1H NMR  
(CDCl3, 400 MHz) 
6.42 (d, 1H, J = 12.9 Hz, CH), 6.23 (d, 1H, J = 12.9 Hz, CH), 
4.20 (dd, 2H, J = 2.6 Hz, 4.6 Hz, NHCH2), 2.35 (t, 1H, J = 
2.6 Hz, C≡CH) 
FT-IR (ATR) 3261 (s, O-H), 3050 (w, C-H), 1697 (s, C=O), 1592 (s, C=O), 
1538, 1492, 1245, 1056,1018, 852, 715, 676, 624, 590, 530 
 
2.4.3.1.17. N-Propargyl maleimide (14) 
 
13 was suspended in Ac2O (20 mL) and AcONa (1.5070 g) which was stirred for 2 
hours at 65 ºC. The red solution was poured into ice water and extracted in ether (3 x 
50 mL). The organic layer was combined, dried over MgSO4 and reduced under 
vacuum. The product was columned on DCM: EtOAc to give a black oil, which was 
left to crystallise (6.60 g, 48.8 mmol, 47% across two steps). 
 
1H NMR  
(CDCl3, 400 MHz) 
6.76 (s, 2H, CH=CH), 4.30 (d, 2H, J = 2.5 Hz, CH2) 2.22 (t, 
1H, J = 2.5 Hz, C≡CH) 
FT-IR (ATR): 3238 (w, C-H), 3102 (w, C-H), 2127 (w, C≡C), 1730 (s, 
C=O), 1428, 1406, 1346, 1316, 1225, 1175, 1099, 938, 760, 
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2.4.3.1.18. 1-(3-(triisopropylsilyl)prop-2-ynyl)-1H-pyrrole-2,5-dione (18) 
 
The synthesis has been modified from the previously reported method53. Briefly, 
triphenylphosphine (8.1 g, 30.9 mmol) was dissolved in THF (80 mL) and cooled to -
78 °C under an inert atmosphere. DIAD (6.1 mL, 30.9 mmol) was added dropwise 
over 5 minutes followed by 3- (trimethylsilyl)prop-2-yn-1-ol (4.1 mL, 28.1 mmol) 
dropwise over 5 minutes. The maleimide (3 g, 31.6 mmol) was suspended in THF (100 
mL) and added dropwise. The resulting foam was stirred for 10 minutes at the – 78 °C 
and then 24 for hours at 25 ºC. The solvent was removed in vacuo and the residue 
purified by column chromatography first hexane: EtOAc (1:1) with a second column 
using hexane: EtOAc (2:1) followed by the reduction under vacuum to give 1-(3-
(trimethylsilyl)prop-2-ynyl)-1H-pyrrole-2,5-dione as a yellow oil. 
 
1H NMR  
(CDCl3, 400 MHz) 
d: 6.74 (s, 2H, HC=CH), 4.28 (s, 2H, CH2), 0.12 (s, 9H, 
Si(CH3)3 
FT-IR (ATR): 2961 (w, C-H), 2182 (w, C≡C), 1713 (s, C=O), 1425, 1401, 
1344, 1249, 1151, 1041, 1007, 826, 759, 694, 654, 509 
 
2.4.3.1.19. Polymerisation 
2.4.3.1.20. General procedure for polymerisation  
The polymerisation worked in both homopolymerisation and copolymerisation 
systems. The synthesis has been modified from the previously reported method54. The 
polymers were synthesised by RAFT polymerisation using BDTMP as the RAFT 
agent and V601 as the initiator, modified from the previously reported method. 
Briefly, all the components were combined and purged in a Schlenk tube under 
nitrogen flow for 30 minutes, after which point the reaction was put into an oil bath at 
70 ºC to initiate the reaction. Once complete, the reaction was quenched in an ice bath 
followed by exposure to the atmosphere. The solution was precipitated into cold 
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2.4.3.1.21. pVBC (P1) 
 
1H NMR  
((CD3)2CO, 400 MHz) 
d: 7.18 (br, 2H, ortho-CH), 6.68 (br, 2H, meta-CH), 4.64 
(br, 2H, CH2), 1.89 (br, CH backbone), 1.64 (br, CH2 
backbone), 1.39 (br, RAFT-CH2), 0.86 (br, RAFT-CH3) 
FT-IR (ATR): 2925 (w, C-H), 1723 (w, C=C), 1612, 1510, 1443, 1421, 
1264, 1187, 1133, 1019, 824, 671, 638, 534  
 
2.4.3.1.22. pVBC-alt-TMS PMI (P9) 
 
1H NMR  
((CD3)2CO, 400 MHz) 
d: 7.17 (br, 2H, ortho-CH), 6.74 (br, 2H, meta-CH), 4.52 
(br, 2H, CH2), 4.10 (br, 2H, CH2), 3.22 (br, CH backbone), 
2.55(br, CH backbone), 2.08 (br, CH2 backbone), 1.39 (br, 
RAFT-CH2), 0.87 (br, RAFT-CH3), 0.13 (s, 9H, TMS) 
FT-IR (ATR): 2925 (w, C-H), 1723 (w, C=C), 1612, 1510, 1443, 1421, 
1264, 1187, 1133, 1019, 824, 671, 638, 534  
 
2.4.3.1.23. General procedure for polymer azidation.  
The synthesis has been modified from previously reported method33. Briefly, the 
polymer was suspended in DMSO (300 % v/v) followed by the addition of NaN3 (1.5 
equiv per chloride) and stirred 16 hours at 25 ºC. The resulting solution is diluted into 
water and extracted in EtOAc (3 x 50 mL). The organic layers were combined, dried 
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2.4.3.1.24. pVBAz (P2) 
 
1H NMR  
((CD3)2CO, 400 MHz) 
d: 7.12 (br, 2H, ortho-CH), 6.70 (br, 2H, meta-CH), 4.38 
(br, 2H, CH2), 1.85 (br, CH backbone), 1.65 (br, CH2 
backbone), 1.41 (br, RAFT-CH2), 0.88 (br, RAFT-CH3) 
FT-IR (ATR): 2924 (w, C-H), 2091 (s, N3), 1758 (w, C=C), 1721, 1676, 
1611, 1510, 1446, 1421, 1341, 1245, 1205, 1112, 1019, 877, 
843, 805, 753, 703, 666, 556  
 
2.4.3.1.25. pVBAz-alt-TMS PMI (P9) 
 
1H NMR  
((CD3)2CO, 400 MHz) 
7.29 (br, 2H, ortho-CH), 6.74 (br, 2H, meta-CH), 4.66 (br, 2H, 
CH2), 4.07 (br, 2H, CH2), 2.70 (br, CH backbone), 2.07 (br, CH 
backbone), 1.65 (br, CH2 backbone), 1.42 (br, RAFT-CH2), 1.04 
(br, RAFT-CH3).  
FT-IR (ATR): 2960 (w, C-H), 2183 (w, C≡C), 2091 (s, N3), 1773 (w, C=C), 
1700 (s, C=O), 1512, 1417, 1394, 1341, 1248, 1177, 1110, 1011, 
950, 840, 759, 698, 642 
 
2.4.3.1.26. General procedure for CuAAc click reaction on polymers 
The polymer (1 equiv with respect to azide), alkyne sugar (1.5 equiv), Me6TREN (2 
equiv) were suspended in DMSO (2 ml/g of solid) and degassed by gentle bubbling of 
Ar gas for 30 minutes. CuBr was charged into a Schlenk tube and degassed by gentle 
bubbling of Ar gas for 30 minutes. The degassed solution was cannulated into the 
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25 ºC for 2 days. The resulting solution was diluted by water (v/v) and passed through 
Al2O3 (neutral). The resulting solution was dialyzed in the presence of Cuprisorb© 
and then lyophilized to give the pure product. 
 
2.4.3.1.27. Poly(vinylbenzyl) – graft – Glc (P3) 
 
1H NMR  
((CD3)2CO, 400 MHz) 
8.18 (br, 1H, triazole-H), 6.97 (br, 4H, ortho-CH, meta-CH), 5.33 
(br, 2H, CH2), 4.99 (br, 2H, OCH2), 3.55 (br, 5H Sugar-H), 1.30 
(br, RAFT-CH2), 0.89 (br, RAFT-CH3). 
FT-IR (ATR): 3332, (br, O-H), 2917 (w, C-H), 1222, 1018, 787, 557, 459 
 
2.4.3.1.28. Poly(vinylbenzyl) – graft – Man (P4) 
 
1H NMR  
((CD3)2CO, 400 MHz) 
8.18 (br, 1H, triazole-H), 7.08 (br, 4H, ortho-CH, meta-CH), 5.56 
(br, 2H, CH2), 4.92 (br, 2H, OCH2), 3.70 (br, 5H Sugar-H), 1.30 
(br, RAFT-CH2), 0.90 (br, RAFT-CH3). 
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2.4.3.1.29. Poly(vinylbenzyl) – graft – Gal (P5) 
 
1H NMR  
((CD3)2CO, 400 MHz) 
8.11 (br, 1H, triazole-H), 6.96 (br, 4H, ortho-CH, meta-CH), 5.53 
(br, 2H, CH2), 4.50 (br, 2H, OCH2), 3.70 (br, 5H Sugar-H), 1.22 
(br, RAFT-CH2), 0.81 (br, RAFT-CH3) 
FT-IR (ATR): 3348, (br, O-H), 2928 (w, C-H), 1611, 1512, 1425, 1345, 1223, 
1041, 789, 540 
 
2.4.3.1.30. Poly(vinylbenzyl) – graft – GlcNAc (P6) 
 
1H NMR  
((CD3)2CO, 400 MHz) 
8.12 (br, 1H, triazole-H), 7.66 (br, 1H, NH), 6.90 (br, 2H, ortho-
CH), 6.40 (br, 2H, meta-CH), 5.47 (br, 2H, CH2), 5.01 (br, 2H, 
OCH2), 4.77 (br, 1H, CH Sugar-H), 4.64 (br, 2H, Sugar-H), 3.69 
(br, 1H, CH), 3.48 (br, 2H, CH2), 3.12 (br, 2H, Sugar-H), 1.67 
(br, 3H, CH3), 1.24 (br, RAFT-CH2), 0.85 (br, RAFT-CH3). 
FT-IR (ATR): 3348, (br, O-H), 2928 (w, C-H), 1611, 1512, 1425, 1345, 1223, 
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2.4.3.1.31. Poly(vinylbenzyl) – graft – GlcA (P7) 
 
1H NMR  
((CD3)2CO, 400 MHz) 
8.13 (br, 1H, triazole-H), 6.90 (br, 2H, ortho-CH), 6.37 (br, 2H, 
meta-CH), 5.39 (br, 2H, CH2), 5.04 (br, 2H, OCH2), 4.80 (br, 1H, 
CH Sugar-H), 4.66 (br, 2H, Sugar-H), 3.69 (br, 1H, CH), 3.48 
(br, 2H, CH2), 3.12 (br, 2H, Sugar-H), 1.24 (br, RAFT-CH2), 
0.85 (br, RAFT-CH3). 
FT-IR (ATR): 3356, (br, O-H), 2919 (w, C-H), 1740, 1605, 1512, 1423, 1289, 
1221, 1043, 789, 544. 
 
2.4.3.1.32. Poly(vinylbenzyl) – graft – GlcNAc-co-(vinylbenzyl)-graft-GlcA (P8) 
 
1H NMR  
((CD3)2CO, 400 MHz) 
8.18 (br, 1H, triazole-H), 7.05 (br, 4H, ortho-CH, meta-CH), 5.33 
(br, 2H, CH2), 3.74-3.55 (br, 4H, Sugar-H), 1.67 (br, 1.5H, 
CH3)1.28 (br, RAFT-CH2), 0.90 (br, RAFT-CH3) 
FT-IR (ATR): 3268, (br, O-H), 2875 (w, C-H), 1608, 1546, 1419, 1345, 1214, 
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2.4.3.1.33. General procedure for TMS deprotection of polymer 
The polymer was suspended in DMSO (10% v/v) in water and put in a dialysis membrane 
(MWCO 1 kDa). The glycopolymer was dialyzed against K2CO3 solution followed by H2O. 
The deprotected glycopolymer was lyophilized to give the deprotected glycopolymer as a 
lyophilized powder. 
 
2.4.3.1.34. Poly(vinylbenzyl) – graft – GlcNAc-alt-(vinylbenzyl)-graft-GlcA (P12) 
 
1H NMR  
((CD3)2CO, 400 MHz) 
7.97 (br, 1H, triazole-H), 6.92 (br, 4H, ortho-CH, meta-CH), 5.50 
(br, 2H, CH2), 4.29-3.33 (br, 14H, backbone, Sugar-H), 1.87 (br, 
3H, CH3)1.28 (br, RAFT-CH2), 0.92 (br, RAFT-CH3) 
FT-IR (ATR): 3293, (br, O-H), 2934 (w, C-H), 1672 (C=O), 1462, 1405, 1324, 
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Chapter 3 Engineering hyaluronan (HA)-binding peptides for 
self-assembly with natural HA 
3.1. Introduction 
Hyaluronan (HA) is the largest polysaccharide found in the human body, being the 
only pure polyanion in the extracellular space. While not forming covalent bonds, HA 
has many natural binders (Table 1.2) which enable its ability to interact with other 
ECM components, such as proteoglycans or collagen, and cells. 
Due to HA biocompatibility and rheological properties, it has been used in the 
formulation of many biomaterials. To form stable HA-based biomaterials, work has 
been undertaken by several groups, most notably by Burdick’s lab1-3, the Ramamurthi 
group4-6 and the Prestwich group7-9, where they have introduced chemical and physical  
crosslinks in the polysaccharide. The physical and chemical crosslinking has been 
achieved through chemical modification of the primary hydroxyls, the carboxylate and 
the N-acetyl when deacetylated to form a primary amine (Figure 3.1). These 
modifications can allow for a range of reactions to be undertaken, such as alkene 
polymerisation, thiol-ene click reaction10 or the use of divalent molecules such as 
dihalides, diamines and dihydrazides.  
 
Figure 3.1. The potential chemical modifications on HA, through the carboxylate, primary alcohol and breaking of 
the saccharide ring. Taken from Burdick and Prestwich 201111 
These modifications are aimed at producing permanent crosslinks between HA chains 
and generating more stable biomaterials. HA chemical modification can lead to 
detrimental effects, such as lack of control over the modifications, polymer 
degradation, as well as changing the HA repeat unit which serves as a recognition unit 
by HA-binders. 
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In recent years, researchers have looked at more dynamic/reversible crosslinking 
systems, as they have the ability to re-assemble over time and reform after breaking 
of the intermolecular forces, conferring self-healing properties. The most famous 
example of a dynamic system is the use of cyclodextrin (Cd) and adamantane (Ada) 
for host-guest interactions. Cd and Ada have been conjugated to HA to form self-
assembling hydrogels 12-13 that can be used for 3D printing14 as well as a drug delivery 
vehicles15. Whilst these systems are dynamic, they still require the modification of 
HA. 
An alternative approach consists in producing supramolecular HA biomaterials using 
peptides and pure intermolecular forces without covalent crosslinking. This ensures 
HA is in its native form with its intrinsic physical and biochemical properties retained. 
This approach also does not require the use of harsh or toxic reagents used for the 
chemical modifications. Within the HABPs, the sequences of the binding domain have 
been determined (Table 1.2). A pattern is evident in the natural HA-binding sequences, 
following the B(X7)B design, where B is a basic residue and X is a non-acidic residue, 
with at least one of the X amino acids being basic. Fundamentally, these peptides work 
through charge-charge interactions between the positive charge of the basic residues 
and the negative carboxylates of HA at physiological pH. An early example of the use 
of a polysaccharide and peptide can be seen from the interaction of heparin and with 
a positively charged heparin-binding peptide (LRKKLGKA) included into a s 
structure16-17. Examples of HA-peptide systems can be taken from the Stevens18 and 
Bryant19 groups who have used sequences taken from the binding site of HABPs in 
order to build biomaterials which can interact through intermolecular forces with HA. 
As an alternative to the use of sequences derived from natural proteins, phage display 
offers the possibility to identify new sequences through panning on the target of 
interest (Scheme 1.20). Pep-120 is a 12-mer peptide (GAHWNFQALTVR) discovered 
by phage display in 2000 with binding affinity to HA. Whilst Pep-1 does not conform 
to the B(X7)B design, it has one of the highest affinities for HA with a KD = 1.64 µM 
and will compete with other HABPs. Since its discovery and demonstrated binding, 
work has been undertaken to utilise Pep-1 to monitor the localisation of HA21-22, to 
reduce inflammatory responses caused by HA23-24 and inhibit the HA binding to its 
receptors25-27 such as CD44 and toll-like receptor (TLR). By inhibiting HA binding to 
receptors, the role of HA on cell signalling can be studied. Diseases have been shown 
to utilise HA, as patients with conditions such as lung fibrosis, asthma and 
osteoarthritis have abnormal levels of HA28. HA based biomaterials, therefore, could 
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lead to a potential use as probes or therapeutics to combat these diseases. By 
understanding the role of HA in these diseases we can begin to treat them. For this 
reason HA is being used to form hydrogels and drug delivery vehicles29. 
In this chapter, we have looked into the formation of new supramolecular biomaterials 
based on HA and different HABPep, such as Pep-1 and others taken from the link 
protein and CD44. These peptides were synthesised and characterised using their 
native sequences before testing their SAs with HA of varying sizes. In the second half 
of the chapter, the work discusses how the peptides were modified to form PAs a self-
assembling design pioneered by the Stupp group30-32 (Figure 1.19). 
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3.2. Results and Discussion 
3.2.1. Unmodified HA-Binding Peptides 
3.2.1.1. Synthesis and Characterisation 
The HABPeps were synthesised by SPPS and purified by High-Performance Liquid 
Chromatography (HPLC) coupled to Electrospray Ionisation Mass Spectroscopy 
(ESI-MS). The peptide sequences taken from natural proteins, i.e. the Link Protein 
(HABPep-1) and CD44 (HABPep-2) were acetylated at the N-terminus, whilst Pep-1 
(HABPep-3) was synthesised to bear a free amine at the N-terminus (Figure 3.2). This 
was due to the N-terminus on the phage being displayed to HA during the panning 
experiments, whilst the sequences taken from the natural sources are within a protein 
sequence and the N-terminus is capped by the neighbouring amino acid, therefore not 
available to bind.  
 
Figure 3.2. Chemical structures of the native HABPeps derived from natural HABPs (HABPep-1, HABPep-2) and 
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The secondary structure of the peptides can be deduced by circular dichroism (CD). 
CD uses circular polarised light through the sample and measures the change in angle 
of the outputted polarised light given by the ellipticity parameter. Proteins and 
peptides can display different secondary structures, such as a random coil, β-sheets 
and α-helices. The peptides were analysed at 0.01 mM and at different pHs to see the 
effect of charge on the peptide’s conformation (Figure 3.3). These peptides possess 
several residues which can be charged (e.g. lysine, histidine and arginine). 
 
Figure 3.3. CD spectra of HABPep-1, 2 & 3 at pH 3 (light blue), 7 (blue) and 10 (grey) at 110 μM 
The CD spectra of HABPep-2 and HABPep-3 show random coil behaviour at all pHs, 
due to the minima seen at between 205 – 195 nm. HABPep-1 spectra display random 
coil at pH<10 which is a transition to a β-sheets at pH>10. This is due to the minimum 
coming at 195 nm but a peak appearing at 201 nm. HABPep-1 is a highly charged 
peptide, with 50% of the residues being basic residues (4 arginines and 1 lysine). Using 
zeta-potential (ζ-potential) to measure the molecular charge in solution (Figure 3.4), 
it becomes apparent that at the lower pHs the molecules have a higher positive ζ-
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potential. This increase in charge will affect the secondary structure of the peptide due 
to charge-charge repulsion. 
   
Figure 3.4. ζ-potential of native HABPep-1 and HABPep-2 at various pHs. Analysed by two-way ANOVA 
analysis, where * significant at P < 0.0332, ** significant at P < 0.0021, *** significant at P < 0.0002 and **** 
significant at P < 0.0001. 
The ζ-potential also shows that HABPep-2 has significant charge between neutral pH 
and pH 3 and increasing the pH to 10 results in a substantial drop in charge. HABPep-
2 has an estimated isoelectric point (pI) of 12.5, indicating that at pH closer to the pI 
the amine groups will become unprotonated (neutral). 
 
3.2.1.2. Self-assembly with HA 
The peptides were screened against a variety of HA molecular sizes to test their ability 
to form self-assembled structures. When mixing HABPep-1 and HABPep-2 with HA 
no structures was observed, whereas HABPep-3 lead to the formation of a membrane 
with HA (Figure 3.5).  
The membranes formed were imaged by scanning electron microscopy (SEM) to give 
details on the microstructure formed. From the SEM images, it is possible to observe 
that the surface topology of these membranes can be tuned depending on the HA to 
HABPep-3 weight percentage ratio (Figure 3.6). The SEM images show that whilst 
maintaining a constant weight percentage, there is an increase in density of the fibres 
on increasing the HA molecular weight; this might be a result of the long HA strands 
being linked together by HABPep-3. The topology caused by tuning the percentage 
and size of HA gave membranes with different physical characteristic. These differing 
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Figure 3.5 Photography of the membrane formed when combining 700 kDa HA 1% with 20 mM HABPep-3. 
 
Figure 3.6. SEM images of the surface of complexes obtained by combining different concentrations of HABPep-
3 (wt%), 1% (top), 2% (middle) and 3% (bottom) with HA of various MWs: 60, 200 & 700 kDa at 1% (.wt%) (left 
to right).  
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The inverse is seen as the wt% of HABPep-3 is increased. By increasing the HABPep-
3 concentration, the peptide provides more interaction sites for HA, because of the 
change in the surface. Changing the concentration of HABPep-3 leads to the formation 
of aggregates in solution. This aggregation can be measured using Nile Red as a probe 
dye. In aqueous environments, Nile Red exhibits low fluorescence. However, upon 
incorporation into a hydrophobic pocket, Nile Red blue shifts to a lower wavelength 
and the fluorescence intensity increases linearly with increasing concentration. The 
concentration at which the peptide aggregates in solution is known as the critical 
aggregation concentration (CAC). Using the Nile Red assay to probe the HABPep-3, 
there is a clear aggregation at 6.7 ´ 10-5 M (Figure 3.7). 
 
Figure 3.7. Nile Red assay of HABPep-3 with fluorescence maxima (blue) and fluorescence intensity (grey) at 620 
nm at pH 7. 
The aggregation of HABPep-3, as demonstrated by the CAC, produces a scaffold that 
HA can bind upon to creating more intricate network leading to formation of a stable 
membrane (Figure 3.5). By comparison, HABPep-1 and HABPep-2 show no CAC 
point, this can be attributed to the high solubility of these peptides. HABPep-3 also 
bears a ζ-potential of 55.1 ± 4.1 mV, a higher charge than that of the other two 
peptides, whilst bearing less basic amino acid residues. Using transmission electron 
microscope (TEM) on HABPep-3 (Figure 3.8), the images show the formation of 
nanofibrous structures with an average cross-section of 47.9 ± 12.9 nm.  
These short fibres show no morphological change upon the screening of charge by 
increasing the pH to 10. The HABPep-3 bares 2 residues with amine-containing side 
chains, arginine at the C-terminus and histidine at position 10, and an amine group at 
the N-terminus, giving a total charge of +3. The other residues in the sequence are 
highly hydrophobic. Within the hydrophobic core, the aromatic residues lead to the 
formation of pi-pi stacking. The CAC and hydrophobicity of the peptide, along with 
the TEM result, explain the high ζ-potential of the peptides. The TEM and 
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arrangement of the hydrophobic residues in peptide lead to arginine of HABPep-3 to 
be displayed on the exterior of the nanofibers. A surface of predominately arginine’s 
will cause the high ζ-potential observed.  
The nanofibrous structure and high positive charge seen in the HABPep-3, explains 
the formation of a stable membrane with the negatively charged HA. The SA of 
HABPep-1 and HABPep-2 with HA was also attempted. However, these did not form 
any stable structures. This is not due to a lack of binding of the peptides to HA, but 
due to the lack of stable SA structures formed by the HABPep-1 and HABPep-2 alone. 
Whilst the addition of the peptide to HA caused increased turbidity of the solutions, 
this faded over time, as the peptides diluted into the HA solutions.  
 
Figure 3.8. TEM images of HABPep-3 at 0.1 mM showing fibrous structures at pH 7 (left) and pH 10 (right) 
The lack of stable HA complexes formed by HABPep-1 and HABPep-2 sequences, 
compared with HABPep-3, can be explained by the mode by each sequence was 
derived. HABPep-3 was discovered through phage display (12-mer attached to the 
phage surface) whilst HABPep-1 and HABPep-2 are sequences taken from a binding 
site in a much larger and more complex protein structure. By taking the sequence from 
the binding cavity of HABPs, the 3D environment is lost. A way to circumvent the 
lack of optimal presentation of these sequences for binding HA would be to 
incorporate these sequences into a self-assembling molecular platform for the 
multivalent display of the peptide. To form stable structures from HABPep-1 and 
HABPep-2, an amphiphilic design was implemented. 
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3.2.2. N-terminus Modifications of HA-Binding Peptides for Amphiphilic Design  
3.2.2.1. Synthesis and Characterisation of Amphiphiles 
With the lack of self-assembly with HA of both the HABPep-1 and HABPep-2 
sequences, the N-terminus was modified to possess additional domains able to drive 
their controlled SA. This amphiphilic design was incorporated to try and give these 
peptides a 3D structure. By displaying the binding epitopes of HABPep-1 and 
HABPep-2 across the surface of a micelle or a fibre, the HA binding sequence can 
interact multiple time with HA to create stable a self-assembly. The PA design 
approach was utilised, but, due to the high solubility of HABPep-1 and HABPep-2, 
the charged domain was deemed unnecessary. Therefore, this portion of the PA design 
was not included in the design whilst the C16 and the β-sheet domain was included to 
create HABPA-1 & HABPA-2 based on HABPep-1 & HABPep-2, respectively 
(Figure 3.9). 
 
Figure 3.9. The PA structures of HABPA-1 and HABPA-2 based on HABPep-1 and HABPep-2 respectively. 
Once synthesised and purified by HPLC, with conformation by ESI-MS, the PAs were 
analysed for their secondary structure by CD (Figure 3.10). HABPA-1 showed a 
random coil at all pHs; at lower pHs, this can be explained by the charge on the HA-
binding sequence which has 5 basic residues, including 4 at the head of the peptide. 
At higher pHs, the charge of these residues will become neutral, but HABPA-1 still 
presents random coil conformation suggesting sterics between the amino acid residues 
are playing a role in preventing the formation of a defined secondary structure.  
Whilst the peptide contains the V3A3 sequence, known to form β-sheets, the sequence 
contains two prolines and one serine which have a high propensity for β-turn, 
disturbing the formation of stable β-sheets. Compared to the sequence of HABPep-1, 
HABPep-2 has only 3 charged residues, but these are evenly spread throughout the 9 
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leads to hydrophobic residues within the β-sheet domain to be the dominating factor 
on the secondary structure. The CD spectra for HABPA-2 display β-sheet at all pHs. 
  
Figure 3.10. CD spectra of HABPA-1 & 2 at pH 3 (light blue), 7 (blue) and 10 (grey) at 110 μM 
Using Nile Red, the CAC of HABPA-1 (Figure 3.11) was determined to be 5.4 ´ 10-2 
mM. HABPA-1 displayed a dramatic increase in fluorescence after 5 ´ 10-3 mM, with 
a blue shift from 646 to 618 nm indicative of the formation of an aggregate. By 
contrast, HABPA-2 showed no blue shift with a consistent peak maximum at 620 nm 
through all pH ranges, inferring any self-assembly was occurring below 1 nM. The 
comparisons in structures and charge location within the two PAs showed that 
electrostatic repulsion caused an increase of the CAC for HABPA-1 compared to 
HABPA-2. 
ζ-potential can be measured to estimate the surface charge of the aggregates (Figure 
3.12). HABPA-1 and HABPA-2, as well as their parent peptide sequences of 
HABPep-1 and HABPep-2, all show a positive ζ-potential, due to the number of 
arginine and lysine residues within the sequence. 
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Figure 3.11. Nile Red assay of HABPA-1 & 2 with fluorescence maxima (blue) and fluorescence intensity (grey) 
at 620 nm at pH 7. 
What is evident from the ζ-potential is that due to the amphiphilic design, there is a 
significant increase in surface charge. This increase in ζ-potential (> +30 mV) infers 
that stable aggregates have been formed. The data also shows a significance (P < 
0.0001) between the charge on the surface of the two PAs. Again, this is due to the 
higher number of charged residues on the binding sequences of HABPep-1 compared 
to HABPep-2 on the PAs. 
 
Figure 3.12. x-potential for HABPA-1 and HABPA-2 and comparison to the unmodified/native sequences 
(HABPep-1 and HABPep-2). Analysed by two-way ANOVA analysis, where * significant at P < 0.0332, ** 
significant at P < 0.0021, *** significant at P < 0.0002 and **** significant at P < 0.0001.  
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Using the information obtained from the Nile Red assay and ζ-potential, TEM images 
could be captured at concentrations above the CAC and by varying the pH to adjust 
the charge. At neutral pH, HABPA-1 sequence showed predominantly micelle 
structures as well as some short fibrous structures. Whilst the incorporation of C16 and 
V3A3 favour the formation of fibres over micelles, the charge-charge repulsion on the 
head of the PA will negate this effect33-35. Increasing the pH from 7 to 10, the charge-
charge repulsion is cancelled due to charge screening on the basic residues of arginine 
(pKa = 12.5) and lysine (pKa = 10.5)36, leading to the formation of long fibres as the 
predominant structure.  
  
 
Figure 3.13. TEM images of the nanostructures formed by HABPA-1 (top) and HABPA-2 (bottom) at 0.1 mM and 
pH 7 (left) and pH 10 (right) 
In comparison, HABPA-2 showed small fibres and micelles at pH 7, following the 
trends seen in the literature when using the C16 and V3A3 domains. However, when 
increasing the pH to 10, large bundles of fibres are formed potentially driven by 
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hydrogen bonding between the serine’s, arginine’s, lysine and the tyrosine, once the 
charge has been screened, these residues can interact through hydrogen bonding. At 
pH 7 the side chains of the basic residues are positively charged causing repulsion 
between adjacent PAs inhibiting long fibre self-assembly. 
From this data, it can be seen that charge plays a large role in the SA of these two PAs 
as the difference seen between the two in both secondary structures and the 
nanostructures formed by the PAs (Table 3.1). 
Table 3.1. Characterisation of HABPAs from CD, TEM and ζ-potential 
PA CD pH Morphology Width a (nm) Length a (nm) ζ-Potential (mV) 
HABPA-1 RC at all pHs 
7 Micelle 58 ± 8 - 65.6 ± 9.4 
10 Fibre 69 ± 7 1240 ± 160 - 
HABPA-2 β at all pHs 
7 Short Fibres 70 ± 11 570 ± 180 52.7 ± 1.4 
10 Short Fibres 24 ± 4 197 ± 54 - 
RC = Random Coil, β = Beta Sheet. a average measurement acquired using ImageJ analysis. 
N-terminus modifications was also undertaken on HABPep-3. Whilst HABPep-3 was 
able to form complexes with HA, this was not controllable due to the random 
interaction of the peptide rather than through its controlled presentation. In the initial 
publication reporting the discovery of Pep-1 in 2000, alanine scanning studies were 
performed which showed that the hydrophobic residues W, F, A, L, T and V, as well 
as G and Q, were essential for binding, whilst the charged residues H and R, as well 
as N, where non-essential for binding (Figure 3.14). Since the core of HABPep-3 is 
highly hydrophobic, upon aggregation, these residues which are essential to interact 
with HA will be trapped in the core of the aggregates.  
 
Figure 3.14. Hydrophobicity of individual amino acids in HABPep-3 according to the Hoop & Wood 
hydrophobicity, highlighting the essential (blue) and the non-essential (grey) residues for HA binding.  
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By designing a PA version of HABPep-3, the binding residues would be freed up to 
bind to HA in a more controlled manner. Due to the hydrophobicity of the Pep-1, the 
initial designs moved away from the use of V3A3 for the b-sheet segment, using (VQ)2 
instead. Glutamine (Q) has been shown to be β-sheet promotor, compared with 
alanine37, as well as has lower hydrophobicity: -0.5 (A) and 0.2 (Q). For this reason, 
V3A3 was replaced with (VQ)2 (Figure 3.15). Whilst SPPS was able to form HABPA-
3, as shown by ESI (data not shown). The hydrophobicity of this HABPA-3 led to 
insolubility in water and therefore an inability to purify by HPLC.  
 
Figure 3.15. Amphiphilic design of HABPep-3 based PAs with use of a β-sheet forming domain (HABPA-3) and 
reduction in hydrophobicity by removal of the β-sheet forming domain (HABPA-4) and reduction the alkyl tail 
(HABPA-5, HABPA-6). 
The minimum requirement for several PA designs is a hydrophobic alkyl tail and 
bioactive domains. To improve solubility, the β-sheet domain was removed, leaving 
the alkyl tail which was systematically shortened in an attempt to increase the 
solubility. Again, the SPPS showed no problem in the synthesis of these peptides 
(confirmed by ESI for the crude materials), but solubility still remained a challenge.  
By looking at the manner in which the HABPep-3 is displayed by the phage, we can 
look at exploiting similar designs to replicate the mode the phage displays the peptide. 
On the phage (Figure 3.16), the peptide is displayed from the C-terminus rather than 
the N-terminus, so in fact, adding the modification to the N-terminus would cause the 
peptide to be displayed in the reverse orientation as to the phage. Furthermore, the 
peptide is anchored on the phage surface through a linker, known as the fusion linker, 
which is made up of 3 glycine residues, which spaces the peptide out from the phage 
to allow the 12-mer freedom to bind without sterics. With these two features in mind, 
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Figure 3.16. Cartoon of a phage showing the pendant peptide attached to the phage through the C-terminus by a 
fusion linker (green). 
 
3.2.2.2. Self-assembly with HA 
HA was added onto HABPA-1 leading to the formation of a membrane (Figure 3.17). 
Varying the HA size from 60 kDa to 700 kDa, a change in the morphology is observed 
under SEM (Figure 3.18). With low molecular weight HA, two distinct sides of the 
membrane are observed. One is highly fibrous, and the other is more uniform. In 
comparison, the longer HA produces two sides which show no distinct differences, 
both forming a fibrous network on the membrane’s surface. The high viscosity of the 
large Mw HA solution allows it to sink into the PA solution, forming sac compared to 
the lighter, low Mw HA which forms a facial interaction with the PA. This facial 
interaction leads to two distinct sides in the SEM images of the 60 kDa HA and 
HABPA-1 example.  
 
Figure 3.17. Photography of the membrane formed when combining 700 kDa HA 1% with HABPA-1 1% (wt.%).  
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Comparing the cross-sections of the membranes, the lower molecular weight produces 
a disorganised array of fibres. Using higher molecular weights, the fibres within the 
interior begin to align. Collagen is the primary structural element in connective tissues 
38-39. Collagen type 1 packs in fibrillar elements through SA, which produces fibres 
with directionality40. This alignment of the collagen fibres has been shown to 
determine the morphology and function of several cell types41. Alignment with a 
matrix has been shown to guide migration cells in morphogenesis, wound healing, and 
tissue regeneration42-43. The fibres seen in the membrane cross-section (Figure 3.18) 
resemble the bundles of collagen fibres. The formation of aligned fibres with HA, 
produces a biomimetic environment in which cells could grow and proliferate. 
Compared to HABPA-1, HABPA-2 failed to form any assemblies with HA at any 
weight percentage or various HA molecular weights, whilst in the TEM HABPA-2 
showed the ability to form defined nanofibers. These are short and carry less charge. 
These peptides follow the B(X)7B design of HABPs, with one of the X residues 
requiring to be another basic residue (B). However, on displaying the peptide as a PA, 
sterics will begin to be a factor. The residues closest to the alkyl tail will be difficult 
for a longer macromolecule such as HA to intercalate into the SA structure. 
 
Figure 3.18. SEM images of the membranes formed with HABPA-1 1% (wt.%) comparing the effect of high and 
low molecular weight HA.  
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Two of HABPep-2’s basic residues are buried into the structure of the PA, reducing 
the ability for HA to interact to those charged residues. Therefore, HABPA-1 and 
HABPA-2 are likely to bind through electrostatic interactions through the residues 
located at the surface of the PA. If we only consider that only the first 3 amino acids 
are presented to HA, due to steric of the remaining sequence, HABPep-1 has 3 basic 
residues at the surface whilst HABPep-3 only has 1. HABPep-2 sequence does not 
possess another basic residue until the 6th amino acid in the sequence. The ζ-potential 
shows both PAs with a high positive surface, HABPA-1 shows an increase in the ζ of 
+12.9 mV. This, coupled with the placement of the charged residues, allow HABPA-
1 to form stable assemblies with HA but not HABPA-2. 
 
3.2.3. PA design by C-terminus modifications 
3.2.3.1. Synthesis and Characterisation of C-terminus modifications  
HABPep-3 was modified at the C-terminus to include 4 domains30. This design 
includes the fusion protein linker of the triple glycine, a charged domain of two 
lysine’s, the HA-binding sequence (HABPep-3) and the C16 alkyl tail (Figure 3.19). 
Whilst previous examples of PAs use the V3A3 sequence to provide the β-sheet 
forming domain34, the N-terminus work highlighted HABPep-3 extremely low 
solubility. This block was removed following the example from the Chun Group44. 
 
Figure 3.19. Amphiphilic design of HABPA-7 with the incorporation of HABPep-3. 
Compared with coupling onto the N-terminus, the C terminus presents additional 
synthetic challenges in conventional SPPS. The use of lysine protected with a 4–
methyltrityl (Mtt) group can be inserted as the first amino acid. The side chain can be 
selectively deprotected with 4% TFA and 2.5% TIS in DCM followed by 5% DIEA 
in DCM to neutralise the remaining TFA. These mild conditions provide the removal 
of the Mtt group with minimal loss of lysine from the resin surface. The exposed 
epsilon amine can be easily confirmed qualitatively by the Kaiser test. This amine can 
be capped by a palmitic acid in order to attach the C16 at the C-terminus. Some 
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the Lys-(Mtt) with the alkyl tail at the end. However, because of the steric bulky and 
hydrophobic groups loaded on the resin, this was low yielding. Whilst “preloading” 
the C16 onto the resin before building the remainder of the peptide allows the C16 tail 
to be attached from which the peptide can be grown stepwise. The crude result of 
HABPA-7 synthesised by this approach showed dual peaks on the HPLC (Figure 
3.20). Mass analysis of each peak showed the peptide with and without the lysine 
functionalisation. It was necessary to perform double deprotection and coupling of the 
Lys (Mtt). 
 
Figure 3.20. HPLC traces of crude of HABPA-7 showing the difference in conversion of the Lys (Mtt) by single 
or double coupling (offset by 100). 
Despite the Kaiser test gives a qualitative analysis of the resin, the Mtt group is also 
heat sensitive, so it can give a false positive as the Kaiser test run at 120 ºC; when 
double coupling of the C16 group was performed, the predominant peak is now the C16 
coupled. Once purified by HPLC, the PA secondary structure was characterised by 
CD (Figure 3.21). The CD spectrum of HABPA-7 showed that at pH 3 the peptide 
behaved as a random coil, whilst at pH 7 and 10 it indicated β-sheet propensities. 
 
Figure 3.21. CD spectra of HABPep-7 at pH 3 (light blue), 7 (blue) and 10 (grey) at 110 μM  
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This result is expected as at acidic pH basic amino acids can be charged, including the 
histidine (pKa = 6.4). This would lead to mutual repulsion among PA molecules 
leading to a random coil conformation. In contrast, at basic pH, these charges are 
screened. The Nile Red assay (Figure 3.22) showed a CAC of 4.3 ´ 10-1 mM, which 
compared to HABPA-1 is two orders of magnitude higher, but within a similar 
magnitude to that of HABPep-3. 
 
Figure 3.22. Nile Red assay of HABPA-7 with fluorescence maxima (blue) and fluorescence intensity (grey) at 
620 nm at pH 7. 
The TEM of the HABPA-7 (Figure 3.23) showed worm-like fibres, which was 
consistent at both pH 7 and 10. These fibres are significantly shorter than those of 
HABPep-3 (Figure 3.8); this might be caused by the amphiphilic design of HABPA-
7 breaking up the aggregation of the HABPep-3 sequence. The addition of the V3A3 
to the HABPA-7 sequence would increase the β-sheet propensity leading to the 
increased probability of elongated fibres, if soluble. 
 
Figure 3.23. TEM image of HABPA-7 at 1 mM, pH 7 (left) and pH 11 (right).  
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3.2.3.2. Self-assembly of C-terminus PA with HA 
When combining HABPA-7 with HA, on average thicker fibres are observed in the 
SEM of the membranes formed (Figure 3.24) compared with those of HABPep-3 at 
125 nm ± 25 nm compared to 78 nm ± 12 nm (Figure 3.6), this might be due the 
difference in the self-assemblies seen in TEM. HABPA-7 forms shorter fibres with 
HABPep-3 being displayed on the exterior of the short nanofibers. These nanofibers 
therefore become more fibrous as there are more points on the HABPA-7 for the HA 
to interact with compared to HABPep-3. By displaying the HABPep-3 on the PA of 
HABPA-7 more of the essential amino acids in the HABPep-3 sequence are exposed 
to interact with HA.  
 
Figure 3.24. Photography of the membrane formed when combining 700 kDa HA 2% with 20 mM HABPA-7 (A) 
and SEM images of the membrane showing: cross-section (B), surface (C) and the opposing surface (D). 
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Whilst HABPA-7 with HA lead to a more fibrous material shown by the SEM images, 
HABPA-7 has a ζ-Potential of +58 mV similar to that of HABPep-3. This suggests 
that HABPep-3 sequences are aggregating on the surface of the aggregates formed 
(Scheme 3.1). The free N-terminus will be displayed on the surface of the nanofibers, 
but the histidine and arginine are buried in the aggregate within the self-assembly. 
Changing the pH showed no dramatic nanostructure variation in TEM when compared 
to HABPA-1 and HABPA-2 (Figure 3.13). This is caused by the difference in 
sequences with HABPA-1 and HABPA-2 possessing several basic residues towards 
the surface of the PA structure. To utilise the full HABPep-3 sequence in a similar 
manner to the phage, the intramolecular interactions between the HABPep-3 sequence 
in the HABPA-7 require separation. 
 
Scheme 3.1. Schematic representation of HABPA-7 as isolated PA monomers below the CAC and a cross-section 
of the self-assembly formed above the CAC.45 
 
3.2.4. Peptide Amphiphile Co-assembly 
To space out the HABPep-3 sequence, to allow for improved interactions with HA, a 
complementary PA was designed. This PA can interact with HABPA-7 through non-
covalent interactions, such as electrostatics35, 46-47 and opposing charge48, as well as 
through the formation of chemical bonds such disulphide bridges44 to allow their co-
assembly. Studies have also used this dual system to look into the dynamics of self-
assembly49; these dual co-assembly systems also allow control over 
theircytotoxicity50. This idea of a complementary peptide as a ‘diluent PA’ or ‘control 
Engineering hyaluronan (HA)-binding peptides for self-assembly with natural HA 
 140 
PA’ has been previously shown to control the percentage of a bioactive epitope on the 
surface of a PA51-53.  
 
3.2.4.1.  Synthesis and Characterisation of Diluent Peptide Amphiphile 
The aim of using a diluent peptide (Dil-PA) was to reduce the aggregation on the 
surface of HABPA-7 caused by hydrophobic residues in HABPep-3 (Scheme 3.2). 
The Dil-PA was designed to incorporate an opposing charge domain of glutamic acids 
to interact with the lysines of HABPA-7. The Dil-PA was synthesised through 
standard SPPS but reversed the sequence in comparison to HABPA-7. This is due to 
the simplicity at which the peptide can be synthesised compared to the Lys (Mtt) 
approach. However, by reversing the sequence, the PA will still align with the 
complementary domains of the HABPA-7.  
 
Scheme 3.2. Amphiphilic design of Dil-PA (top) and the co-assembly of HABPA-7 with Dil-PA monomers below 
the CAC and a cross-section of the self-assembly formed above the CAC. 
The Dil-PA peptide was purified by HPLC and mass confirmed by ESI-MS. The Dil-
PA showed random coil at pH 7 and 10, however, at pH 3 the CD showed weak β-
sheet propensity (Figure 3.25A). At neutral pH, the Dil-PA has a x-potential of -38 
mV, whereas at pH 3 the two glutamic acids (pKa = 4.3) of the PA are protonated 
causing screening of charge repulsion, leading to the conformation change. The Dil-
PA had a much lower CAC (Figure 3.25B) in comparison to that of HABPA-7, with 
a CAC of 2.2 ´ 10-3 mM, two orders of magnitude lower. However, above 0.1 mM, 
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whilst the fluorescence increased rapidly, the peptide started to crash out of solution 
causing the fluorescence output to become inconsistent. At this high concentration, 
aggregation led to precipitation and therefore data had to be discarded. 
 
Figure 3.25. CD spectra (A) of Dil-PA at pH 3 (light blue), 7 (blue) and 10 (grey) at 110 μM and Nile Red assay 
(B) with fluorescence maxima (blue) and fluorescence intensity (grey) at 620 nm at pH 7. 
Looking at the peptide under TEM (Figure 3.26) at 0.1 mM, aggregation of fibres are 
seen by the darker areas on the TEM as the fibres bundled together. The Dil-PA 
showed very elongated nanostructures with an average width of 136 nm ± 22 nm. 
These nanostructures closely resemble assemblies observed by the Stupp54-55 group 
using C16(VE)2 PA which formed nanobelt structures, which had a monodisperse 
width of 150 nm. 
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Figure 3.26. TEM images of the nanostructures formed by Dil-PA at 0.1 mM and pH 7 showing a high density of 
elongated structures. 
 
3.2.4.2. Co-assembly Study 
The co-assembly of the two PAs was monitored by combining different methods. The 
two PAs were mixed in a 50:50 molar ratio. If the co-assembled system would show 
two distinct blue shifts, then it could be inferred that the two PAs were assembling 
separately. Also, due to the solution having a 50:50 ratio of both PAs, if the PAs were 
self-assembling individually, then the CAC of HABPA-7 would be unmeasurable on 
the concentration scale, whilst the Dil PA would show a shift in 10-1 to 10-2 mM range. 
The mixture has a single CAC of 3.6 ´ 10-4 mM. The single blue shift at 7.5 ´ 10-4 mM 
infers co-assembly of the PAs (Figure 3.27).  
 
Figure 3.27. Nile Red assay of the mixed PA system at a 50:50 ratio with fluorescence maxima (blue) and 
fluorescence intensity (grey) at 620 nm at pH 7. 
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The mixture of PAs at 50:50 ratio acts synergistically to help solubilise each other, 
due to the absence of precipitation at higher concentrations of the Dil-PA. This is due 
to the positively charged domain of the lysine residues on HABPA-7, interacting with 
the negative charge of the carboxylates of the glutamic acid residues on Dil-PA. 
Therefore, the CAC analysis suggests the successful co-assembly of HABPA-7 with 
Dil-PA. 
CD analysis of individual PAs at lower concentrations showed β-sheet for Dil PA 
whilst HABPA-7 showed a random coil. When changing the ratio of the two PAs in 
the co-assembling system, the CD showed a shift in the propensity from random coil 
to β-sheet, as the percentage of the Dil-PA was increased (Figure 3.28). The dotted 
lines represent the simulated CD spectra by summing the individual PA’s CD signal 
at the mixture percentages. If the CD of the co-assembled systems was simply the sum 
of the two individual CD spectra at the various ratios, then CD trace would overlay 
with those of the simulated. The fact that the observed CD signal does not coincide, 
we can infer their co-assembly rather than individual assemblies. The CD also shows 
the highest β-sheet maxima for HABPA-7 and Dil PA at a ratio of 20:80, almost 
double that of 40:60; this indicates the co-assembly system is more ordered at this 
ratio. The peak then decays back down in intensity when scanning the 0:100 ratio. 
 
Figure 3.28. CD analysis of the co-assembled system of HABPA-7 and the Dil-PA at varying compositions with 
the actual data at pH 7 (solid) overlaid on the simulated data (dotted). 
When varying the composition of the PAs in the co-assembly system, an effect was 
seen in the CD. To further confirm the co-assembly, the ζ-potential was measured 
(Figure 3.29). At 100% of each individual PA, the observed charge was as expected. 
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HABPA-7 shows a positive ζ-potential due to the charge domain of HABPep-3 as well 
as the additional positive charge arising from the free amine at the N-terminus.  
Upon addition of the Dil-PA, an initial decrease in the ζ-potential is observed as the 
inner positively charged lysine domain of HABPA-7 is quenched by the glutamic acid 
domain of the Dil-PA. However, through the aggregation of the HABPep-3 sequence, 
the N-terminus amine creates a positive surface of the co-assembly, which is remains 
constant until the 40% of HABPA-7, where the charge drops off dramatically from 
40.1 mV (40% HABPA-7) to 4.5 mV (20% HABPA-7). The N-terminus and the 
arginine in the HABPep-3 sequence remain positive, hence a net positive ζ is observed 
until 0% HABPA-7. However, the drop-off in the magnitude of the charge at 20% 
HABPA-7 infer small localisations of charge rather than large clusters of positive 
charge. The simulated ζ-potential shows a linear growth with increasing % of 
HABPA-7. 
In a similar manner, the simulated data for the co-assembly system is giving larger 
values of ζ-potential eluding the co-assembly of the two PAs as the negative charge 
of Dil-PA is suppressed by the positive charge domain of HABPA-7 leaving the 
HABPep-3 of HABPA-7 to dictate the charge of the self-assembly. 
 
Figure 3.29. ζ-potential of the co-assembled system of HABPA-7 and the Dil-PA at varying compositions of the 
PAs with the actual data (solid) overlaid on the simulated data (dotted). 
Analysis by Nuclear Overhauser effect (NOE) NMR provided more conclusive proofs 
of the co-assembly of the two PA into a single assembly. By taking background NOE 
and correlation spectroscopy (COSY) NMRs, background couplings between intra 
and intermolecular bonds between each PA in a single assembly can be determined. 
From here, a 50:50 solution of HABPA-7 and Dil-PA can be measured to seek out any 
cross peaks. The NOE spectra of the 50:50 solution (Figure 3.30) showed a new 
additional cross peak between 1.37 ppm and 2.58 ppm. The two major differences 
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between the two PAs is the HA-binding sequence in HABPA-7 and the charged 
domain. Of these, the peak corresponds to the CH2 of the lysine (1.37 ppm) and the 
CH2 of the glutamic acid (2.58 ppm). For a cross peak to exist in the NOE NMR, these 
hydrogens need to be in close proximity as the NOE with a maximum distance of 6 Å 
as the NOE rapidly decays by 1/r6, where r is distance. 
 
Figure 3.30. NOE NMR spectra at 400 MHz in D2O of the PA mixture 50:50 ratio with the cross peak (yellow), 
lysine CH2 at 2.58 ppm (red) and the glutamic acid CH2 at 1.37 ppm (blue). 
The NOE analysis, along with the results from CD, CAC and ζ-potential, provides 
evidences that points towards the co-assembly of HABPA-7 with Dil-PA. Using TEM, 
the nanostructures formed can be visualized. Morphological differences are observed 
between HABPep-3 and HABPA-7 assemblies due to the PA design. In the lowest 
percentage of Dil-PA, HABPA-7 dominates in the aggregate with little differences 
seen between 20% - 40% (Figure 3.31A-B). At 50%, a morphology switch, with long 
fibrous aggregates is seen in the TEM, as the hydrophobicity of the HABPep-3 
epitopes on the surface are reduced in number (Figure 3.31C). Upon increasing the 
amount of Dil-PA further, larger aggregates are seen. The likely cause of this is the 
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reduction of surface aggregation upon the fibres from the HABPep-3 epitopes, but 
with adjacent fibres through inter-fibre interactions of the HABPep-3 sequence. 
The hydrophobicity of the HABPep-3 sequence causes a strong tendency to aggregate 
caused by hydrophobic residues in an aqueous environment. This aggregation drops 
as the percentage of the Dil-PA increases towards the formation of nanobelt-like 
structures of 60% Dil-PA (Figure 3.31D-F) which complies with the ζ-potential of the 
co-assembly (Figure 3.29). 
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Figure 3.31. TEM comparison Co-assembly of HABPA-7 and Dil-PA, with increasing Dil PA: 20% (A), 40% (B), 
50% (C), 60% (D), 80% (E) and 100% (F) showing the morphology change of the co-assembly system. 1 nm for 
all scale bars. 
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3.2.4.3. Self-assembly with HA 
To form macroscopic assemblies, higher peptide concentrations are necessary. When 
trying the co-assembly of two PAs, solubility difficulties were found, caused by Dil-
PA, which becomes insoluble at higher concentrations as seen during the CAC 
measurements (Figure 3.25). The Dil-PA was insoluble at 1 % (% .wt) in H2O, 
however, the solubility increased on the addition of HABPA-7 inferring a synergistic 
effect between the HABPA-7 and Dil-PA. Though, the solution remained turbid with 
small insoluble particles. The key to forming a homogenous co-assembly solution was 
to raise the pH to 10, by doing this the Dil-PA solubilises (Scheme 3.3). By dissolving 
HABPA-7 in pH 10 solution and then adding this onto dry powder of Dil-PA ensure 
the solubility of Dil-PA through both effects of the pH and the synergy with HABPA-
7. The solution can then be adjusted to pH 7 to produce a stable solution. It was noted 
that by reducing the pH below pH 7 the Dil-PA precipitated from the solution. 
 
Scheme 3.3. A flow chart depicting the solubilisation routes tested (grey) with the steps (blue) and the outcome 
(dark blue). 
The co-assembly solution was mixed with HA (700 kDa, 2%) to compare the 
assemblies formed with and without the Dil-PA. Upon addition of the Dil-PA at a 
50:50 molar ratio, the membranes formed were opaquer (Figure 3.32a) as opposed to 
the formation of membranes with HABPA-7 alone.  
A change in the surface topology is seen for the membranes formed dependent on the 
order of HA addition (Figure 3.32b). By adding the HA first, two distinct sides can be 
seen in the membrane, with one side showing rough irregular layers, whilst the 
opposing side shows a smooth surface covered by globular aggregates (Figure 3.33A). 
By adding HA onto the co-assembled PA solution, both surfaces become littered with 
these small globular structures, which are consistent upon repetition of the membrane 
preparation and imaging.  
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Figure 3.32. Co-assembly of HABPA-7 and Dil-PA (10 mM, 50:50) mixed with HA 700 kDa (2%) showing the 
change in transparency of the membranes formed (A) and the change in surface dependent on the order of mixing 
with HA (B). 
 
Being denser and more viscous, the HA solution gets enveloped into the PA solution, 
similar to examples from the Stupp group56. When focusing on the topology, 
regardless of these globular structures, the surface still remains very fibrous similar to 
that of HABPA-7 alone (Figure 3.24). The differences in structure also becomes 
apparent in the cross-section examination. By adding the Dil-PA, we observe the 
alignment of the fibres (Figure 3.33B), similar to those of the HABPA-4 (Figure 3.18)  
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Figure 3.33. SEM images of 50:50 PA co-assembly (10 mM) mixed with HA 700 kDa (2%) showing the surface 
(A) and cross-section (B). 
This phenomenon is only witnessed by the inclusion of the Dil-PA, as HABPA-7 on 
its own with HA shows an irregular cross-section, consistent to the two sides of the 
HABP-7 membrane (Figure 3.24). To gain insights on the nature of the globular 
aggregates formed on the surface of the membranes using the co-assembled PA 
system, energy-dispersive X-ray spectroscopy (EDX) was performed (Figure 3.34). 
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Figure 3.34. Globular structures shown in the SEM image (top-left) with the EDX analysis (top-right) and detailed 
elemental composition percentages (bottom) 
No signals of salts were detected. Only peaks of the gold coating used for sample 
preparation for SEM was observed, plus peaks of oxygen and carbon, the main 
elements present in the two PAs and HA. These globular structures were consistent 
when repeating these experiments, as well increasing the two PA concentrations from 
10 mM to 20 mM. To determine if these globular spheres were HABPA-7 with the 
Dil-PA, HA or a combination of both, the membranes were reproduced with 10% of 
HA 700 kDa within the solution supplement with HA 1.5 MDa which had been 
fluorescently tagged with Texas red. The Z-stacks collected from confocal microscopy 
show evidence of the HA being spread throughout the membrane (Figure 3.35).  
 
Figure 3.35. Z-stacks of the membrane formed with 2% HA (700 kDa 90% and 10% of Texas Red-labelled 
1.5MDa) and HABPA-7: Dil-PA (50:50 ratio). Stacks taken from (a) bottom to (p) top of the membrane. 
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All the images show small red regions, with a build-up of HA localised towards the 
lower end of the membrane. This is expected as on addition the HA would sink 
towards the bottom of the solution due to the density difference between 700 kDa HA 
and 2.1 kDa of HABPA-7. The envelopment of HA by PAs of opposite charge has 
been previously shown by the Stupp group with the formation of sacs56. The lack of 
hot spots at the edges of the membrane infers that these globular structures are caused 
by the addition of the Dil-PA with the HABPA-7; the globular aggregates are not 
present in the absence of the Dil-PA nor does the Texas red labelled of HA suggest it 
is caused by the HA. Comparing the TEM images of HABPA-7 (Figure 3.23) and the 
50:50 mixture (Figure 3.31E) the large aggregated fibres on the TEM of the mixture 
give rise to the ball-like structures on the SEM. HABPA-7 and Dil-PA are first allowed 
to co-assemble before self-assembly with HA. The aggregates seen in the TEM when 
mixed with HA appear to cause these globular structures. Whilst the true compositions 
of these globular structures are as yet unknown they are repeatable. What is important 
is the cross-section of the membranes showing again alignment similarly to HABPA-
1 with HA, producing an environment where cells have the potential to bind and grow.  
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3.3. Conclusion 
In conclusion, it has been demonstrated that we can engineer the self-assembly of 
HABPeps by controlling their secondary structure through the design of the peptide 
sequence. For example, HABPA-1 shows promise to be used in drug delivery 
applications due to its pH-sensitive behaviour, whilst the HABPA-2 showed no stable 
assemblies. CD44 possesses two other HA binding sequences that could tested as PA 
(Table 1.7). Alternatively, a co-assembly between two or three of these HA binding 
sequences taken from CD44 as in a PA design as a co-assembly could lead to stable 
SA structures with HA such as membranes or gels. Of all the peptides, HABPep-3 
shows the most promise, as it successfully assembled with HA as both a native peptide 
and as PA. Hydrophobicity is the clear driving force for the assembly, but tests would 
need to be carried out to confirm this, using for example a X11R sequence, where X is 
hydrophobic residue such as alanine. By running this test, it can be determined if the 
if HABPep-3 is interacting through the entire peptide or simply the arginine. HABPA-
7 with Dil-PA shows promising results with the increased solubility seen from 
HABPA-7 compared to HABPep-3. The addition of a β-sheet domain within the two 
PAs could form longer fibres in the TEM, to produce gels for cell encapsulation 
studies.  
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3.4. Methods and Materials 
3.4.1. Materials 
Fmoc-amino acids and 4-methylbenzhydrylamine (MBHA) rink amide resin were 
purchased from Novabiochem. 1-hydroxybenzotriazole hydrate (HOBt), N,N′-
diisopropyl carbodiimide (DIC), piperidine, dimethylformamide (DMF), 
dichloromethane (DCM), trifluoroacetic acid (TFA), anisole, thioanisole, 1,2-
ethanedithiol (EDT) triisopropyl silane (TIS), diethyl ether, acetonitrile (ACN), acetic 
anhydride (Ac2O) and the Kaiser Test Kit were purchased from Sigma-Aldrich and 
used without further purification. 
 
3.4.2. Instruments and Analysis 
3.4.2.1. Electrospray Ionization Mass Spectrometry (ESI-MS) 
The peptide’s mass was determined using an LC-MS, comprising a 1100 Series LC 
and SL Ion Trap MSD (Agilent, USA). 
 
3.4.2.2. Analytical High-Performance Liquid Chromatography (HPLC) 
The crude and purified peptides were analysed on analytical HPLC (Alliance HPLC 
System, Waters, UK) using a RP X-bridge column (C18, 3.5 μm, 4.6 × 150 mm) with 
a gradient running from 98:2 to 0:100 of water/acetonitrile over a 30-minute period at 
1 mL/min flow rate at 25 ℃. The peptide elution was monitored by UV at 220 nm 
(2489 UV/Vis Detector, Waters, UK) controlled by Alliance software. 
 
3.4.2.3. Preparative High-Performance Liquid Chromatography (prep-HPLC) 
The peptides were purified on a Waters Auto Purification System using a preparative 
reverse-phase C18 column (XBridge, 130 Å, 5 μm, 30×150 mm, Waters, USA) with 
a gradient (Waters 2545 Binary Gradient HPLC system, Waters, USA) running from 
98:2 to 0:100 of water/acetonitrile over a 30-minute period at 20 mL/min flow rate at 
25 ℃. The peptide elution was monitored by UV at 220 nm (2489 UV/Visible 
(UV/Vis) Detector for Purification and Modular LC Systems, Waters, USA) and ESI-
MS (SQ Detector 2, Waters, USA) with mass directed fraction collection (2747 
Sample Manager-Injector, Waters, USA) controlled by Mass Lynx software. 
3.4.2.4. Circular Dichroism (CD)  
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The peptides were dissolved in Milli-Q water to obtain 11 µM solutions with the pH 
adjusted to 3, 7 and 10 using NH4OH (0.1 M) and HCl (0.1 M). The CD measurements 
were taken on a Chirascan CD spectrometer (Applied Photophysics, UK) in the far-
UV, from 190 to 300 nm, at 25 °C under a constant flow of N2 using a quartz cuvette 
with 3-mm in path length. The spectra displayed are an average of 3 spectra with molar 
ellipticity [θ] calculated form the measured ellipticity θ taken from the CD and 
converted using Equation 3.1. [𝜃] = 	 𝜃𝑐𝑙 Equation 3.1 
 
Where c is concentration in dmol L-1 and l is path length in cm. 
 
3.4.2.5. Nuclear Magnetic Resonance (NMR) Spectroscopy  
Spectra of the peptides were collected on a Bruker AV-III spectrometer at 400 MHz 
for 1H NMRs and at 101 MHz for 13C NMRs. CDCl3 was used as a solvent and the 
resonance signal at 7.26 ppm (1H) and 77.16 ppm (13C) served as a reference for the 
chemical shift δ of the spectra. NOE experiments where run at 8 scans with the 
corresponding COSY also ran beforehand. 
 
3.4.2.6. Transmission Electron Microscopy (TEM) 
The peptide solutions were prepared at 0.01 wt% in ultrapure water and their pH was 
adjusted with 0.1 M HCl or 0.1 M NH4OH. After being aged for 48 hours, the peptide 
solutions were loaded onto the carbon film coated copper grids (400 mesh, Agar 
Scientific, UK) and negatively stained by 2 wt% uranyl acetate (Agar Scientific, UK). 
The excess staining solution on the grids was removed with filter paper and the grids 
were allowed to dry at room temperature for at least 3 hours. Bright field TEM imaging 
was performed on a JEOL 1230 TEM operated at an acceleration voltage of 100 kV 
and the TEM images were recorded by an SIS Megaview III wide-angle CCD camera.  
 
3.4.2.7. ζ-Potential Measurement 
ζ-potential of the peptide solutions was measured on a Nano-ZS Zetasizer (Malvern 
Instruments) at 100 μM with the pH adjusted to 7.4, 3 and 11 using 0.1 M HCl or 0.1 
M NH4OH. 
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3.4.2.8. Critical Aggregation Concentration (CAC) 
The CAC for the peptides was determined by producing a serial dilution of peptide 
solutions from 1 mM to 1 nM. These solutions were added to Eppendorf’s containing 
Nile Red, with the samples being left 16 hours to allow the incorporation of the Nile 
Red into any aggregates formed by the peptides. The fluorescence emission spectrum 
was measured on an LS55 fluorescence spectrometer (PerkinElmer) ranging from 580 
to 720 nm with an excitation wavelength at 550 nm.  
 
3.4.2.9. Scanning Electron Microscopy (SEM)  
The micro/nanostructure of HA-peptide assemblies was examined by SEM. The 
membranes or gels were first fixed in 2% glutaraldehyde in PBS for 1 hour at 4 ℃ 
followed by washing with PBS. Sequential dehydration in increasing percentages of 
ethanol (from 20 to 100%) was performed and ethanol removed by a critical point 
dryer (EMS 850 Electron Microscopy Science, USA). The samples were stored in a 
desiccator until coated with a gold layer (5 – 30 nm) using an Emitech SC7620 sputter 
coater (Quorum Technologies, UK). The samples were imaged in a scanning electron 
microscope equipped with a field emission gun (FEG SEM, Inspect F50, FEI, 
Netherlands) 
 
3.4.2.10. Confocal Microscopy 
Membranes with components possessing fluorophores were imaged under a confocal 
microscopy (Leica TCS SP2) fitted with fluorescent filters. With Z-stacks taken to 
build a 3D image of the membranes. 
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3.4.3. Methods 
3.4.3.1. Peptide Synthesis 
3.4.3.1.35. Peptide Synthesis 
The peptides were synthesised using standard 9-fluorenyl methoxycarbonyl (Fmoc) 
and solid phase peptide synthesis (SPPS) on Rink amide 4-methylbenzhydrylamine 
resin assisted by a Liberty Blue automated microwave peptide synthesizer (CEM). The 
Fmoc-amino acids, HOBt and DIC in a 4 times excess were dissolved in DMF. The 
Fmoc group was deprotected with 20% piperidine in DMF (v/v). After each cycle, the 
resin was subsequently washed with DMF followed by DCM.  
 
3.4.3.1.36. Acetyl Capping 
The peptide on the resin was N-capped with acetyl groups by shaking the resin-bound 
peptide with acetic anhydride in DMF (10% w/v) for 10 minutes twice. After the 
capping cycle, the resin was subsequently washed with DMF followed by DCM with 
Kaiser test confirming the coupling. 
 
3.4.3.1.37. C-Terminus Modification  
PAs were synthesized in the same manner, but Fmoc-Lys(4-methyltrityl) was loaded 
onto the resin, followed by the cleavage of the 4-methyltrityl (Mtt) by 5% TFA in 
DCM for 10 minutes followed by 10% DIPEA in DCM for further 10 minutes. This 
cycle was repeated twice to ensure full cleavage of the side chain Mtt. The deprotected 
e-amine of the lysine was coupled with palmitic acid (4 equivalents) using the same 
coupling reagents and repeated twice to ensure high conversion. 
 
3.4.3.1.38. Cleavage 
Once the desired peptide sequence was achieved, the peptide and acid-labile side 
groups were cleaved by TFA/TIS/H2O (95:2.5:2.5) for 3 hours. The solution was 
collected, concentrated by reduced pressure and precipitated in cold ether. The 
resulting suspension was collected by centrifugation and decanting the supernatant, 
followed by lyophilisation of the resulting white solid.  
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3.4.3.1.39. Purification 
The crude peptides were passed through a 0.2 µm filter and then injected on a 
preparative reverse-phase C18 column (XBridge, 130 Å, 5 μm, 30×150 mm, Waters, 
USA) in an Auto Purification System (Waters, USA) using a gradient from H2O to 
ACN supplemented with 0.1% TFA for positively charge peptides and 0.1% NH4OH 
for negatively charged peptides. The fractions were detected by the SQ Mass Detector 
(Waters, USA). These fractions were combined, reduced under reduced pressure and 
then lyophilised to produce a white powder. 
 
3.4.3.2. Peptide-HA Membrane Preparation 
Peptide-HA membranes were prepared in a vial by solvating the peptide first followed 
by the addition of 2% HA solution. Upon addition of HA, an interface was observed 
instantaneously, but allowed to form fully at 37 ºC for 16 hours at which point the 
membrane was removed from the vial, washed with ultrapure water to remove any 
unreacted HA or peptide and left for 16 hours to test the stability in water. 
 
3.4.3.3. Co-assembled PAs-HA Membrane Preparation 
For a mixture of PAs, the PAs were combined as a dry powder in a vial and dissolved 
in ultrapure water. The sample was vortexed to aid solubilisation of the two PAs and 
incubated at 37 ºC for 16 hours to allow the SA of the two peptides. 2% HA solution 
was cast on top of the PAs solution and incubated again for 16 hours at 37 ºC. The 
membrane which was formed was removed from the vial, washed with ultrapure water 
to remove any unreacted HA or peptide and left for 16 hours to test the stability in 
water. 
  




1. Dorsey, S.M., et al., Visualization of Injectable Hydrogels Using Chemical Exchange 
Saturation Transfer MRI. ACS Biomaterials Science & Engineering, 2015. 1(4): p. 
227-237. 
2. Rodell, C.B., et al., Selective Proteolytic Degradation of Guest–Host Assembled, 
Injectable Hyaluronic Acid Hydrogels. ACS Biomaterials Science & Engineering, 
2015. 1(4): p. 277-286. 
3. Burdick, J.A. and G.D. Prestwich, Hyaluronic acid hydrogels for biomedical 
applications. Advanced Materials, 2011. 23(12): p. H41-56. 
4. Ramamurthi, A. and I. Vesely, Ultraviolet light-induced modification of crosslinked 
hyaluronan gels. Journal of Biomedical Materials Research Part A, 2003. 66A(2): p. 
317-329. 
5. Ramamurthi, A. and I. Vesely, Evaluation of the matrix-synthesis potential of 
crosslinked hyaluronan gels for tissue engineering of aortic heart valves. 
Biomaterials, 2005. 26(9): p. 999-1010. 
6. Ibrahim, S., et al., Characterization of glycidyl methacrylate - crosslinked hyaluronan 
hydrogel scaffolds incorporating elastogenic hyaluronan oligomers. Acta 
Biomaterialia, 2011. 7(2): p. 653-65. 
7. Skardal, A., J. Zhang, and G.D. Prestwich, Bioprinting vessel-like constructs using 
hyaluronan hydrogels crosslinked with tetrahedral polyethylene glycol tetracrylates. 
Biomaterials, 2010. 31(24): p. 6173-81. 
8. Pouyani, T. and G.D. Prestwich, Functionalized Derivatives of Hyaluronic Acid 
Oligosaccharides: Drug Carriers and Novel Biomaterials. Bioconjugate Chemistry, 
1994. 5(4): p. 339-347. 
9. Luo, Y., K.R. Kirker, and G.D. Prestwich, Cross-linked hyaluronic acid hydrogel 
films: new biomaterials for drug delivery. Journal of Controlled Release, 2000. 69(1): 
p. 169-184. 
10. Vanderhooft, J.L., B.K. Mann, and G.D. Prestwich, Synthesis and Characterization 
of Novel Thiol-Reactive Poly(ethylene glycol) Cross-Linkers for Extracellular-
Matrix-Mimetic Biomaterials. Biomacromolecules, 2007. 8(9): p. 2883-2889. 
11. Burdick, J.A. and G.D. Prestwich, Hyaluronic Acid Hydrogels for Biomedical 
Applications. Advanced Materials, 2011. 23(12): p. H41-H56. 
12. Charlot, A. and R. Auzély-Velty, Synthesis of Novel Supramolecular Assemblies 
Based on Hyaluronic Acid Derivatives Bearing Bivalent β-Cyclodextrin and 
Adamantane Moieties. Macromolecules, 2007. 40(4): p. 1147-1158. 
13. Charlot, A., et al., Controlled Synthesis and Inclusion Ability of a Hyaluronic Acid 
Derivative Bearing β-Cyclodextrin Molecules. Biomacromolecules, 2006. 7(3): p. 
907-913. 
14. Ouyang, L., et al., 3D Printing of Shear-Thinning Hyaluronic Acid Hydrogels with 
Secondary Cross-Linking. ACS Biomaterials Science & Engineering, 2016. 2(10): p. 
1743-1751. 
15. Elamin, K.M., et al., Supramolecular Complex of Methyl-β-cyclodextrin with 
Adamantane-Grafted Hyaluronic Acid as a Novel Antitumor Agent. Chemical and 
Pharmaceutical Bulletin, 2018. 66(3): p. 277-285. 
16. Rajangam, K., et al., Heparin Binding Nanostructures to Promote Growth of Blood 
Vessels. Nano Letters, 2006. 6(9): p. 2086-2090. 
17. Chow, L.W., et al., Self-assembling nanostructures to deliver angiogenic factors to 
pancreatic islets. Biomaterials, 2010. 31(24): p. 6154-61. 
18. Chow, L.W., et al., Peptide-directed spatial organization of biomolecules in dynamic 
gradient scaffolds. Advanced Healthcare Materials, 2014. 3(9): p. 1381-6. 
19. Roberts, J.J., et al., Interaction of Hyaluronan Binding Peptides with 
Glycosaminoglycans in Poly(ethylene glycol) Hydrogels. Biomacromolecules, 2014. 
15(4): p. 1132-1141. 
20. Mummert, M.E., et al., Development of a peptide inhibitor of hyaluronan-mediated 
leukocyte trafficking. Journal of Experimental Medicine, 2000. 192(6): p. 769-779. 
Engineering hyaluronan (HA)-binding peptides for self-assembly with natural HA 
 160 
21. Zmolik, J.M. and M.E. Mummert, Pep-1 as a novel probe for the in situ detection of 
hyaluronan. Journal of Histochemistry and Cytochemistry, 2005. 53(6): p. 745-751. 
22. Rudrabhatla, S.R., C.L. Mahaffey, and M.E. Mummert, Tumor Microenvironment 
Modulates Hyaluronan Expression: The Lactate Effect. Journal of Investigative 
Dermatology, 2006. 126(6): p. 1378-1387. 
23. Zaleski, K.J., et al., Hyaluronic acid binding peptides prevent experimental 
staphylococcal wound infection. Antimicrobial Agents and Chemotherapy, 2006. 
50(11): p. 3856-3860. 
24. Uchakina, O.N., et al., The role of hyaluronic acid in SEB-induced acute lung 
inflammation. Journal of Clinical Immunology, 2013. 146(1): p. 56-69. 
25. Campo, G.M., et al., Combined treatment with hyaluronan inhibitor Pep-1 and a 
selective adenosine A2 receptor agonist reduces inflammation in experimental 
arthritis. Innate Immunity, 2013. 19(5): p. 462-478. 
26. Riehl, T.E., X. Ee, and W.F. Stenson, Hyaluronic acid regulates normal intestinal 
and colonic growth in mice. American Journal of Physiology-Gastrointestinal and 
Liver Physiology, 2012. 303(3): p. G377-88. 
27. Riehl, T.E., et al., CD44 and TLR4 mediate hyaluronic acid regulation of Lgr5+ stem 
cell proliferation, crypt fission, and intestinal growth in postnatal and adult mice. Am 
J Physiol Gastrointest Liver Physiol, 2015. 309(11): p. G874-87. 
28. Liang, J., D. Jiang, and P.W. Noble, Hyaluronan as a therapeutic target in human 
diseases. Advanced Drug Delivery Reviews, 2016. 97: p. 186-203. 
29. Al-Qadi, S., et al., The role of hyaluronic acid inclusion on the energetics of 
encapsulation and release of a protein molecule from chitosan-based nanoparticles. 
Colloids and Surfaces B: Biointerfaces, 2016. 141: p. 223-232. 
30. Cui, H., M.J. Webber, and S.I. Stupp, Self-assembly of peptide amphiphiles: From 
molecules to nanostructures to biomaterials. Peptide Science, 2010. 94(1): p. 1-18. 
31. Hartgerink, J.D., E. Beniash, and S.I. Stupp, Self-Assembly and Mineralization of 
Peptide-Amphiphile Nanofibers. Science, 2001. 294(5547): p. 1684. 
32. Hartgerink, J.D., E. Beniash, and S.I. Stupp, Peptide-amphiphile nanofibers: a 
versatile scaffold for the preparation of self-assembling materials. Proceedings of the 
National Academy of Sciences of the United States of America, 2002. 99(8): p. 5133-
8. 
33. Ferreira, D.S., et al., Hyaluronan and self-assembling peptides as building blocks to 
reconstruct the extracellular environment in skin tissue. Biomaterials Science, 2013. 
1(9): p. 952-964. 
34. Pashuck, E.T., H. Cui, and S.I. Stupp, Tuning Supramolecular Rigidity of Peptide 
Fibers through Molecular Structure. Journal of the American Chemical Society, 
2010. 132(17): p. 6041-6046. 
35. Niece, K.L., et al., Self-Assembly Combining Two Bioactive Peptide-Amphiphile 
Molecules into Nanofibers by Electrostatic Attraction. Journal of the American 
Chemical Society, 2003. 125(24): p. 7146-7147. 
36. Lide, D.R., Handbook of Chemistry and Physics. 88 ed. Vol. 130. 2007. 
37. Costantini, S., G. Colonna, and A.M. Facchiano, Amino acid propensities for 
secondary structures are influenced by the protein structural class. Biochemical and 
Biophysical Research Communications, 2006. 342(2): p. 441-51. 
38. Pins, G.D., et al., Self-assembly of collagen fibers. Influence of fibrillar alignment and 
decorin on mechanical properties. Biophysical Journal, 1997. 73(4): p. 2164-2172. 
39. Lee, K.Y. and D.J. Mooney, Hydrogels for Tissue Engineering. Chemical Reviews, 
2001. 101(7): p. 1869-1880. 
40. Mouw, J.K., G. Ou, and V.M. Weaver, Extracellular matrix assembly: a multiscale 
deconstruction. Nature reviews. Molecular cell biology, 2014. 15(12): p. 771-785. 
41. Nam, E., W.C. Lee, and S. Takeuchi, Formation of Highly Aligned Collagen 
Nanofibers by Continuous Cyclic Stretch of a Collagen Hydrogel Sheet. Macromol 
Biosci, 2016. 16(7): p. 995-1000. 
42. Lowe, C.J., et al., Production of Highly Aligned Collagen Scaffolds by Freeze-drying 
of Self-assembled, Fibrillar Collagen Gels. ACS Biomater Sci Eng, 2016. 2(4): p. 
643-651. 
Engineering hyaluronan (HA)-binding peptides for self-assembly with natural HA 
 161 
43. Nikkhah, M., et al., Directed endothelial cell morphogenesis in micropatterned 
gelatin methacrylate hydrogels. Biomaterials, 2012. 33(35): p. 9009-18. 
44. Jin, H.-E., et al., Biomimetic Self-Templated Hierarchical Structures of Collagen-Like 
Peptide Amphiphiles. Nano Letters, 2015. 15(10): p. 7138-7145. 
45. Webber, M.J., et al., Development of bioactive peptide amphiphiles for therapeutic 
cell delivery. Acta Biomaterialia, 2010. 6(1): p. 3-11. 
46. Yu, Z., et al., Co-assembly of Peptide Amphiphiles and Lipids into Supramolecular 
Nanostructures Driven by Anion−π Interactions. Journal of the American Chemical 
Society, 2017. 139(23): p. 7823-7830. 
47. Hamley, I.W., A. Dehsorkhi, and V. Castelletto, Coassembly in binary mixtures of 
peptide amphiphiles containing oppositely charged residues. Langmuir, 2013. 
29(16): p. 5050-9. 
48. Behanna, H.A., et al., Coassembly of Amphiphiles with Opposite Peptide Polarities 
into Nanofibers. Journal of the American Chemical Society, 2005. 127(4): p. 1193-
1200. 
49. Ortony, J.H., et al., Internal dynamics of a supramolecular nanofibre. Nature 
Materials, 2014. 13(8): p. 812-6. 
50. Toft, D.J., et al., Coassembled Cytotoxic and Pegylated Peptide Amphiphiles Form 
Filamentous Nanostructures with Potent Antitumor Activity in Models of Breast 
Cancer. ACS Nano, 2012. 6(9): p. 7956-7965. 
51. Castelletto, V., et al., New RGD-peptide amphiphile mixtures containing a negatively 
charged diluent. Faraday Discussions, 2013. 166: p. 381. 
52. Matson, J.B., et al., Nanostructure-templated control of drug release from peptide 
amphiphile nanofiber gels. Soft Matter, 2012. 8(13): p. 3586-3595. 
53. Lee, S.S., et al., Gel scaffolds of BMP-2-binding peptide amphiphile nanofibers for 
spinal arthrodesis. Advanced Healthcare Materials, 2015. 4(1): p. 131-141. 
54. Cui, H., et al., Self-Assembly of Giant Peptide Nanonbelts. Nano Letters, 2009. 9(3): 
p. 945-951. 
55. Moyer, T.J., H. Cui, and S.I. Stupp, Tuning nanostructure dimensions with 
supramolecular twisting. Journal of Physical Chemistry B, 2013. 117(16): p. 4604-
10. 
56. Capito, R.M., et al., Self-assembly of large and small molecules into hierarchically 
ordered sacs and membranes. Science, 2008. 319(5871): p. 1812-6. 
 
Engineering hyaluronan (HA)-binding peptides for self-assembly with natural HA 
 162 
3.5. Appendix 
3.5.1. Peptide Characterisation 
3.5.1.1. Ac-RYPISRPRKR-CONH2 (HABPep-1) 
 
 
Figure A 3.1. HPLC trace of purified HABPep-1 running a gradient of 98: 2 to 0: 100 (H2O + 0.1 % TFA: ACN + 
0.1 % TFA) over a 30-minute period at a flow rate of 1 ml/min 
 
Figure A 3.2. ESI Mass spectrum of HABPep-1 measured in the positive ion channel 
RP-HPLC (mins) 9.85 
Purity (%) > 99 






































Engineering hyaluronan (HA)-binding peptides for self-assembly with natural HA 
 163 
3.5.1.2. Ac-KNGRYSISR-CONH2 (HABPep-2) 
 
 
Figure A 3.3. HPLC trace of purified HABPep-2 running a gradient of 98: 2 to 0: 100 (H2O + 0.1 % TFA: ACN + 
0.1 % TFA) over a 30-minute period at a flow rate of 1 ml/min 
 
Figure A 3.4. ESI Mass spectrum of HABPep-2 measured in the positive ion channel 
 
RP-HPLC (mins) 9.23 
Purity (%) > 99 
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3.5.1.3. H2N-GAHWNFQALTVR-CONH2 (HABPep-3) 
 
 
Figure A 3.5. HPLC trace of purified HABPep-3 running a gradient of 98: 2 to 0: 100 (H2O + 0.1 % TFA: ACN + 
0.1 % TFA) over a 30-minute period at a flow rate of 1 ml/min 
 
Figure A 3.6. ESI Mass spectrum of HABPep-3 measured in the positive ion channel 
 
RP-HPLC (mins) 14.11 
Purity (%) > 99 










































Engineering hyaluronan (HA)-binding peptides for self-assembly with natural HA 
 165 
3.5.1.4. C16-VVVAAARYPISRPRKR-CONH2 (HABPA-1) 
 
 
Figure A 3.7. HPLC trace of purified HABPA-1 running a gradient of 98: 2 to 0: 100 (H2O + 0.1 % TFA: ACN + 
0.1 % TFA) over a 30-minute period at a flow rate of 1 ml/min 
 
Figure A 3.8. ESI Mass spectrum of HABPA-1 measured in the positive ion channel 
 
RP-HPLC (mins) 21.75 
Purity (%) > 97 
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3.5.1.5. C16-VVVAAAKNGRYSISR-CONH2 (HABPA-2) 
 
 
Figure A 3.9. HPLC trace of purified HABPA-2 running a gradient of 98: 2 to 0: 100 (H2O + 0.1 % TFA: ACN + 
0.1 % TFA) over a 30-minute period at a flow rate of 1 ml/min 
 
Figure A 3.10. ESI Mass spectrum of HABPA-2 measured in the positive ion channel 
 
RP-HPLC (mins) 24.57 
Purity (%) 97 
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3.5.1.6. H2N-GAHWNFQALTVRGGGKK[K](C16)-CONH2 (HABPA-7) 
 
 
Figure A 3.11. HPLC trace of purified HABPA-7 running a gradient of 98: 2 to 0: 100 (H2O + 0.1 % TFA: ACN 
+ 0.1 % TFA) over a 30-minute period at a flow rate of 1 ml/min 
 
Figure A 3.12. ESI Mass spectrum of HABPA-7 measured in the positive ion channel 
 
RP-HPLC (mins) 19.8 
Purity (%) > 99 
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3.5.1.7. C16-EEGGG-CONH2 (Dil-PA) 
 
 
Figure A 3.13. HPLC trace of purified Dil-PA running a gradient of 98: 2 to 0: 100 (H2O + 0.1 % NH4OH: ACN 
+ 0.1 % NH4OH) over a 30-minute period at a flow rate of 1 ml/min 
 
Figure A 3.14. ESI Mass spectrum of Dil-PA measured in the positive ion channel 
 
RP-HPLC (mins) 19.6 
Purity (%) > 99 
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3.5.2. Additional Spectra 
3.5.2.1. Nile Red Fluorescence 
 
Figure A 3.15. Nile Red emission when excited at 550 nm at increasing concentrations of HABPep-3 in H2O 
 
Figure A 3.16. Nile Red emission when excited at 550 nm at increasing concentrations of HABPA-1 in H2O 
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Figure A 3.17. Nile Red emission when excited at 550 nm at increasing concentrations of HABPA-2 in H2O 
 
Figure A 3.18. Nile Red emission when excited at 550 nm at increasing concentrations of HABPA-7 in H2O 
 
Figure A 3.19. Nile Red emission when excited at 550 nm at increasing concentrations of Dil-PA in H2O 
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Figure A 3.20. Nile Red emission when excited at 550 nm at increasing concentrations of 50:50 ratio of HABPA-
7 and Dil-PA in H2O 
 
3.5.2.2. Nuclear Overhauser Effect (NOE) NMR 
   
Figure A3.21. NOE NMR analysis of Dil-PA (left) and HABPA-7 (right) in D2O at 400 MHz. The negative peptide 
was supplemented with a drop of NaOH to aid solubility
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Chapter 4 Physical, Chemical, Biological and Binding Properties 
of Hyaluronan Glycopolymers 
4.1. Introduction 
As previously mentioned, HA has many important functions in the human body. It is 
believed that some of these functions are derived from its physico-chemical properties, 
including high viscosity and polyelectrolyte behaviour. At physiological pH, the 
carboxylic groups of GlcA are unprotonated and HA displays a negative charge which 
is 1 nm apart1. In the first half of this chapter, the HA-based glycopolymers are 
compared to natural HA in terms of physical properties, such as viscoelasticity, charge 
and conformation. A second group of HA glycopolymers were also synthesised from 
an acrylate backbone. These were compared to styrenic glycopolymers and HA to 
determine the effect of the polymer backbone upon their physical properties. 
The alternating structure of HA might be important for the binding to specific HA-
binding proteins such as CD44, LYVE-1 and TSG-6, but the role of each HA sugar in 
the binding process is not completely clear. For example, are both sugars essential for 
the binding and is the order necessary? Using the diverse HA glycopolymers described 
in chapter 2, their binding to a group of selected molecules was probed using SPR. In 
order to do this, HABPeps2-3 described in chapter 3 were functionalized with a thiol 
terminus group to allow their immobilisation onto the surface of a gold (Au) chip. 
Carbohydrates in the body are known to be recognised by cell surface receptors, such 
as lectins. The interaction between lectins and carbohydrates are responsible for a 
plethora of biological processes such as pathogen invasion, immune system activation 
and cell proliferation. Predominantly found on the cell surface, lectins elicit a weak 
cellular response when binding to a carbohydrate. These multivalent interactions cause 
the lectin to initiate a larger cellular response, thus triggering downstream effects from 
the system, which in most cases leads to an immune response. Upon the binding of a 
single monosaccharide, a weak response is produced by the lectin. However, many of 
these carbohydrate-binding proteins exist as dimers, trimers and higher orders of 
oligomers, therefore they have sites to bind as multiple carbohydrates. By increasing 
the local concentration of the carbohydrate on a glycopolymer, the lectins on the cell 
surface can bind multiple carbohydrates, known as the multivalent effect4. When 
binding multiple lectin domains simultaneously a large response is elicited leading to 
a response from the system such as cytokine release leading to downstream effect 
through cell signalling (Scheme 4.1). This multivalency leading to a larger system 
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response is known as produces a “cluster-glycoside effect”. C-type lectins 
predominantly bind through the C4 and 3 hydroxides in the equatorial position 
mediated by a metal ion such as calcium5.  
 
Scheme 4.1. Schematic representation of the cellular response from the lectin upon reversible binding of a single 
saccharide compared to the binding of a glycopolymer with multiple saccharides. Adapted from Ref4 
Glycopolymers offer the possibility to present multiple monosaccharides to lectins in 
order to cause a larger response, since the glycosidic bond does not exist in these 
synthetic alternatives. In the last section of the chapter, the glycopolymers are used as 
probes to test the binding to lectins, to obtain an improved understanding of the 
binding. With hits for HA from to 2 of the 5 lectins tested the glycopolymers can give 
an improved assessment of the binding of lectins. The glycopolymers allow for a vast 
array of monosaccharides to be tested against multiple lections to give a better picture 
of the binding process to lectins as potential therapeutics. 
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4.2. Results and Discussion 
4.2.1. Physical Properties of Glycopolymers 
The properties of the synthetic HA glycopolymers (Table 4.1) were compared to those 
of natural HA with 20 kDa, as the glycopolymers possess a similar molecular weight. 
HA is water soluble and in order to be soluble in organic solvents, such as DMF or 
DMSO, HA requires chemical modification or ion exchange of the carboxylate 
counter (commonly sodium) to a larger counter-ion such as tetrabutylammonium ion 
(TBA). After the grafting of the sugars, the solubility of the glycopolymers switched 
from organic based to aqueous-based solvents, due to the large number of free 
hydroxides along the backbone of the polymer. 
Table 4.1. Summary of polymers from Chapter 2. 
Polymer Type 
Mn (g mol-1) 
Ðb 
Theoa GPCb 
P1 pVBC56 Homopolymer 12800 13100 1.13 
P2 pVBAz56 Homopolymer 13400 13400 1.20 
P3 pVB-Glc56 Glycohomopolymer 32000 4400 1.07 
P4 pVB-Man56 Glycohomopolymer 32000 4400 1.08 
P5 pVB-Gal56 Glycohomopolymer 32000 4300 1.04 
P6 pVB-GlcNAc56 Glycohomopolymer 36000 6900 1.13 
P7 pVB-GlcA56 Glycohomopolymer 35000 6300 1.02 
P8 pVB-GlcA23-co-VB-GlcNAc23 Statistical Glycocopolymer 35500 4100 1.04 
P9 pVBC24-alt-TMS PMI24 Alternating Copolymer 12800 19500 1.57 
P10 pVBAz24-alt-TMS PMI24 Alternating Copolymer 19900 18300 2.40 
P11 pVB-GlcNAc24-alt-PMI24 Alternating Glycocopolymer 27000 4800 1.02 
P12 pVB-GlcNAc24-alt-PMI-GlcA24 Alternating Glycocopolymer 40000 5700 1.06 
a 1H NMR (400 MHz, d-DMSO), bDMF + 5 mM NH4BF4 eluent, calibrated with PS standards. 
 
4.2.1.1. Viscoelastic Behaviour  
HA is used as a viscoelastic supplement in conditions such as osteoarthritis, with 
injections into the knee to relieve symptoms. In solution, HA acts as a non-Newtonian 
liquid with viscoelastic properties which arise from the HAs elongated linear structure, 
aid by the glycosidic bond and reinforced with intramolecular hydrogen bonds 
(Scheme 4.2) causing the polysaccharide to become semi-flexible. When shear is 
applied to non-Newtonian fluids, their viscosity decreases with increased in shear rate 
and this behaviour is known as shear-thinning. Rheological data of natural HA shows 
a correlation between viscosity and the molecular weight (Figure 4.1A) matching 
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trends seen in literature6. HA with 20 kDa presents an average viscosity of 1.3 ´ 10-3 
Pa×s and the shear-thinning effect is negligible.  
 
Scheme 4.2. Schematic representation of a HA dimer with an addition GlcA showing the internal hydrogen bonding 
represented by the dotted lines (A) and purposed hydrogen bonding within P12 (B). 
In contrast, the glycopolymers do not bare multiple glycosidic bonds between 
saccharides, but a single glycosidic bond with an alcohol (e.g. propargyl alcohol and 
2-azidoethanol) used to click onto the polymer backbone. While the glycopolymers 
lack the glycosidic bonds of HA, there is still the possibility for intra and 
intermolecular hydrogen bonds between the saccharide pendant groups. The lack of 
glycosidic bonds in the glycopolymers causes a detrimental effect on the viscosity 
when compared to 20 kDa HA with a four-fold decrease due to the increased flexibility 
(Figure 4.1B). Comparing the viscosity among the glycopolymers, higher viscosity is 
seen for P7. This infers that the carboxylic acid group of GlcA in a regular repeating 
structure is forming stronger intra/intermolecular hydrogen bonding. From the trends 
observed in the viscosity with increasing molecular weight of HA infers a longer 
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Figure 4.1. Viscosity versus shear rate of HA (1%. wt), glycopolymers solutions (1%. wt) and water (A) with a 
zoom of the lower viscosity results (B).  
The rheology data, as well as the data found in literature, indicates a dependence of 
viscosity with molecular weight and concentration. By setting one of the parameters 
as constant and increasing the other, an increase in viscosity of HA solutions is 
observed7-8. Increasing the concentration of the glycopolymers would lead to increase 
in viscosity but would require concentrations greater than 3%. There is a relation of 
R3 dependency on the viscosity (ƞ) in Equation 4.1, where R is root-mean-square end-
to-end distance and N is the number of monomers. 
[η] ≅ 𝑅S 𝑁=  Equation 4.1 
 
Since the overall length of the polymer leads to a cubic increase on the viscosity, 
polymerisation was attempted to create large polymers. By increasing the ratio of 
monomers to initiator and RAFT agent, large polymers could be produced, but the Ð 
becomes broader through by this method (Figure 4.2).  
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Figure 4.2. Normalised GPC traces of the polymerisation results of various different polymers with increasing Mw 
to mimic 20, 60, 200 and 600 kDa HA showing a loss in control of dispersity upon scaling the polymerisation. 
Consequently, the chain extension was tested over direct polymerisation. Products of 
RAFT polymerisation retain the reactive C-S bond which can fragment to release the 
chain for further polymerisation as a macroinitiator. By this method a further degree 
of control is achieved as there is not a large excess of monomers in the solution. Using 
an alternating polymer of VBC and TMS PMI with an Mw of 11800, the chain was 
extended to 21800 while retaining a narrow Ð, from 1.23 to 1.30 (Figure 4.3). 
 
Figure 4.3. Normalised GPC traces of the polymerisation results of VBC and TMS PMI by chain extension. 
A small peak was observed at 18.5 minutes from unreacted TMS PMI, which caused 
the slight broadening in the peak. The ability to chain extend the polymer has the 
potential to synthesis longer glycopolymers to begin to rival the size of HA whilst 
maintaining a low Ð. This proof of concept is promising but current controlled radical 
polymerisation techniques of complex monomers still lags behind the capabilities of 
enzymes. 
 
4.2.1.2. Polyelectrolyte Behaviour 
In aqueous solutions, HA also behaves as a polyelectrolyte (PE) due to the presence 
of carboxylates 1 nm apart. This negative charge across HA gives a large negative ζ- 
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potential of -20.08 mV. For the synthetic glycopolymers, a negative z-potential is also 
observed for those polymers containing a GlcA residue. In contrast the homopolymers 
of P3-6 show a neutral ζ- potential (Figure 4.4).  
 
Figure 4.4. ζ-potential of the glycopolymers compared to HA. Analysed by two-way ANOVA analysis, where * 
significant at P < 0.0332, ** significant at P < 0.0021, *** significant at P < 0.0002 and **** significant at P < 
0.0001. 
The z-potential values also provide information on the stability of the aggregates 
formed. HA has the largest negative potential, due to the regularity of the negative 
charged is place across the polysaccharide. P7 and P12 also have regular negative 
charge however due to a smaller proportion of the molecule is charged the ζ-potential 
is lower compared with HA, which has a higher charge density. P7 and P8 show no 
significant difference on their negative charge. In P7, GlcA is placed regularly across 
every unit whereas in P8 the GlcA being placed randomly across the polymer chain. 
The charge density on P12 is significantly greater than the one for P7 and P8. The 
even distribution of the GlcA spaced by a GlcNAc in P12 leads to a higher stability of 
the negative charge. This suggests a low repulsion caused by alternation of a charged 
saccharides and non-charged saccharide within P12. 
The differences between the glycopolymers charge and HA is also evident in their 
small angle X-ray scattering (SAXS) patterns (Figure 4.5). The scattering pattern of 
natural HA exhibits a peak at 0.04 A-1 which is characteristic for the scattering of salt-
free polyelectrolyte solutions. This peak, often referred to as a ‘correlation peak’, 
represents an average distance between the charged domains in solution (i.e. the HA 
chains)9-10. Although negative, the scattering patterns of P6, P7, P8 and P12 do not 
display a correlation peak. A qualitative analysis of the glycopolymers scattering 
patterns yields a power law dependence of the scattered intensity on q with an 
exponent of ~ -0.8 indicative of a short cylindrical object.  
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Figure 4.5. SAXS patterns for HA and glycopolymers at 0.2 mM at pH 7 with each line offset by factors of 10.  
The scattering of P6, P7, P8 and P12 could be fitted to a semi-flexible chain model11 
Equation 4.2 which describes a chain comprised of a series of locally stiff segments 
by three parameters b - Kuhn's length, a measure of the chain’s flexibility, L - the 





The best fit to the model is presented as solid lines in the appendix (Figure A 4.1), and 
the best-fit parameters are given in Table 4.2. For the different glycopolymers, the 
Kuhn length (~50 Å) and the radius (~15 Å) parameters are similar suggesting that the 
flexibility of the chains does not change. The result of the physical studies are 
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Table 4.2. Parameters from the SAXS fitted models for the glycopolymers 
Contour Length (Å) Radius (Å) Kuhn length (Å) Glycopolymer 
700 16 51 P6 
660 16 49 P7 
570 15 50 P8 
700 15 52 P12 
 
Table 4.3. Summary of properties of glycopolymers 
Polymer R Type z-potential (mV) a CAC (nM) a PE b 
HA GlcNAc & GlcA Natural Polysaccharide -20.07 ± 1.44 n/a Y 
P3 Glc Homo-glycopolymer -1.55 ± 0.76 550 n.m. 
P4 Man Homo-glycopolymer 1.59 ± 1.93 630 n.m. 
P5 Gal Homo-glycopolymer -0.86 ± 1.73 < 1 n.m. 
P6 GlcNAc Homo-glycopolymer 0.18 ± 0.53 85 N 
P7 GlcA Homo-glycopolymer -4.67 ± 0.67 3200 N 
P8 GlcNAc & GlcA Statistical Glycopolymer -3.70 ± 1.21 2100 N 
P12 GlcNAc & GlcA Alternating Glycopolymer -9.98 ± 0.71 830 N 
R = Side Chain. PE = Polyelectrolyte. n/a = not applicable. n.m. = not measured. a measured in H2O at pH 7. b 
measured by correlation peak on SAXS. 
 
4.2.1.3. Conformation 
According to the GPC results (Table 4.1), the glycopolymers showed a reduction in 
the molecular weight and Ð compared to the polymers before grafting. This may infer 
degradation of the polymer but there is no sign of degradation seen in the 1H NMR. 
The GPC measures the size of the polymers by their hydrodynamic volume and using 
calibrations the molecular weight can be determined. All the glycopolymers showed a 
CAC point inferring the glycopolymer aggregates forming a hydrophobic pocket 
(Figure 4.6A). This change in the glycopolymer conformation explains the 
inconsistent behaviour in the GPC upon the addition of the monosaccharides.  
Interestingly, it was not possible to determine the CAC for P5 as the glycopolymer has 
already formed an aggregate according to the wavelength maxima at 620 nm as well 
as increased turbidity of the solution (Figure 4.6B), with the highest concentration 
tested, 0.1 nM, forming a pink solution.  
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Figure 4.6. Nile Red assay of the glycopolymers (A), turbidity measurements at 650 nm (B) with insert of P5 dyed 
with Nile Red at 0.1 mM, The fluorescent output of the Nile Red in the glycopolymer solutions at 620 nm (C) and 
P7 insolubility at pH 3 (D). 
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For those glycopolymers which bare a GlcA monosaccharide a later CAC point is seen 
due to the electrostatic repulsion of these monosaccharides as well as an overall 
decrease in fluorescence output by P7 and P8 (Figure 4.6C). By comparison, the CAC 
of P12 is reduced compared with P7 and P8 following the trend of the uncharged 
glycopolymers. The two factors that contribute to the reduction of the CAC. Firstly, 
increasing the distance between the charged monosaccharides leads to a reduction in 
repulsion and secondly the benzyl rings are not adjacent leading to a reduction in 𝜋-𝜋 
stacking. These two factors could be the cause for the lowering of the CAC to values 
seen for the other non-GlcA glycopolymers. Attempts to screen the charge of the 
polymers containing GlcA using HCl to lower the pH, led to the formation of 
aggregates, which crashed out of solution (Figure 4.6D).  
The glycopolymer aggregates were imaged using TEM (Figure 4.7A-D) at pH 7 and 
1 mM to ensure all the glycopolymers were above the CAC. All the glycopolymers 
tested showed the ability to form spherical aggregates of different sizes (Figure 4.7E).  
These spherical structures can arise due to the differences in hydrophobicity across 
the polymer. The styrenic, RAFT group with the alkyl tail and/or maleic anhydride 
backbone are not water soluble and aggregate through hydrophobic interactions 
including 𝜋-𝜋 stacking between the adjacent styrene rings. The aggregates formed by 
the glycopolymers containing GlcA show a significantly lower mean diameter than 
those formed by the homopolymer of GlcNAc (P6) when measured using Image J 
(Figure 4.7E). This trend is also seen by DLS (Figure 4.7F) as P6 maximum is higher 
than that of any the GlcA-containing glycopolymers. The largest spread of sizes in the 
DLS was observed for the P6 with the largest error in measurement. This result, 
together with the values of z-potential (Figure 4.4) showing the negative charge of the 
GlcA-containing glycopolymers can be associated with charge on the surface of the 
aggregate, but it is also a competition between the hydrophobicity of the backbone 
against the charge-charge repulsion. This charge-charge repulsion causes the higher 
CAC observed for P7 and P8 (Figure 4.6A). The charge inhibit aggregation with 
multiple glycopolymer chains. In the absence of the charge repulsion, the non-
charged, P6 can aggregate with multiple glycopolymer chain in solution to form a 
larger aggregate. This aggregation is not restricted by charge and therefore causes a 
larger distribution of sizes observed with a large associated error. When screening the 
charge of the GlcA-containing polymer, P7 shows aggregation which causes the 
precipitation of the glycopolymer into the solution as the aggregation is no longer 
governed by charge repulsion (Figure 4.6D). 
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Figure 4.7. TEM images of the glycopolymers at 1 mM and pH 7 for (A) P6, (B) P7, (C) P8 and (D) P12 with the 
mean size distribution (E) of the formed aggregates measured by ImageJ analysis.  DLS (F) of the glycopolymers 
at 0.1 mM and pH 7. Analysed by two-way ANOVA analysis, where * significant at P < 0.0332, ** significant at 
P < 0.0021, *** significant at P < 0.0002 and **** significant at P < 0.0001. 
The size of the glycopolymer aggregates seen in the TEM images is two orders of 
magnitude higher than those obtained from the SAXS (Figure 4.5). TEM was 
performed on dried samples while SAXS is done in solution. The drying process in 
TEM increases the polymer concentration inducing their aggregation into larger 
particles. Cryo-TEM could be an alternative to obtain images of the glycopolymer 
aggregates in the solution state through a thin film of vitrified solvent. The styrenic 
backbone was postulated to be the cause of aggregation seen for the glycopolymers. 
Therefore, a new class of glycopolymers was synthesised to determine if the backbone 
was restricting the glycopolymer from acting as a polyelectrolyte. 
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4.2.2. Acrylate-based Glycopolymers 
The acrylate polymerization system presents an alternative to the styrene-based 
polymers. The acrylate is a monomer two orders of magnitude more reactive than 
styrene12 at 30 ℃ (Table 4.4). The monomer is more flexible when we consider the 
functionality orthogonal to the polymerisable group compared to the benzene ring of 
a styrene monomer.  
Table 4.4. Propagation rate coefficients of different monomers at 30 ℃12 
Monomer kp (mol-1 s-1) 





Methyl methacrylate 390 
Chloroprene 500 
Vinyl Acetate 3000 
Methyl Acrylate 15000 
 
4.2.2.1. Homoglycopolymers 
The monomer was synthesised by the coupling of acryloyl chloride with 2-
bromoethanol to form bromoethyl acrylate13 (BEA, 20) (Scheme 4.3). In the 1H NMR 
for 20, a small shift is seen between the conjugated alkene of the acryloyl chloride and 
the pair doublet of the 2-bromoethanol in the product 20. The monomer was 
polymerised using the same RAFT protocol as VBC monomer to form poly 
bromoethyl acrylate (pBEA, P13) (Table 4.5). 
Table 4.5. Polymerisation of acrylate-based glycopolymers 
Entry Polymer Reaction Type Time (h) 𝜌 (%) Mn, (g mol—1) Ð b 
Theo a GPC b 
P13 pBEA RAFT 2 60 10800 9800 1.26 
P14 pAEA Azidation 5 >99 7500 10700 1.40 
P15 pEA-GlcNAc CuAAc 16 >99 32000 3100 1.05 
P16 pEA-GlcA CuAAc 16 >99 32000 2400 1.05 
a 1H NMR (400 MHz, DMSO), bDMF + 5 mM NH4BF4 eluent, calibrated with PS standards.  
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The GPC traces showed the high molecular weight shoulder similar to the styrene 
family of glycopolymers on azidation (Figure 4.8A). The azidation caused a shift in 
the pair of the CH2’s in the pendant group and in the 1H NMR upfield due to change 
from an electron withdrawing halide to an electron donating azide (Figure 4.8B), with 
a peak at 2096 cm-1 for the azide on the FT-IR (Figure 4.8C). 
 
Scheme 4.3. Schematic representation of the synthesized acrylate-based glycopolymer via RAFT polymerisation, 
azidation and finally CuAAC
 
Using the CuAAc determined previously, the sugars of 4 and 10 were grafted onto the 
pendant azide group of P14. In both cases, the 1H NMR showed the shift of the pair 
of CH2 with the change of environment again, as well as the addition of the triazole 
peak at 8.00 ppm. The FT-IR also shows a loss in the azide peak at 2096 cm-1 due to 
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Figure 4.8 Results of the formation of the acrylate glycopolymer P15 and P16 by GPC (A), 1H NMR at 400 MHz 
in d-Acetone  (B) monitoring the two CH2 of the ethyl group from P13 to P14 and FT-IR (C)  highlighting the 
azide and OH peaks. 
 
4.2.2.2. Dual Acrylate Glycopolymers 
While substantial research has been developed around the styrene-maleic anhydride 
system, less has been carried out on alternating polymers with acrylates. The 
monomers reactivity and polarization affects the ability for the co-monomer 
polymerisation to alternate, as an electron acceptor monomer with a low electron 
density, such as maleimide, will preferentially react with an electron donating 
substituent such as a styrene that with itself14. Therefore, for an alternating polymer to 
be successful, rather than producing a statistical polymerisation it must have a low 
propensity to hompolymerise. The low polarity of the acrylate bond results in being a 
poor monomer to produce an alternating polymer, unless a Lewis acid15 or complex 
reagents16-17 are present. Instead, the formation of glycomonomer based on an acrylate, 
which can bare two monosaccharides which would not require any complex 
alternating acrylate polymerisation is a more suitable approach18-21. Examples of this 
type of acrylate exists for monomers containing the same sugar twice, typically using 
a thiol-alkyne reaction for a double substitution. Conversely, in this work two different 
Physical, Chemical, Biological and Binding Properties of Hyaluronan Glycopolymers 
 187 
monosaccharides would be required to be synthesised on the same monomer. 
Epihydrins are molecules containing a ring stained epoxypropane as well as a halide 
group. Examples from the literature shows the use of NaN3 to ring open and form an 
asymmetric molecule which bares an azide for click chemistry with the potential for a 
second click reaction (Scheme 4.4). 
 
Scheme 4.4. Schematic representation of the synthesized acrylate-based glycopolymer from (±) epichlorohydrin, 
with (red) synthetic pathway to be verified. 
 
The ring opening of the epibromohydrin can be monitored by 1H NMR and FT-IR as 
the azide is introduced. The 1H NMR shows an asymmetric splitting in the alkyl 
hydrogen due to the different groups adjacent to them (Figure 4.9A). Initially, 21 was 
coupled to acryloyl chloride in the reaction used to synthesise 20, to form 22 in order 
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saccharides. However, the monomer was unstable and auto-polymerised. The 
autopolymerisation in the presence of an azide in situ causes a broad uncontrolled 
polymer, similar to that seen with VBAz (Table 2.5).  
 
Figure 4.9. Monitoring of the formation of 21 by 1H NMR in d-Acetone at 400 MHz (A) of (±) epichlorohydrin 
(top) and 1-azido-3-chloro-propan-2-ol (bottom) showing the asymmetric product formed by the equivalency of 
alkyls adjacent to the secondary alcohol and FT-IR (B) of compounds 21 to 24 showing the addition and 
consumption of the azide at 2098 cm-1. 
By reordering the synthesis to incorporate the monosaccharides first, followed by the 
addition of the polymerisable group, this would avoid any auto-polymerisation. Using 
FT-IR, the azide production and consumption can be monitored from compound 21 to 
24 (Figure 4.9B). The consumption and formation of the azide is clear with a peak at 
2098 cm-1. On the formation of the second azide, a loss in the C-Cl is observed at 725 
cm-1. Upon the addition of the second acetylated monosaccharide, the broad peak 
between 3200 – 3600 cm-1 is reduced as the hydroxide is blocked from hydrogen 
bonding due to the sterics around the hydroxide. The 1H NMR becomes challenging 
as the complexity of increase molecule due to the region between 3.0 ppm to 5.0 ppm 
being incredibly crowded due to the sugar hydrogens, which upon adding the second 
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monosaccharide become a large multiplet. The 1H NMR however, does show an 
increase intensity of the triazole peak upon addition of the second monosaccharide 
through CuAAc coupling. 
Further work needs to be undertaken on the diacrylate monomer in order to verify the 
successful synthesis of the compound before the addition of the acryloyl chloride and 
deprotection of the sugar acetyl groups. There is concern over the use of MeONa due 
to the potential of hydrolysis of the ester bond in the acrylate at the same time. 
 
4.2.2.3. Physical Properties of Acrylate Glycopolymers 
Using the acrylate homoglycopolymers, SAXS was used to determine if the polymer 
backbone was the cause for lack of polyelectrolyte behaviour. The polymers show no 
sign of a CAC, from 1 nM up to 1 mM, confirming the backbone of the styrene 
polymers has an effect on the conformation of these glycopolymers in solution. There 
is a significant increase in the negative ζ-potential of the P16 compared to the styrene 
based glycopolymer P7 (Figure 4.10).  
The increased flexibility of the alkane chain between the polymer, as well as the lack 
of aggregation, will allow the charge to distribute evenly over the polymer by repelling 
the monosaccharides which is not available to the rigid styrene homopolymers. 
Although the charge of the acrylate-based glycopolymers is still significantly lower 
than HA, the increase in negative charge suggest that the acrylate backbone may be 
suited better to mimic HA in terms of the larger negative ζ-potential.  
 
Figure 4.10. Fluorescence output of Nile red (A) with increasing concentrations of P16; ζ-potential (B) of the 
glycopolymer comparing the styrene homopolymers of P6 and P8 to their acrylate counterparts of P15 and P16. 
Analysed by two-way ANOVA analysis, where * significant at P < 0.0332, ** significant at P < 0.0021, *** 
significant at P < 0.0002 and **** significant at P < 0.0001 
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The more flexible linker between the polymer backbone and the saccharides produces 
for P16 with higher negative ζ-potential in comparison to the styrene variant P7, as 
well as displaying the polymer as linear. However, ζ-potential still remains lower than 
HA with the SAXS showing no evidence of a correlation peak for polyelectrolyte 
behaviour (Figure 4.11).  
  
Figure 4.11. SAXS patterns for both the styrene and acrylate glycopolymers and HA at 0.2 mM at pH 7 with each 
line offset by factors of 10. 
 
4.2.3. Biological Properties 
4.2.3.1. Cytotoxicity 
Before using the glycopolymers in biological applications, they must first be tested for 
their cytotoxicity. The monomers of VBC22, as well as maleimides23, are known to be 
toxic compounds, but many glycopolymers reported in the literature are known to be 
non-toxic. This reduction in toxicity comes from the biocompatibility of the 
monosaccharide pendant groups. Luc4 cells were used due to their high expression of 
CD44 on the surface. Using the Luc4 cells, the cytotoxicity of the glycopolymers was 
assessed by supplementing them into the culture media.  
Over a 24-hour period, the normalised fluorescent reading showed that P6, P7 and P12 
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cell appears to have proliferated more when compared to the untreated cells (control) 
(Figure 1.12A) P8, the statistical polymer, shows a significant drop in the cell numbers 
over the 24-hour period. However, analysing the cell death over the same period. P8 
does not show a higher number of dead cells, compared to the other glycopolymers 
and untreated cells (Figure 1.12B). 
 
Figure 4.12. Cytotoxicity of glycopolymers at various concentrations by analysis of live cells (A) and dead cells 
(B) normalised against controls of untreated (live) and methanol (dead). Analysed by two-way ANOVA analysis, 
where **** significant at P < 0.0001. 
 
4.2.3.2. Antimicrobial Properties 
Cationic macromolecules such as polylysine have been shown to have antimicrobial 
activity, by interacting through the positive charge with the negative bacterial cell 
membrane causing disintegration and cytoplasmic leakage. However, this positive 
charge also leads to high cytotoxicity towards mammalian cells. The charge can be 
reduced or balanced by additional functionality such as saccharides24. The saccharides 
can also act as a targeting moiety for binding carbohydrate receptors on the bacteria25. 
The glycopolymers were tested against pathogens found in a hospital environment 
(Table 4.6).   
It is evident from the results that the glycopolymers showed a high degree of toxicity 
to bacterial pathogens, whereas no inhibition was seen for the fungi tested even at the 
highest concentration. Since these glycopolymers have a negative ζ-potential, no 
antibacterial activity was expected due to the surface of many bacteria being 
negatively charged, causing repulsive interactions. However, due to the low negative 
potentials (Table 4.3) this repulsion between the glycopolymer aggregates and 
bacterial membrane appears not to be evident.  
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Table 4.6. MICs of HA-based glycopolymers against typical pathogens found in hospitals. 
Entry Polymer 
MIC (ug/mL) 
E. Coli* P. Aeruginosa* MRSA† Fungi 
P6 pVB-GlcNAc56 0.78 6.25 1.56 > 25 
P7 pVB-GlcA56 0.78 12.50 3.13 > 25 
P8 pVB-GlcA23-co-VB-GlcNAc23 1.56 12.50 3.13 > 25 
P12 pVB-GlcNAc24-alt-PMI-GlcA24 0.78 6.25 1.56 > 25 
* Gram Negative † Gram Positive 
HA is not known as an bactericidal molecule but, is used as a scaffold for which 
cationic species such as peptides26 to be grafted or the incorporation of metal ions27 to 
form antibacterial materials. HA however, does display exhibited bacteriostatic affects 
dependent on the bacteria strain and Mw of HA28-29. Reports infer that bacteria 
produce hyaluronate lyase to break down HA for tissue permeability. Increased 
concentrations of HA leads to saturation of these enzymes and therefore slow the rate 
of the bacteria’s tissue permeability.  
 
4.2.3.3. Haemolytic Activity  
With the glycopolymers showing low toxicity towards mammalian cells, but a high 
degree of toxicity towards bacteria, a haemolytic assay was carried out to determine 
the potential toxicity on red blood cells. As shown in Figure 4.13A, haemolysis was 
observed as the red colour is localised within the cells by comparison to those treated 
with Triton-X, which showed dispersion of red colour into the supernatant at 450 nm, 
due to the rupturing of the red blood cell (Figure 4.13B). 
Bacteria have a different cellular organization compared to mammalian cells in terms 
of cell membrane composition and bacteria possess an additional cell wall. The cell 
membrane is composed by phospholipids, glycolipids, and proteins. In contrast, 
bacteria possess an addition cell wall made of a thick peptidoglycan for Gram-positive 
bacteria and thinner peptidoglycans with an additional outer membrane for Gram-
negative bacteria. Fungi do not possess a peptidoglycan layer within the fungi cell 
membrane construct30 and that only bacteria, which have this peptidoglycan within 
the membranes layer, showed toxicity to the glycopolymers.  
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Figure 4.13. Haemolytic test for the glycopolymers with image of the intact red blood cells (A) and absorbance of 
the supernatant at 450 nm (B) with Triton-X control. 
The glycopolymers bactericide properties might arise from their aggregated 
conformation, possible bacterial uptake or even the bacteria’s inability to breakdown 
the glycopolymers but the mode of action is unclear at this stage with further studies 
required. 
 
4.2.4. Glycopolymers Binding to Peptide and Proteins 
4.2.4.1. Synthesis and Immobilisation of Thiolated HA-binding Peptides 
Thiolate peptides enable their direct binding to a gold surface as well as other metallic 
surfaces without the need to chemically modify the surface. It has been shown 
previously that the use of cysteine at the N-terminus caused reduced surface density 
across the gold surface22. This is due to the amine of the N-terminus causing repulsive 
interaction due to sterics and charge repulsions. Mercapto acid terminated peptides 
can be produced with various lengths, not being restricted by the number of CH2, 
compared with cysteine and no amine. Using the 3-mercaptopropionic acid, the thiol 
can be protected using 4-methoxytriphenylmethyl chloride (Mmt).  
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Scheme 4.5. Protection of 3-mercaptopropionic acid. (i) 4-Methoxytrityl chloride, DIPEA, DCM: DMF (1:1 v/v). 
The 1H NMR showed the loss of the thiol hydrogen, a shift in the CH2 groups, as well 
as the change in splitting patterns caused by the loss of the thiol hydrogen. The reaction 
also showed quantitative conversion of the thiol due to the ratio of 2:2:3 of the two 
CH2 at 2.2 and 2.6 ppm on the backbone of the mercapto acid and the methoxy CH3 at 
3.8 ppm (Figure 4.14). 
 
Figure 4.14. 1H NMR spectra in CDCl3 at 400 MHz comparing the 3-mercaptopropionic acid (grey) and the 
protected thiol product (blue). 
This protecting group is acid labile, allowing to be cleaved off in the TFA cleavage of 
the peptide, thus requiring no extra step in the existing procedures. The thiol variants 
of the peptides were synthesised by automated peptide synthesis with the final thiol 
tail coupled by hand (Figure 4.15). The peptides were cleaved using a slightly adjusted 
cleavage cocktail (90% TFA, 5% thioanisole, 2.5% anisole and 2.5% ethane dithiol) 
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Figure 4.15. Structure of thiolated HABPeps (Thiol-HABPeps) synthesised.
 
The binding of the peptide to a Au surface was first analysed by measuring the surface 
contact angle. The bare gold showed a contact angle of 67.6° and a decrease in the 
contact angle was observed upon incubation of the peptides 16 hours.  
Both Thiol-HABPep-1 (40.0°) and Thiol-HABPep-2 (49.4°) produce large change in 
contact compared to bare Au (P = <0.0001), but the two peptides have similar contact 
angle with minor significance (P = 0.0132) between one another. Since Thiol-
HABPep-3 (67.6°) is very hydrophobic, low significant change in hydrophobicity 
compared with the native bare Au surface (77.2°) was observed (Figure 4.16).   
Thiol-HABPep-1 has a lower surface hydrophobicity compared to that of Thiol-
HABPep-2, this is caused by a significantly higher hydrophobicity observed for the 
three outer amino acid residues of Thiol-HABPep-2. After incubation with HA 1.5 
MDa, the contact angle of the droplet on the surface increases for Thiol-HABPep-1 
and Thiol-HABPep-2, 61.6° & 58.4° respectively, while decreases for Thiol-
HABPep-3 (56.1°).  
The lack of significance in contact angle between all three surfaces after the coverage 
of HA, infers that all three thiol peptides are mediating the binding of HA to the 
surface. As control, the bare gold was incubated with ethanol in the absence of 
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significant difference in the contact angle compared to the initial bare Au surface, 
indicating the inability of the Au to retain HA on the surface and the need for the 
HABPep to mediate the efficient HA immobilization.  
 
  
Figure 4.16. Immobilization of HA (1.5 MDa) on a gold surface mediated by Thiol-HABPeps analysed by contact 
angle measurements. Images of water droplets on the gold surface (top) and contact angle values (below) measured 
using ImageJ. Data analysis by two-way ANOVA analysis, where * significant at P < 0.0332, ** significant at P 
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Binding of thiols to gold is not only limited to planar 2D surfaces, but gold 
nanoparticles (AuNPs) have also been used. For AuNPs, the larger the particles the 
higher the wavelength in which they absorb. Therefore, small diameter AuNPs appear 
red in colour whilst larger appear purple. When binding a thiol to a gold NP, a shift of 
2-3 nm is normally observed if the gold NP is stable, any more than that the gold has 
begun to aggregate causing the AuNP to destabilise. As a proof of concept, Thiol-
HABPep-1 was adsorbed onto AuNPs using two different buffer solutions; citrate 
(Cit) and a stronger solution of Bis(p-Sulfonatophenyl) Phenylphosphine (BSPP). 
Using first the citrate buffer, the solution of AuNPs  appears to become purple in 
colour even at the lowest concertation of 1 µM (Figure 4.17A); the weaker citrate 
buffered solution cannot prevent aggregation of the AuNPs. The UV trace of the Au-
Cit shows a large shift (> 3 nm) from the maximum of the bare Au at 520 nm.  
 
Figure 4.17. Thiol-HABPep-3 adsorbed onto AuNPs (Eppendorf’s from left to right: 1, 5, 15, 25 & 125 μM) with 
two different Au capping agents: citrate (A) and BSPP (B) and corresponding UV spectra (below). UV spectra of 
BSPP capped AuNP with Thiol-HABPep-3 at 25 mM comparing the UV shift in differing polarity solvents (C). 
Comparing the Cit results to BSPP capped AuNPs (Figure 4.17B), 1 uM shows more 
promise with a shift from 520 to 526 nm, remaining in the blue region of the visible 
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light spectra, whilst for higher concentration a shift in colour is observed towards 
purple. The results show the strength of the BSPP to prevent aggregation compared 
with Cit, but still does not overcome the high hydrophobicity of the peptide sequence. 
Switching the solvent from H2O to isopropanol (IPA), a lower polarity solvent, the 
UV peak of HABP-3 at 25 mM moves from 561 nm in H2O to 549 nm in isopropanol 
(Figure 4.17C), but this remains large than 2-3 nm. This in an improvement with a 
peak shift of 29 nm compared to 41 nm in water, due to the reduction in aggregation 
caused the use of a more hydrophobic and lower polar solvent of IPA. 
TEM images of the AuNPs confirms the formation of aggregates (Figure 4.18), with 
more aggregation seen in the Cit buffer compared with the BSPP buffer. Both show a 
reduction in aggregation at lower concentrations of Thiol-HABPep-3. 
  
Figure 4.18. TEM images of AuNPs capped with (A, B) Cit and (C, D) BSPP at (A, C) low concentrations (5 μM) 
and (B, D) high concentrations (25 μM) of Thiol-HABPep-3.  
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4.2.4.2. Binding of Glycopolymers to HA-Binding Peptides by Surface Plasmon Resonance 
To determine the binding of the HA-based glycopolymers to HABPeps the Thiol-
HABPeps were bound to a gold SPR chip. SPR is a technique used to measure the 
binding of an analyte to a ligands bound to a metal surface. This can be done through 
direct binding to the gold, such in this case, or mediated through modified dextran or 
Ni chelating coatings on the gold. One advantage of SPR is that it does not require 
labelling of molecules, but the ligand requires to be bound onto the SPR chip. Light is 
passed through a prism in order to oscillate the electron of the metal surface at an 
incident angle to create the surface plasmon. The surface plasmon is very sensitive to 
change in the surface. Upon binding, the intensity of the light is reduced as well as the 
angle of light reflected. This leads to a change in the refractive index of the surface, 
which can be used to measure the binding affinity to the surface. The binding of the 
thiolate peptide showed a rapid association to the gold surface (Figure 4.19). Once the 
analyte flow was removed, a small drop off in response was seen, that stabilised once 
the excess had been washed off from the channel. 
  
Figure 4.19. SPR sensorgrams of the binding of the Thiol-HABPeps to the gold SPR chip. 
SPR was used to study the interaction with Thiol-HABPep-1and Thiol-HABPep-2 
with HA and the glycopolymers. The KD values for both peptides on the gold surface 
show an overall preference for the P3 and P6, with no binding seen for HA or the other 
HA-based glycopolymers (Figure 4.20). The peptides appear to have a preference for 
the glucose epimers as no binding is seen to the other epimers of Man (P4) and Gal 
(P5). Both peptides similarly show a lack of binding to negatively charged GlcA of 
P7, P8, P12 even though these peptides carry a large positive charge seen in the ζ-
potential. The sensorgrams of P3 and P6 in both systems shows a larger response for 
these polymers suggesting the N-acetyl plays an important role in the binding to the 
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peptides. The KD for P6 shows a tighter binding for Thiol-HABPep-2 over Thiol-
HABPep-1. The sequence of HAPep-3 where 4 out of 9 residues are hydrophobic is 
more hydrophobic than HAPep-2 in which only 2 of the 10 residues are hydrophobic. 
Since the acetyl CH3 is hydrophobic, the decreased hydrophobicity of HAPep-2 in 
Thiol-HABPep-2 will increase the binding with P6.  
 
Figure 4.20 SPR sensorgrams of Thiol-HABPep-1 (left) and Thiol-HABPep-2 (right) with the glycopolymers P3 
(top), P6 (middle) and KD overview (bottom). 
As seen earlier, HABPep-3 has a ζ = + 55.1 ± 4.1 mV and would be expected to 
associate with GlcA-based polymers which have a negative ζ- potential (Figure 4.4). 
However, through alanine scanning, HABPep-3 sequence was shown to bind to HA 
through more of the hydrophobic residues2. The SPR shows that HA binds to the 
peptide with a KD of 9.7 μM, which is within the literature value of 1.65 μM found by 
radioactive 125I labelled HABPep-32. 
The SPR also indicates that Thiol-HABPep-3 prefers the HA sugars of GlcNAc (P6) 
and GlcA (P7) over other monosaccharides of Glc (P3), Man (P4) and Gal (P5) (Figure 
4.21). According to the KD values, the individual sugars have a 100-fold strong 
binding affinity than the natural HA. Using Equation 4.3, it is easy to see why the KD 
of P7 matches that P6. The RU maximums of each of the three sensorgrams (Figure 
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4.22),  P7 has a strong binding affinity due to the low ka along with an even lower kd 
whereas, P6 gives a large response and ka but gives also a large kd. 
 𝐾W = 	𝑘;𝑘8 = 	 1𝐾3 Equation 4.3 
Where: 
 ka = rate of association 
kd = rate of disassociation 
KA = Equilibrium association constant 
KD = Equilibrium disassociation constant 
 
Figure 4.21. KD values for the binding of the glycopolymers to Thiol-HABPep-3. 
Comparing P6 with HA, a similar binding pattern is seen for the top concentration of 
2000 nM, but a tighter binding is seen for P6 (Figure 4.22). The ka is larger giving a 
higher RU maximum of 2490.1 RU compared to HA with gave a response of 1379.0. 
P6 also produces a stronger binding, as when the analyte flow is stopped the response 
decreases by 271.16 RU for HA, but only 195.97 RU for P6. These results indicate 
that the HABPep-3 prefers the hydrophobic residue of the N-acetyl group on the 
GlcNAc, rather than the electrostatic interactions of the GlcA. 
The SPR however also shows a lack of binding for P8 and P12 which infers the that 
having the two sugars in the same polymer is inhibiting the binding to the peptide by 
interacting with each other. Thiol-HABPep-1 and Thiol-HABPep-2 did display 
binding to some of the glycopolymers despite the lack of binding to HA. These 
peptides are derived from sequences in the Link Protein and CD44, but they are taken 
from a much larger protein. The crystal structure gives us an indication of the binding 
to HA (Figure 4.23). For the link protein31-32 it is observed that the aromatic residues 
of Tyr-12, Tyr-59, Tyr-78, and Trp-88 as well as basic and acid residues of Lys-11, 
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Figure 4.22. SPR sensorgrams for HA 20 kDa and homopolymers mimics of P6 and P7 
CD44 is known to bind to 8-mers of HA as shown in the crystal structure33 (Figure 
1.23). Within the groove in CD44, where the 8-mers of HA bind, there are thirteen 
residues along the channel: Arg45, Tyr46, Cys81, Arg82, Tyr83, Ile92, Asn98, Ile100, 
Cys101, Ala102, Ala103, His105 and Tyr109. Of these, the aliphatic residues of Ile92, 
Ile100, Ala102 and Ala103 provide a large contribution to the binding of HA, 
recognising the N-acetyl group of the GlcNAc as it sits in a hydrophobic pocket. These 
results support the importance of the N-acetyl group during binding with the HABPs. 
 
Figure 4.23. Surface crystal structure of HABPs of Link Proteins (left) and CD44 (right) with the grooves 
highlighted with either an arrow or with 8-mer of HA.  
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4.2.4.3. Binding of Glycopolymers to CD44 Protein by Surface Plasmon Resonance 
Both the Link Protein and CD44 bind HA superficially in a binding “channel” or 
“cleft” rather than a binding pocket. The limitation of using a peptide sequence taken 
from a protein is that the peptide will not reproduce the necessary tertiary structure for 
optimal binding to HA. Using the recombinant protein of the CD44 extracellular 
domain (24 kDa), SPR was used to monitor the binding of the glycopolymers. The 
protein is coupled to the surface through amine coupling. The binding is much slower 
(Figure 4.24) compared to the absorption of the thiol onto the Au surface (Figure 4.19). 
 
Figure 4.24. SPR sensorgram showing the immobilisation of CD44 onto a CM5 dextran covered SPR chip by 
amino coupling. 
Similarly, to the CD44-derived peptide, the protein shows binding to Glc epimers with 
P3, P6 as well as P7 (Figure 4.25A-C). The protein shows a high response upon 
binding towards P3 by comparison to the others glycopolymer. The CD44 protein 
shows no binding towards P4, P5 of the other monosaccharide epimers, showing a 
specificity for the Glc epimer. Again, no binding is seen for the copolymers of P8 and 
P12. This is due to a difference the aggregation of the glycopolymer (Figure 4.7) 
compared to the elongated structure of HA in solution34. The CD44 is shown to bind 
the saccharides in a cleft region (Figure 4.23). If the glycopolymers are in spherical 
aggregates, this will impair their binding to CD44, for those with P8 and P12. 
Binding to natural HA is not seen for lower HA concentrations (Figure 4.25D). This 
is caused by irreversible binding of HA at 2 mM, as in the regeneration of the surface 
the HA does not dissociate in the current buffers and therefore a KD value is unreliable 
from the SPR. Examples of HA8-CD44 complex monitored by SPR have previous 
been carried out yielding a Kd value of 24.6 μM35-36. 
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In comparison, the literature example binds the HA to the surface rather than the CD44 
to ensure the protein isn’t affected by the binding to the surface. Through this method 
ligands or modified HA effect on the HA-CD44 complex36-37 can be studied. The HA-
CD44 protein SPR therefore require fine tuning in order to regenerate the surface. The 
binding of CD44 to the surface via amino coupling lacks control and therefore the 
addition of CD44 though a C-terminus His-Tag and Ni combination would provide a 
more control method of binding. 
 
Figure 4.25. SPR sensorgrams of P3 (a), P6 (b), P7 (c) and HA (d) to the extracellular domain of CD44. 
 
4.2.4.4. Binding of Glycopolymers to HA-Binding Peptides by Quartz Crystal Microbalance 
As previously mentioned, the limitation in the use of a peptide on the surface of the 
gold is the surface itself being sterically hindering. It has been shown that several 
different sulphur containing functional groups will in fact bind to a metal surface38. 
By binding the glycopolymer over the peptide on the gold surface, this could reduce 
the sterics between surface and the analyte. This is because the peptides used are no 
longer than 12 mers, whereas the glycopolymers are 56 repeats in length. Therefore, 
the distance between the end of macromolecule and the gold surface is longer with the 
glycopolymer, leading to a high degree of freedom in which to interact, by comparison 
to the peptide. The backbone will limit this degree of freedom as it tends to aggregate 
as shown by TEM (Figure 4.7), but these are in the dry state so are a result of 
increasing concentration of the solution as it removed. The RAFT agent has the 
potential to bind to an Au substrate, but the RAFT agent decomposed during the 
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azidation (Figure 2.8), using UV-Vis the RAFT agent can be observed with the peak 
between 240-340 nm corresponds to the RAFT agent (Figure 4.26A). 
Alternatively, to SPR, quartz crystal microbalance (QCM) can be used to measure the 
deposition of the glycopolymer onto gold substrate by monitoring the change of 
frequency. This change of frequency, through the Sauerbrey Equation 4.4 can be 
linked to the mass deposition. ∆𝑓 =	− 2𝑓]A𝐴_𝜌`𝜇` 	∆𝑚 Equation 4.4 
Where: 
f0 Resonant frequency (Hz) 
Δf Frequency change (Hz) 
Δm Mass change (g) 
A Piezoelectrically active crystal area (cm2) 
ρq Density of quartz (g cm-3) 
μq Shear modulus (g cm−1 s−2) 
 
The QCM (Figure 4.26B) for P7 shows the binding of the glycopolymer onto the gold 
surface (region I) with minimal mass loss upon washing the system with water (region 
II). The frequency then decreases again upon injection of acetylated HABPep-3 into 
the chamber (region III). Once this has stabilised after the water washing (region IV).  
shows a small decrease in the frequency, but the frequency has still dropped 
substantially. These results point for the use of different techniques and formats for 
performing the binding studies. In addition, the QCM can be utilised to investigate 
both the glycopolymers on the surface binding to the peptide in solution as well as the 
inverse.  
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Figure 4.26. UV trace of the glycopolymer highlighting the small peak between 240 – 340 nm (grey) caused by the 
RAFT agent (A) followed by the QCM (B) showing the 4 regions of the QCM. 
 
4.2.4.5. Binding of Glycopolymers to HA-Binding Peptides by Turbidity Assays 
Where SPR and QCM require complex instruments as well as software to analyse the 
data produced, turbidity can also give an insight to binding through the transparency 
of solution to opaque as the two components bind. This can be used to screen binding 
as well as determine molar ratio. An initial screen for P6 and P7 showed that on 
addition of a 10-fold molar excess HABPep-3 a precipitate formed. This was due to 
the glycopolymer aggregates (Figure 4.7) binding to the HABPep-3 and forming an 
insoluble aggregate by the covering of the saccharide epitopes, which provide the 
glycopolymer with their solubility in water. The interaction between HABPep-3 & 
HA lead to the formation of membranes as observed previously (Figure 3.5). This 
precipitation can be seen by looking at the change in turbidity of the glycopolymer in 
solution with/without HABPep-3 (Figure 4.27A).  
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Figure 4.27. Turbidity of 1% (wt%) glycopolymer and monomer solutions with 1% (wt%) of HABPep-3 at pH 7. 
visual turbidity in 96-well plate (A) quantified by visible light absorbance at 400 nm (B). 
A small increase in turbidity is observed between P6 and HABPep-3, suggesting a 
small amount of binding is occurring. The turbidity was quantified by the 
transmittance through the sample at 400 nm compared to the sample without 
HABPep3 (Figure 4.27B). When HABPep-3 is not bound to a surface such as a gold 
SPR chip, it can self-assemble producing extended positively charged nanofibers to 
interact with negatively charged GlcA. The turbidity measurements of the 1% 
solutions also confirm the lack of binding seen by the SPR to P8 and P12. Although 
these glycopolymers contain the GlcA residue, with no change in turbidity was seen. 
Interestingly, when placing P6 and P7 in a 50:50 ratio mixture, the absorbance is 0.722 
AU of is approximately a fifth of that of P7 alone at 3.271 AU. When considering the 
Beer-lambert law Equation 4.5, absorbance is linear to concentration if the extinction 
coefficient and path length are kept constant. 
The decreased turbidity in the 50:50 glycopolymer mixture infers the sugars may 
interact with one another over the peptide, reducing the turbidity. Applying this to P8 
and P12 no turbidity is observed inferring the saccharide upon the glycopolymer 
interact with themselves rather than the HABPep-3. 𝐴	 = 	𝜀𝑐𝑙 Equation 4.5 
Where: 
A Absorbance (AU) 
ε Extinction Coefficient (mol-1 dm3 cm-1) 
c Concentration (mol dm-3) 
l path length (cm) 
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These observations also highlight the importance of the glycosidic bond in the 
polysaccharide, by reducing intramolecular interaction with HA. For P6 and P7, the 
binding can be seen as a function of the molar ratio of HABPep-3 (Figure 4.28). Upon 
increasing the molar ratio above 1, an increase in turbidity is seen for both 
glycopolymers as the HABPep-3 coats the monosaccharides of the aggregates making 
the glycopolymer insoluble in water. 
 
Figure 4.28. Turbidity curve for P6 and P7 at 1 mmol with increasing molar ratio of HABPep-3 at pH 7 monitoring 
the change in turbidity at 450 nm. 
From the results, a clear influence of the surface such as the gold SPR chip or QCM 
electrode can influence the binding. The binding of HABPep-3 is clearly affected by 
the self-assembly of the peptide. When self-assembling on a surface, the hydrophobic 
core is available to bind the GlcNAc residues, whilst when allowing the HABPep-3 to 
self-assemble into the long nanofibrous structures, the stacking of these hydrophobic 
sections produce the arginine’s of the peptide to be exposed across the surface leading 
to a charge interaction with the GlcA. In comparison to the peptides, lectins are large 
proteins and their binding to a surface is expected to have a reduced effect on their 
binding capabilities. 
 
4.2.4.6. Binding of Glycopolymers to Lectins by Surface Plasmon Resonance 
Dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin 
Dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin or 
more commonly known as DC-SIGN or CD209 is a type II C-type lectin part of the 
Type-2 receptor family found on the membrane surface39 of macrophages and 
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multiple domains come together due to the hydrophobic section along the protein 
assembling together to produce a hydrophobic core. 
 
Figure 4.29. Crystal structure of the tetramer of DC-SIGN showing (A) along with the multiple domains (B) and 
binding pocket of DC-SIGN (C) showing the interactions between mannose and a Ca2+ ion. 
DC-SIGN is able to recognize mannose-based compounds as well as fructose found 
on Lewis-type determinants41 and GlcNAc39-40. The binding of these saccharides also 
facilitates a vast array of pathogens, which possess saccharides on their surface. 
Several of these diseases bind to DC-SIGN cause the antigens to be taken up leading 
by T-cells. However, other pathogens, such as human immunodeficiency virus (HIV) 
and hepatitis C virus (HCV), utilize DC-SIGN in order to go unnoticed to the immune 
system and to allow HCV and HIV to spread. For this reason, DC-SIGN has been well 
studied for its interactions with monosaccharides42-44. The SPR sensorgrams show a 
positive response for both P4 as well as P3 with KD values of 37.9 nM and 0.4 nM, 
respectively (Figure 4.30A). However, the response from the SPR is much higher for 
P3 (Figure 4.30B) than P4 (Figure 4.30C) at 2 mM, the ka is much quicker, 47.3 M-1 
s-1 compared to 2.1 ´ 103 M-1 s-1 for P3 and P4, respectively (Table 4.7). This can be 
seen by the initial slopes of the SPR sensorgrams. 
Once the flow of the analyte is stopped, the kd of P3 is 1.79 ´ 10-6 s-1 compared to 8.3 
´ 10-7 s-1 for P4. The response can also be correlated to a mass change. A mannose 
glycopolymer, P4, which has a stronger binding affinity is statistically more likely to 
bind across several saccharides on the same glycopolymer leading to a smaller mass 
change on the SPR chip. Whereas a low affinity glycopolymer such as glucose, P3 
will bind, but with multiple chains. With more chains binding, this causes a significant 
mass increase leading to a larger response (Scheme 4.6).  
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Figure 4.30. KD values (A) and trends of the glycopolymers and HA along with individual SPR sensorgrams of P3 
(B), P4 (C), P6 (D) and P7 (E). 
Compared to literature examples the mannose polymer is an order of magnitude lower 
in KD. However, it is challenging to directly compare literature values to P4 as the 
composition of the polymers in terms of morphology and polymer backbone are 
different.  
Since this lectin binding is dependent on chelation using the Ca2+, the binding to P5, 
the Gal epimer, shows no binding to lectin as expected. This is caused by the lack of 
equatorial hydroxide at C4. HA showed no specific binding to DC-SIGN, this is due 
to the large polysaccharide structure of HA, which DC-SIGN is unable to bind as the 
lectin binds terminus monosaccharides (Scheme 4.7). Therefore, the probability for 
HA to bind is low.  
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Table 4.7. Kinetic data of DC-SIGN with the various polymers. 
Macromolecule 
DC-SIGN 
ka (1/Ms) kd (s) RUMax Ka (M) Kd (1/M) 
HA  n.s. n.s. n.s. n.s. n.s. 
P3  47.3 1.8 ´ 10-6 1107 2.6 ´ 107 3.8 ´ 10-8 
P4  2.1 ´ 103 8.7 ´ 10-7 166 2.5 ´ 109 4.0 ´ 10-9 
P5  n.s. n.s. n.s. n.s. n.s. 
P6  259 1.5 ´ 10-3 1700 1.8 ´ 105 5.6 ´ 10-6 
P7  419 3.4 ´ 10-3 1100 1.2 ´ 106 8.1 ´ 10-7 
P8  n.s. n.s. n.s. n.s. n.s. 
P12  n.s. n.s. n.s. n.s. n.s. 
n.s. non-specific binding. 
When considering the multivalent effect to stabilise the ligand-lectin binding, HA can 
never form more than one interaction, with a C-type lectin. The glycopolymers can 
however form multiple to stabilise the interaction and produce a stronger binding 
affinity.  
 
Scheme 4.6. Schematic representation of difference in RUMax caused multiple chains binding (blue) compared with 
a single chain binding (red) the same number of receptors with mass and SPR directly. 
The homopolymers of P6 and P7 showed binding to DC-SIGN (Figure 4.30D-E). 
Since GlcNAc and GlcA are in the same epimers conformation as Glc, they show a 
reduced binding compared to the Man-based polymer (P4). What can be inferred is 
the two-functional groups of the acid at C5 on GlcA and the N-acetyl group at C2 of 
GlcNAc have caused a reduction in binding. A 100-fold decrease in binding is 
observed for P6 when comparing to P3. This decrease can be attributed to the steric 
bulk of the N-acetyl group as well as the loss of a potential hydrogen bonding 
hydroxide. The addition of a carboxylic acid at C5 for P7 shows a moderate increase 
compared to P6 but remains weaker than P3. This indicates that the C2 hydroxide is 
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important, with a preference to be axial, with a destabilising effect seen by the addition 
of the carboxylate at C5, either sterics or electrostatic repulsion. 
 
Scheme 4.7. Schematic representation comparing the binding of a C-type lectin, such as DC-SIGN, to a 
glycopolymer displaying multiple C-3, C-4 equatorial hydroxide (left) and a polysaccharide, such as HA, where 
only the terminus C-3, C-4 equatorial hydroxide exists (right). Image inspired by ref4 
When both sugars are present in the same polymer, P8 and P12, the polymers show 
no specific binding to DC-SIGN. By comparing to P5 and P6, this infers that the 
monosaccharide in the same polymer again disturbs the binding to the lectin. This 
could be caused by potential intramolecular hydrogen bonding affecting the 
conformation of the sugars. 
From these results, it was shown the C4 and C3 hydroxides should remain as 
equatorial, whilst C5 and C2 functionality reduces the KD when binding to DC-SIGN. 
To further investigate the binding properties of this lectin, the use of sugars such as 
N-acetyl-D-mannose (ManNAc) and mannuronic acid (ManA) would be useful to 
look at the binding once the C2 stereochemistry is inverted to the mannose epimer.  
 
Mannose Binding Lectin 
The mannose binding lectin (MBL) or mannose-binding protein is a soluble lectin type 
III and part of the collectin family45-46. The MBL is formed of a tetramer of 250 kDa 
with these tetramers linked together by disulphide bonds (Figure 4.31). As part of the 
immune system found within the blood, it recognises a large range of microbial 
saccharides which coat yeast, bacteria and viruses. 
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Figure 4.31. Crystal structure of the tetramer of MBL (A) showing the Ca2+ ions (green) along with the trimeric 
structure of which forms MBL (B) and binding pocket (C) where Ca2+ ions are found on the surface of the lectin. 
Upon binding to pathogens, the lectin associates with the MBL-associated serine 
protease (MASP) leading to the destruction of pathogen. The lectin has been observed 
to bind to Man and GlcNAc, but can also bind nucleic acids through the Ca2+ 
dependency47. This Ca2+ dependency can be seen in the sensorgrams due to the non-
specific binding seen for P5. Similarly, to DC-SIGN, the lectin has a specificity for 
C4 and C3 equatorial hydroxides (Table 4.8). 
Table 4.8. Kinetic data of MBL with the various polymers. 
Macromolecule 
MBL 
ka (1/Ms) kd (s) RUMax Ka (M) Kd (1/M) 
HA  n.s. n.s. n.s. n.s. n.s. 
P3  13.8 2.8 ´ 10-4 1342 5.0 ´ 104 9.4 ´ 10-5 
P4  7.6 ´ 102 1.2 x 10-6 155 6.3 ´ 108 1.6 ´ 10-9 
P5  n.s. n.s. n.s. n.s. n.s. 
P6  1.0 ´ 104 9.5 ´ 10-4 417 1.1 ´ 1012 9.4 ´ 10-13 
P7  n.s. n.s. n.s. n.s. n.s. 
P8  n.s. n.s. n.s. n.s. n.s. 
P12  n.s. n.s. n.s. n.s. n.s. 
n.s. non-specific binding.
 
Comparing P3 and P4, the data shows MBL to be mannose specific, due to the 10,000-
fold decrease in KD from P3 to P4 (Figure 4.32A). Again, the larger response is seen 
from the glucose glycopolymer (Figure 4.32B), however the larger ka is seen from 
mannose glycopolymer (Figure 4.32C). Similarly, to DC-SIGN, a change of 
stereochemistry at C4 position inhibits the binding to P5 due to the Ca2+ dependency. 
P6, whilst being a glucose epimer, shows a further 10,000-fold decrease in KD 
compared to P4. Though the addition of GlcA onto the polymer backbone showed no 
binding in the homopolymer, P7, it also leads to inhibition of the P8 and P12, which 
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possess equal quantities of GlcA and GlcNAc. This infers for MBL is a mannose 
receptor, but with an increased significance of the functionality and stereochemistry 
at the C2 and C5 position. 
 
Figure 4.32. KD values (A) and trends of the glycopolymers and HA along with individual SPR Sensorgrams of P3 
(B), P4 (C), P6 (D) and P7 (E). 
The MBL binding results show, as expected, that the lectin requires the C3 and C4 
position for chelation using the Ca2+. The lectin has been shown to prefer 
hydrophobicity at the C2 position due to the increase in binding with P6 whereas 
charge and/or functionality at the C5 position leads to inhibition of the binding. To 
further investigate the preference for ligand sugars, ManNAc should be used to test 
the hydrophobicity being placed in the axial position as well as Iduronic acid (IdoA). 
By using IdoA, the position of the charge can be tested to determine whether there is 
a steric effect or an intolerance to negative charge at the C5 position. The carboxylate 
can easily be esterified to screen the charge of the glycopolymers to test without the 
charge. 
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Surfactant protein-D  
Surfactant protein-D (SP-D) (Figure 4.33A) is another C-type lectin found 
predominately within the lungs but also found in gastrointestinal and genitourinary 
tracts. This soluble C-type lectin, like MBL, is part of the Collectin Family and a 
Group III lectin. SP-D is divided in 3 main components, a triple-helical collagen, an ⍺-helical coiled-coil neck and a C-type lectin domain.  
 
Figure 4.33. SP-D crystal structure (A) bound to 3 Glc units, the trimer subunits (B), the binding of Glc (C) by 
Ca2+ held within the binding pocket and natural ligand of SP-D, glucosylceramides (D), a glucose-based 
cerebroside.
 
The C-type domain is found at the C-terminus of the protein whilst the other two 
domains are found towards the N-terminus. The SP-D is formed of 3 of these units to 
make a trimeric structure (Figure 4.33B) by the linking of the cysteine rich N-
terminuss. SP-D binds to glucosylceramide, a glucose-based ceramide by coordination 
with Ca2+ (Figure 4.33C) but has also shown binding to phosphatidylinositol and 
lipopolysaccharides. Glucosylceramides are cerebrosides which is the common name 
for glycosphingolipids (Figure 4.33D). These molecules are sugars which have a 
glycosidic linkage to a ceramide. These glycosphingolipids exist as only glucose and 
galactose based epimers. SP-A, an analogue of SP-D, binds to the galactose-based 
ceramides, galactocerebroside. Within the lungs, both SP-A and SP-D are potent 
innate immune molecules which bind to lipopolysaccharides found on various 
pathogens, such as bacteria, yeast and fungi. The binding of these pathogens to SP-
A/D leads to their destruction, as SP-A/D are also able to bind to phagocytic cells 
(white bloods cells) which envelope the protein-microbe complex. Since SP-D binds 
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glucose-based ceramides, upon testing with the glycopolymers it is evident that this 
lectin is exclusive for the glucose polymer (P3) with binding seen with a KD of 265 
nM, whereas the other epimers P4 and P5 show no binding, showing  specificity for 
the glucose epimer  (Figure 4.34A).  
 
Figure 4.34.  KD values for the binding to SP-D (A) with individual SPR sensorgrams of P3 (B) and P6 (C). 
Binding of free galactose to SP-D has been reported48 and this is due to the ability of 
the molecule to rotate and bind through the C1 and C2 hydroxide, which in both the 
glycopolymers and glucosylceramides, the C1 is used to connect the monosaccharide. 
Compared to P3 (Figure 4.34B), P6 shows a lower affinity to SP-D (Figure 4.34C) 
reflected by smaller RU seen in the SPR sensorgrams. Although the two 
glycopolymers show small ka values, 5.95 M-1s-1 and 19.2 M-1s-1 for P3 and P6 
respectively, they differ in the dissociation, kd, where there is a 1,000-fold difference 
(1.57 ´ 10-3 s-1 compared to 5.09 ´ 10-6 s-1) (Table 4.9).   
Due to the mechanism in which SP-D binds saccharides through the Ca2+ with the C3 
& 4 hydroxyls, HA does not exhibit binding, as well as any glycopolymer containing 
a GlcA unit also does not bind inferring an intolerance for C5 modification or 
electrostatic repulsion, similar to MBL. To further investigate this lectin, the use of 2-
deoxy-D-glucose and 6-deoxy-D-glucose would provide a valuable insight to the 
binding. By removing these two hydroxides and comparing to P3, Glc glycopolymer, 
the stabilities of the lectin-saccharide without the hydroxide can be tested.  
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Table 4.9. Kinetic data of SP-D with the various polymers. 
Macromolecule 
SP-D 
ka (1/Ms) kd (s) RUMax Ka (M) Kd (1/M) 
HA  n.s. n.s. n.s. n.s. n.s. 
P3  19.2 5.1 ´ 10-6 1004 3.8 ´ 106 9.4 ´ 10-5 
P4  n.s. n.s. n.s. n.s. n.s. 
P5  n.s. n.s. n.s. n.s. n.s. 
P6  6.0 1.6 ´ 10-3 16.3 3.8 ´ 103 9.4 ´ 10-13 
P7  n.s. n.s. n.s. n.s. n.s. 
P8  n.s. n.s. n.s. n.s. n.s. 
P12  n.s. n.s. n.s. n.s. n.s. 
n.s. non-specific binding. 
 
Dectin-1 
Found on the cell membrane surface, Dectin-1 is a group V lectin and is part of the 
natural killer (NK) cell receptor49-50. Unlike DC-SIGN, MBL and SP-D, it binds 
saccharides without the requirement of a Ca2+ ion. This can be seen in the crystal 
structure (Figure 4.35A). Upon binding to the lectin, the carbohydrate sits within a 
recess/cleft rather than a binding pocket formed between the two dimers (Figure 
4.35B-C)51. This binding cleft is similar to that seen in the link protein and CD44 
(Figure 4.23). Dectin-1 binds to carbohydrates with a β(1-3) but this is enhanced by 
the addition of a β(1-6) bond upon the saccharide. Dectin-1 binds to polysaccharides 
such as zymosan, laminarin and pustulan. However, it will not recognise 
carbohydrates which solely possess a β(1-6) bond52. Compared to a binding pocket, 
the cleft accepts a longer carbohydrate leading to the inability to bind individual 
monosaccharides as the lectin binds weakly to several of the saccharides in a 
carbohydrate. 
With HA possessing β(1-3) linkages, it meets the criteria for Dectin-1 binding. Whilst 
the response is low from the sensorgrams, the actual ka is large with the steep increase 
upon the addition of HA. The kinetic data acquired from the SPR sensorgrams shows 
the HA binding to Dectin-1 with a KD of 150 nM (Figure 4.36A). The KD of HA is 
similar to a known β-glycan of laminarin which has a KD of 200 nM53. These β-glycans 
are based on glucose linked together by β(1-3) linkages, yet for P3 the data cannot be 
fitted as there is lack of binding with only the 1 μM solution producing a typical SPR 
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sensorgram. The lectin shows selectivity towards the other glucose epimers of HA-
based glycopolymer with P4 and P5 showing no specific binding.  
 
Figure 4.35. Dectin-1 crystal structure (A) with a bound β-glycan trimer, the dimer subunits (B) and the binding of 
Glc (C) by Ca2+ held within the binding pocket. 
Of the two monosaccharides found in HA, a clear preference is seen for P7, due to the 
non-specific binding to P6 once the analyte flow is stopped. When examining the 
crystal structure of the binding site within the lectin, several hydrophilic residues line 
on the surface of the binding cleft, including histidine’s and arginine’s which can 
interact electrostatically with the carboxylic acid of GlcA, whilst other residues such 
as serine and aspartic acids can interact through hydrogen bonding. When comparing 
the KD of the GlcA-containing glycopolymers, the largest KD is seen for that of P7 
with a KD of 2 pM, due to the low dissociation constant (Figure 4.36B). The KD is 
affected by the organisation of the charge, whereas the ka for P8 is the fastest of the 
three, the binding is the weakest as the irregularity of the charge destabilises the 
interactions leading to the largest kd (Figure 4.36C) of the 3-GlcA glycopolymers. 
From this it can be inferred that the lectin has a preference for regular charge spacing 
in order to bind, with a preference for charge every monosaccharide unit. The largest 
response is however seen from P12 (Figure 4.36D) with 186 RU compared with 125 
RU (P7) and 52 RU (P8) indicating a higher number of interactions between the lectin 
and the polymer (Table 4.10). Those glycopolymer with a controlled GlcA sequence 
(P7, P12) produced the tightest binding and highest response, inferring the necessity 
for the controlled localisation of negative charge in this lectin. 
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Figure 4.36. KD values for the binding to Dectin-1 (A) with individual SPR sensorgrams of GlcA containing 
glycopolymers of P7 (B), P8 (C) and P12 (D).
 
To further investigate this hypothesis of the charge on the glycopolymers, variants 
with iduronic acid (IdoA) should be tested to determine whether the stereochemistry 
of the sugar is necessary for the binding as well as natural alginate. Alginate is a 
polymer of mannose epimers of GlcA and IdoA and the polysaccharide consists of 
carboxylates on every unit, similar to P7. Additionally, the alternating polymers, P12, 
showed the largest response from the SPR. Since GlcA appears to be the crucial 
residue on the glycopolymer, other alternating glycopolymers are required where a 
different non-charged monosaccharide such as Glc could be inserted instead of 
GlcNAc to determine if a different disaccharide creates a stronger binding to this 
lectin. 
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Table 4.10. Kinetic data of Dectin-1 with the various polymers. 
Macromolecule 
Dectin-1 
ka (1/Ms) kd (s) RUMax Ka (M) Kd (1/M) 
HA  5.4 ´ 103 8.2 ´ 10-4 58 6.6 ´ 106 1.5 ´ 10-7 
P3  n.s. n.s. n.s. n.s. n.s. 
P4  n.s. n.s. n.s. n.s. n.s. 
P5  n.s. n.s. n.s. n.s. n.s. 
P6  n.s. n.s. n.s. n.s. n.s. 
P7  5.0 ´ 102 9.8 ´ 10-9 125 5.1 ´ 1011 2.0 ´ 10-12 
P8  3.7 ´ 103 2.3 ´ 10-6 52 1.6 ´ 109 6.3 ´ 10-10 
P12  7.4 ´ 102 3.0 x 10-6 186 2.4 ´ 109 4.2 ´ 10-10 
n.s. non-specific binding. 
 
DEC-205 
DEC-20554-55 is a multi-lectin receptor and has been suggested to be a homologous to 
that of other mannose receptors. It has a c-type lectin domain but no natural ligands 
have been discovered56. Its crystal structure is currently not available with signalling 
pathways still not fully determined, but it has been shown to play a role in sensing of 
cell-death57-58. 
Other mannose receptors, such as DC-SIGN, MBL and SP-D, bind terminus 
saccharides, DEC-205 shows binding to HA of 1.89 ´ 10-7 M suggesting that this lectin 
behaves more closely to Dectin-1 and CD44 (Figure 4.37A). The literature suggests 
that Dectin-1 is thought to be a mannose binding lectin, but when studying the 
individual monosaccharides on the glycopolymers, no specific binding is seen for P4 
or P5, but in contrast P3 showed specific binding with a KD of 91 nM, inferring this 
lectin is actually a glucose specific lectin. Since P5 shows no binding and HA shows 
specific binding to DEC-205, binding is likely to be Ca2+ independent, as the C4 
hydroxide of both of these polymers is unavailable for binding. This hypothesis is 
extended by the binding of P6 and P7, which are glucose-based epimers (Figure 
4.37B-C). When comparing the binding affinities of P6 and P7, an order of magnitude 
difference is observed with a KD of 100 n M and 17 nM, respectively, similarly to 
Dectin-1, inferring potential interaction with amino acid residues of DEC-205 and the 
carboxylic acid of GlcA, but as yet there is no crystal structure of DEC-205. The 
binding affinities are enhanced by the formation of a statistical copolymer containing 
both monosaccharides. A 2 orders of magnitude decrease in KD is observed for P8 (KD 
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= 910 pM). This is due to the steep, rapid association as well as a lower dissociation 
compared to individual homoglycopolymers (Figure 4.37D, Table 4.11).  
 
Figure 4.37. KD values for the binding to DEC-205 (A) with individual SPR sensorgrams of HA-based 
glycopolymers of P6 (B), P7 (C), P8 (D) and P12 (E). 
The binding is further enhanced by an order of magnitude for P12 with a KD of 13 pM, 
with ka of 7.7 ´ 102 M-1s-1 which is half that of P8 at 1.4 ´ 103 M-1s-1 (Figure 4.37A). 
Although the association is slow, the dissociation is tighter with a kd of 1.0 ´ 10-7 s 
compared to 1.3 ´ 10-6 s. This indicates the glycopolymers are associating through 
hydrogen bonding enhanced by the carboxylate at C5. This binding process is slower 
however, the additional time to adjust into the binding site leads to a stronger binding. 
By spacing the carboxylic acid out with units of GlcNAc, the glycopolymer is in a 
superior conformation for favourable interactions with the lectin compared to random 
positioning of the GlcA, inferring the binding site has periodic residues in which to 
interact with. With DEC-205 also being referred to as cluster of differentiation-205 
(CD-205) similarities can be drawn from other CDs including CD4433 and CD168 (or  
RHAMM)59 which are well known for binding HA. 
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Table 4.11. Kinetic data of DEC-205 with the various polymers. 
Macromolecule 
DEC-205 
ka (1/Ms) kd (s) RUMax Ka (M) Kd (1/M) 
HA  5.4 ´ 103 1.0 ´ 10-3 77 5.3 ´ 106 1.9 ´ 10-7 
P3  5.6 ´ 102 5.3 ´ 10-6 635 1.1 ´ 107 9.1 ´ 10-8 
P4  n.s. n.s. n.s. n.s. n.s. 
P5  n.s. n.s. n.s. n.s. n.s. 
P6  6.5 ´ 102 6.5 ´ 10-6 523 1.0 ´ 107 1.0 ´ 10-7 
P7  5.6 ´ 102 9.3 ´10-6 303 6.0 ´ 107 1.7 ´ 10-8 
P8  1.4 ´ 103 1.3 ´ 10-6 254 1.1 ´ 109 9.1 ´ 10-10 
P12  7.7 ´ 102 1.0 ´ 10-7 523 7.5 ´ 1010 1.3 ´ 10-11 
n.s. non-specific binding 
From the results of glycopolymers with DEC-205, to better understand the binding to 
DEC-205 new probes are required. The glycopolymer suggested for Dectin-1 would 
also be beneficial for DEC-205 due to the apparent similarities in binding between 
these two lectins. To interpret the lectin binding, the crystal structure would help to 
define the amino acid residues which line the binding site, to better assess the residues 
available to bind.  
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4.3. Conclusion 
HA-based glycopolymers showed distinct properties from those of natural HA. These 
can be seen in the measurements collect for rheology where the polymers show 
minimal viscoelastic properties by comparison to those of the natural HA. This is 
linked to the TEM images seen for the formation of aggregates compared to HA which 
forms long elongated structures in water. Not only is there a physical structural 
difference, but also a difference in the potentials of the polymers compare to HA. No 
correlation peak was seen in SAXS to show a polyelectrolyte behaviour and a 
significant difference observed in the 𝜁-potential between P12 and HA.  All the 
difference seen between the glycopolymers and HA is based on the lack of a glycosidic 
bond which ensures that semirigid structure which aids to a small extent the 
rheological properties, but to the periodicity of the negative charge producing a large 
negative charge on HA, compare those glycopolymers baring GlcA units. The 
glycosidic bond aided with the increased Mw is the key driving force for the 
viscoelastic properties of large Da HA. Though, at this moment glycopolymer by this 
methodology would struggle to remain at a low polydispersity as the Mw increases in 
the polymer backbone. 
However, the various versions of the glycopolymers synthesized offer insight into the 
role of HA with a far simpler methodology than conventional carbohydrate synthesis. 
As probes the glycopolymers have been shown to be non-cytotoxic towards human 
cell lines and red blood cells, therefore making them potentially applicable to use in 
vivo or in vitro.  Their preliminary antimicrobial activity shows potential for future 
applications, these going against the trends seen by antimicrobial peptide which are 
positively charged, therefore opening an interesting avenue, with HA being 
bacteriostatic, whilst the glycopolymers go one step further to be bactericidal. 
Glycopolymers also offered insights into the binding of HA to peptides and proteins, 
revealing potential new binders such as lectins by SPR, but it has also been shown 
through the RAFT group to applicable to other techniques such as SAMs and SPR 
measurements. Whilst these glycopolymers need fine tuning as HA mimics, there is a 
vast amount of potential for them. 
  




Fmoc-amino acids, Mueller Hinton (MH) and 4-methylbenzhydrylamine (MBHA) 
rink amide resin were purchased from Novabiochem. 3-mercaptopropionic acid, 4-
methoxytriphenylmethyl chloride (Mmt), 1-hydroxybenzotriazole hydrate (HOBt), 
N,N′-diisopropylcarbodiimide (DIC), piperidine, dimethylformamide (DMF), 
dichloromethane (DCM), trifluoroacetic acid (TFA), anisole, thioanisole, 1,2-
ethanedithiol (EDT) triisopropylsilane (TIS), diethyl ether, acetonitrile (ACN), 
acryloyl chloride, triethylamine (TEA), tetrahydrofuran (THF), copper bromide 
(CuBr), dimethyl sulfoxide (DMSO), phosphate buffer saline (PBS), bromoethanol 
and the Kaiser Test Kit were purchased from Sigma-Aldrich and were used without 
further purification. Sodium azide (NaN3), magnesium sulfate (MgSO4), sodium 
phosphate was purchased from VWR. Triton-X purchased from Alfa Aesar and 
LIVE/DEAD™ viability/cytotoxicity Kit for mammalian cells from Invitrogen. 
Recombinant Human CD44 24 kDa was purchased Cambridge Bioscience. The lectins 
are purchased from R and D System. 
 
4.4.2. Instruments and Analysis 
4.4.2.1. Rheology 
Rheology measurements for HA and glycopolymer solutions were carried out in a 
HAAKE RS150 rheometer equipped with 30 mm cone and plate set 0.19 mm apart 
with angle of 5° between the surface the conical surface of the cone. The viscosity was 
measured at 37 °C regulated by a water bath connected to the plate. The viscosity was 
monitored at fourteen different shear rates increasing linearly from 70 s-1 to 1000 s-1. 
The average was taken from 20 measurements, using the Rheowin software. 
 
4.4.2.2. Small Angle X-ray Scattering (SAXS) 
Small angle x-ray scattering patterns of glycopolymer solutions were obtained with a 
SAXSLAB GANESHA 300-XL. CuKa radiation was generated by a Genix 3D Cu-
source with an integrated monochromator, 3-pinhole collimation and a two-
dimensional Pilatus 300K detector. The scattering intensity q was recorded at intervals 
of 0.012 < q < 0.3 Å-1 (corresponding to lengths of 10-800 Å). Measurements were 
performed under vacuum at ambient temperature. The scattering curves were 
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corrected for counting time and sample absorption. The solution under study was 
sealed in thin-walled quartz capillaries with about 1.5 mm in diameter and 0.01 mm 
wall thickness. The scattering spectra of the solvent were subtracted from the 
corresponding solution data using the Irena package for analysis of small-angle 
scattering data60 Data analysis was based on fitting the scattering curve to an 
appropriate model by software provided by NIST (NIST SANS analysis version 7.0 
on IGOR) 61. 
 
Model fitting of small-angle scattering pattern 
The form factor of a semiflexible chain with excluded volume effects is expressed by 





4.4.2.3. Visible Light Spectroscopy 
Visible light spectroscopy was carried out on a Lambda35 Ultraviolet-Visible Light 
Spectrometer (Perkin Elmer), with turbidity measurements done at a fixed wavelength 
of 650 nm, while visible light scans were run between 400-700 nm. Turbidity 
measurements were performed by dissolving the glycopolymer in water at pH 7.0 from 
0.1 mM to 1.0 nM by serial dilution. The resulting solution transmittance was 
measured at 650 nm and compared to a control of water.  
 
4.4.2.4. Critical Aggregation Concentration (CAC) 
The CAC for the glycopolymers was determined by producing a serial dilution of 
peptide solutions from 0.1 mM to 1 nM. These solutions were added to Eppendorf’s 
containing Nile Red, with the samples being left 16 hours to allow the incorporation 
of the Nile Red into any aggregates formed by the peptides. The fluorescence emission 
spectrum was measured on an LS55 fluorescence spectrometer (PerkinElmer) ranging 
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4.4.2.5. Dynamic Light Scattering (DLS) 
Dynamic light scattering of the glycopolymers was measured on a Nano-ZS Zetasizer 
(Malvern Instruments). The solutions were prepared above the CAC (1 mM) at pH 7 
and allowed to stand for 48 hours to ensure aggregation. The solutions were diluted 
10-fold and passed through a 0.2 μm filter. The cell and the machine were cleaned 
using compressed air to ensure removal of large dust particles, before reading. 
 
4.4.2.6. Cell Viability 
Cell viability was assessed using the LIVE/DEAD™ viability/cytotoxicity kit for 
mammalian cells (Invitrogen) and following the manufacturer’s instructions. Briefly, 
LuC4 cells were seeded at 5,000 cells per well into a 96 well plate and grown in a 
humidified atmosphere at 37 °C, 5% CO2 for 48 hours. Cells were treated with 
glycopolymers at a range of concentrations, 0.1, 1, 10, 100, µg/mL, and incubated for 
24 hours. Media was removed, and Live/dead stains of Calcein and Ethidium 
homodimer-1 were added in PBS and incubated for 1 hour. Fluorescence was 
measured using in Synergy HT (BioTek) plate reader at 494 nm excitation & 517 nm 
emission for Calcein and 528nm excitation & 617 nm emission for Ethidium 
homodimer-1. The number of live and dead cells was calculated as a percentage of the 
fluorescent output compared to the controls of untreated for the live control and 
methanol fixed cells for the dead assay with an untreated cell negative for dead assay. 
 
4.4.2.7. Minimum Inhibitory Concentration (MIC) 
The MIC of the glycopolymers was determined by plating the glycopolymers in 
Mueller Hinton (MH) broth (100 µL), which was serially diluted down the wells. The 
bacteria concentration was determined by OD600 measurement and diluted to a 
concentration of cells of 6 ´106. The cells (50 µL) were added to the wells to make a 
final concertation of 3 ´106 cells. The plates were incubated for 16 hours at 37 ℃ and 
then inspected for turbidity. 
 
4.4.2.8. Haemolytic Assay 
Ethics Disclaimer: Fresh blood was obtained from St Georges Hospital Blood Testing 
department and transported in vacutainers containing citrate. No ethical approval 
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was required, due to the blood not being stored and only being used by the researcher 
themselves. 
Blood was centrifuged (2998 rpm, 5 mins) in 2 ml microfuge. The supernatant was 
removed, and PBS (pH 7.4) was added before re-centrifugation, this was repeat three 
time. The red blood cells (RBCs) were diluted in PBS to form 4% suspension. The 4% 
untreated was used as a negative control, whilst the 4% RBC suspension (90 µL) was 
plated with the glycopolymers (40 µL) and serial diluted across the plate. Triton-X 
(0.1%) was used as positive control, PBS and untreated cells as negative controls. The 
plate was incubated for 1 hour at 37 ℃. Plates were centrifuged (2998 rpm, 5 minutes 
at 4 ˚ C). After formation of the red blood cell pellets, 70 µl of supernatant was removed 
from each well and transferred into clear, flat, round bottom 96 well plate, ensuring 
the pellets were not disturbed. The absorbance plates were measured in a Tecan 
INFINITE pro 2000 (Tecan, USA) plate reader at 450 nm. 
 
4.4.2.9. Self-Assembled Monolayers (SAMs) of Thiol-HABPeps on Gold 
The formation of the SAMs was performed on gold, cleaned with basic piranha 
mixture before use. The clean gold surfaces were placed in an ethanoic solution of 
Thiol-HABPep-3 (1% w/v) for 24 hours at 37 ºC, after which the surface was washed 
with water and dried under nitrogen stream. 
 
Surface Analysis 
The contact angle was measured using water (2 μL) a Drop Shape Analyzer – DSA100 
(Kurss, Germany). The incubation process was repeated in an aqueous solution of 1.5 
MDa HA (0.5% w/v). The contact angle was again measured and compared to a 
control of a bare gold surface which had been treated in a similar way but with no 
peptide or HA in the incubation solutions. 
 
3D Analysis 
UV-visible spectra of colloidal gold nanoparticles were collected over the range from 
400 to 800 nm using a Cary 100 UV-Vis spectrophotometer. TEM images were 
obtained on a FEI Tecnai transmission electron 3S microscope operating at a bias 
voltage of 80 kV. All samples (~10 μL) were deposited and evaporated on carbon film 
400 mesh copper grids. 
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4.4.2.10. Surface Plasmon Resonance (SPR) 
Surface plasmon resonance (SPR) was used for investigating the interaction of the 
polymers with peptides and protein. This was performed on a BIAcore 2000 system 
(GE Healthcare, UK). Lectins (0.025 mg/ml) were immobilized via a standard amino 
coupling protocol onto a CM5 sensor chip (carboxymethylated dextran covalently 
attached to a gold surface) that was activated by flowing a 1:1 mixture of 0.1 M N-
hydroxysuccinimide and 0.1 M N-ethyl-N’-(dimethylaminopropyl)carbodiimide over 
the chip for 5 min at 25 °C at a flow rate of 5 µL/min after the system equilibration 
with HEPES filtered buffer (10 mM HEPES pH 7.4, 150 mM NaCl, 5 mM CaCl2). 
Subsequently, channels 1 (blank), 2, 3 and 4 were blocked by flowing a solution of 
ethanolamine (1 M, pH 8.5) for 10 min at 5 µL/min to remove remaining reactive 
groups on the channels.  
 
For the immobilization of peptides, a blank CM5 sensor chip (gold surface without any 
modification) was used and each thiolated peptide (1 mg/ml) was run at a flow rate of 2 
µL/min for 15 min at 25 °C to allow attachment of peptide on the gold surface. 
Glycopolymer solutions were prepared at varying concentrations (2000 nM-125 nM) in the 
same HEPES buffer to calculate the binding kinetics. Sensorgrams for each glycopolymer 
concentration were recorded with a 300 seconds injection of polymer solution (on period) 
followed by 150 seconds of buffer alone (off period). Regeneration of the sensor chip 
surfaces was performed using 10 mM HEPES pH 7.4, 150 mM NaCl, 10 mM EDTA, 0.01% 
P20 surfactant solution. Kinetic data was evaluated using a single set of sites (1:1 Langmuir 
Binding) model in the BIA evaluation 3.1 software. 
 
4.4.3. Methods 
4.4.3.1. Bromoethyl acrylate 
 
The synthesis has been modified from a previously reported method13. Briefly, 2-
bromoethanol (10 mL, 141 mmol) was dissolved in DCM (50 mL) followed by the 
addition of TEA (23.5 mL, 170 mmol) under a nitrogen atmosphere. The reaction was 
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dropwise over an hour. The reaction was then allowed to warm to room temperature 
and stirred for 16 hours. The resulting solid was filtered off and washed with DCM. 
The organic layer was washed with water (2 ´ 100 mL) followed by brine (2 ´ 100 
mL). The organic layer was dried with MgSO4, filtered and reduced under reduced 
pressure to give the product as a colourless oil. 
 
1H NMR  
(CDCl3, 400 MHz) 
d: 6.41 (d, 1H, 16 Hz C=CH2 trans), 6.11 (dd, 1 H, 16 Hz, 9.8 
Hz 1H, HC=C), 5.85 (d, 9.8 Hz, C=CH2 cis), 4.42 (t, 2H, 6.1 
Hz, CH2Br), 3.51 (t, 2H, 6.1 Hz, OCH2). 
 
4.4.3.2. poly bromoethyl acrylate (P13) 
 
1H NMR  
((CD3)2CO, 400 MHz) 
d: 4.40 (br, 2H, CH2Br), 3.55 (br, 2H, CH2O), 2.45 (br, 1H, 
CH), 1.76 (br, 2H, CH2), 1.53 (br, RAFT-CH2), 0.84 (br, 
RAFT-CH3) 
FT-IR (ATR): 2950.5 (C-H), 1731.6, 1710.4 (C=O), 1360.9, 1220.6, 
1152.6, 570.4, 529.3 
 
4.4.3.3. poly azidoethyl acrylate (P14) 
 
1H NMR  
((CD3)2CO, 400 MHz) 
d: 4.20 (br, 2H, CH2Br), 3.48 (br, 2H, CH2O), 2.41 (br, 1H, 
CH), 1.73 (br, 2H, CH2), 1.53 (br, RAFT-CH2), 0.84 (br, 
RAFT-CH3) 
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4.4.3.4. 1-azido-3-chloropropan-2-ol (21) 
 
The synthesis has been modified from previously reported method63. Briefly, 
epibromohydrin (5 mL, 63.3 mmol) was suspended in water (20 mL) with acetic acid 
(2.5 mL). Sodium azide (5 g, 75.7 mmol) was added to the solution and stirred for 5 
hours at 30 °C. The resulting solution was cooled to room temperature and washed 
with diethyl ether (3 ´ 15 mL). The organic layer was collected and washed with 
sodium phosphate buffer (50 mM) (15 mL) followed by the organic layer dried over 
MgSO4, filtered and reduced under reduced pressure to produce a yellow oil. 
 
1H NMR  
((CD3)2CO, 400 MHz) 
d: 3.97 (q, 5.4 Hz, 1H, CHOH), 3.48 (dd, 5.1 Hz, 4.4 Hz, 
2H, CH2N3), 3.44 (d, 5.0 Hz, 2H, CH2N3), 1.73 (br, 2H, 
CH2), 1.53 (br, RAFT-CH2), 0.84 (br, RAFT-CH3) 
FT-IR (ATR): 3367.1 (OH), 2904.3 (CH), 2098.8 (N3), 1707.22, 1257.5, 
1044.8, 929.7, 750.5, 554.7 
 
4.4.3.5. 1-azido-3-chloropropan-2-acryalte (22) 
 
The synthesis has been modified from previously reported method13. Briefly, 21 (5 g, 
27 mmol) was dissolved in DCM (30 mL) followed by the addition of TEA (4.5 mL, 
32 mmol) under a nitrogen atmosphere. The reaction was cooled to 0 ℃ after which 
point acryloyl chloride (2.9 mL, 21.6 mmol) was added dropwise over an hour. The 
reaction was then allowed to warm to room temperature and was stirred for 16 hours. 
The resulting solid was filtered off and washed with DCM. The organic layer was 
washed with water (2 ´100 mL) followed by brine (2 ´100 mL). The organic layer 
was dried with MgSO4, filtered and reduced under reduced pressure to give the product 
as a yellow oil. 
 
FT-IR (ATR): 2952.4 (C-H), 2104.1 (N3), 1732.5 (C=O), 1372.5, 1237.2, 
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4.4.3.6. General procedure for CuAAc click reaction on small molecules 
The monomer (1 equiv with respect to azide), acetylated alkyne sugar (1.5 equiv), 
Me6TREN (2 equiv) were suspended in DMSO (2 ml/g of solid) and degassed by 
gentle bubbling of Ar gas for 30 minutes. CuBr was charged into a Schlenk tube and 
degassed by gentle bubbling of Ar gas for 30 minutes. The degassed solution was 
cannulated into the Schlenk tube, with the solution and catalyst being stirred. The 
reaction was stirred at 25 ºC for 48 hours. The resulting solution was diluted by water 
(v/v) and washed with DCM (3 ´ 20 mL). The organic later were combined, dried 
over MgSO4, filtered and reduced under reduced pressure. 
 
4.4.3.6.40. 1-GlcNAc-3-chloropropan-2-ol (23) 
 
FT-IR (ATR): 3395.4 (OH), 1741.6 (CO), 1661.8, 1552.6, 1435.0, 1370.6, 
1218.3, 1123.6, 1017.3, 949.9 
 
4.4.3.7. General procedure for azidation of small molecule.  
The synthesis has been modified from previously reported method64. Briefly, the 
chloride functionalised compound was suspended in DMSO followed by the addition 
of NaN3 (1.5 equiv per halide) and stirred for 16 hours at 25 ºC. The resulting solution 
was diluted into water and extracted in EtOAc (3 ´ 50 mL). The organic layers were 
combined, dried over MgSO4, filtered and reduced under reduced pressure to give the 
crude product. 
 
4.4.3.7.41. 1-GlcNAc-3-azidoopropan-2-ol (24) 
 
FT-IR (ATR): 3395.2 (OH), 2106.4 (N3), 1739.3 (CO), 1660.4, 1552.6, 
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4.4.3.7.42. 1-GlcNAc-3-GlcA-propan-2-ol (25) 
 
FT-IR (ATR): 3270.4 (OH), 2657.7 (CH), 1741.5 (CO), 1661.5, 1542.7, 
1436.9, 1371.5, 1214.6, 1158.9, 1036.6, 951.4, 897.1, 
788.3, 698.2, 666.9, 634.5, 600.0 
 
4.4.3.8. 3-(((4-methoxyphenyl)diphenylmethyl)thio)propanoic acid 
 
To a stirring solution of Mmt-Chloride (3.5 g, 11.33 mmol) in 1:1 DCM/DMF (30 
mL) and DIPEA (2.8 mL), the mercapto acid (0.82 mL, 9.4 mmol) was added 
dropwise. The reaction was allowed to stir for 16 hours. The reaction mixture was 
concentrated and then suspended in H2O (50 mL) which was washed with ether (3 ´ 
50 mL). The organic layer was washed with brine (100 mL), dried over MgSO4 and 
reduced under reduced pressure. The oil was dried under high vac leaving a white 
powder (1.71 g, 4.5 mmol, 48%).  
 
1H NMR  
(CDCl3, 400 MHz) 
d: 7.49 (d, 4H, 7.5 Hz, m-CH), 7.39 (d, 2H, 8.9 Hz, o-CH), 
7.35 (t, 4H, 7.1 Hz, o-CH), 7.29 (d, 2H, 7.1 Hz, p-CH), 6.89 
(d, 2H, 8.9 Hz, m-CH), 3.86 (s, CH3), 2.54 (t, 5.1 Hz, 2H, 
SCH2), 2.34 (t, 5.1 Hz, 2H, CH2COOH) 
13C NMR  
(CDCl3, 133 MHz) 
177.52 (1C, COOH), 158.23 (1C, H3COC), 145.00 (1C, CC), 
136.78, 130.87 (2C, o-CH), 129.58 (4C, m-CH), 128.04 (4C, 
o-CH), 126.79 (2C, p-CH), 113.32 (2C, m-CH), 66.56 (1H 
CS), 55.35 (1C, CH3), 33.53 (1C, CH2COOH), 26.72 (1C, 
SCH2) 
FT-IR (ATR): 2833.0 (CH), 1708.7 (CO), 1592.9, 1508.1, 1430.9, 1249.7, 
1027.9, 817.7, 740.5, 700.0, 580.5, 534.2 
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The peptide bound to the resin was removed from the peptide synthesiser with the 3-
(((4-methoxyphenyl) diphenylmethyl)thio)propanoic acid coupled manually using 
HOBt and DIC in 4 times excess. The mixture was shaken for 2 hours. After the 
capping cycle, the resin was subsequently washed with DMF followed by DCM with 
Kaiser test confirming the coupling. 
 
4.4.3.10. Thiol Peptide Cleavage 
Once positive coupling was achieved, the peptide and acid-labile side groups were 
cleaved by TFA/thioanisole/anisole/EDT (90:5:2.5:2.5) for 3 hours. The solution was 
collected, concentrated by reduced pressure and precipitated in cold ether. The 
resulting suspension was collected by centrifugation and decanting the supernatant, 
followed by lyophilisation to obtain a white solid.  
 
4.4.3.11. Peptide Characterization and Purification  
The crude peptides were passed through a 0.2 µm filter and then purified on an Auto 
Purification System (Waters) using a preparative reverse-phase C18 column 
(XBridge, 130 Å, 5 μm, 30×150 mm, Waters) at 25 ℃ with a gradient running from 
98:2 to 0:100 of water/acetonitrile supplemented with 0.1% TFA over a 30-minute 
period at 20 mL/min. The fractions were collected by the SQ Mass Detector (Waters), 
combined, reduced under reduced pressure and then lyophilised to produce a white 
powder. 
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4.5. Appendix 
4.5.1. SAXS of the Glycopolymers 
 
Figure A 4.1. SAXS data of the glycopolymers at 0.2 mM at pH 7 fitted to a model shown in the black line 
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4.5.2. Peptide Analysis 
4.5.2.1. HS-RYPISRPRKR-CONH2 (Thiol-HABPep-1) 
 
 
Figure A 4.2. HPLC trace of purified Thiol-HABPep-1 running a gradient of 98: 2 to 0: 100 (H2O + 0.1 % TFA: 
ACN + 0.1 % TFA) over a 30-minute period at a flow rate of 1 ml/min 
 
 
Figure A 4.3. ESI Mass spectrum of Thiol-HABPep-1 measured in the positive ion channel 
RP-HPLC (mins) 10.08  
Purity (%) > 99% 
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4.5.2.2. HS-KNGRYSISR-CONH2 (Thiol-HABPep-2) 
 
 
Figure A 4.4. HPLC trace of purified Thiol-HABPep-2 running a gradient of 98: 2 to 0: 100 (H2O + 0.1 % TFA: 
ACN + 0.1 % TFA) over a 30-minute period at a flow rate of 1 ml/min. 
 
Figure A 4.5. ESI Mass spectrum of Thiol-HABPep-2 measured in the positive ion channel. 
 
RP-HPLC (mins) 9.87 
Purity (%) > 98% 
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4.5.2.3. HS-GAHWNFQALTVR-CONH2 (Thiol-HABPep-3) 
 
 
Figure A 4.6. HPLC trace of purified Thiol-HABPep-3 running a gradient of 98: 2 to 0: 100 (H2O + 0.1 % TFA: 
ACN + 0.1 % TFA) over a 30-minute period at a flow rate of 1 ml/min. 
 
 
Figure A 4.7. ESI Mass spectrum of Thiol-HABPep-3 measured in the positive ion channel. 
RP-HPLC (mins) 13.88  
Purity (%) > 97% 
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4.5.3. Nile Red Assay 
 
Figure A 4.8. Nile Red emission when excited at 550 nm at increasing concentrations of the glycopolymers in H2O 
  




Figure A 4.9. SPR sensorgrams showing the binding of the various polymers on Thiol-HABPep-3. 
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Figure A 4.10. SPR sensorgrams showing the binding of the various polymers on HABTPep-1. 
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Figure A 4.11. SPR sensorgrams showing the binding of the various polymers on Thiol-HABPep-2. 
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Figure A 4.12. SPR sensorgrams showing the binding of the various polymers on the. extracellular domain of 
CD44 protein. 
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Figure A 4.13. SPR sensorgrams showing the binding of the various polymers on DC-SIGN with increased 
concentration used for P6 and P7 denoted by *. 
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Figure A 4.14. SPR sensorgrams showing the binding of the various polymers on MBL. 
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Figure A 4.15. SPR sensorgrams showing the binding of the various polymers on SP-D. 
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Figure A 4.16. SPR sensorgrams showing the binding of the various polymers on Dectin-1. 
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Figure A 4.17. SPR sensorgrams showing the binding of the various polymers on DEC-205.  
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Chapter 5 Conclusion and Future Work 
In this final chapter the aims laid out in chapter 1 are reviewed, recognizing the 
limitations of the work undertaken and identifying opportunities for further research.   
 
“Synthesis of hyaluronic acid (HA)-based glycopolymers using alternating polymers” 
Chapter 2 described the synthesis of HA-based glycopolymers using RAFT 
polymerisation followed by click reactions to graft the HA monosaccharides on the 
polymer backbone. This approach was shown to be effective and versatile, allowing 
the synthesis of glycopolymers based on other GAGs by sulfonation of grafted 
monosaccharide.  
The main limitations of this approach are the RAFT end group used and the length of 
the polymers produced. As described in Chapter 2, the RAFT end group using NaN3 
caused some degree of disulphide bridging between the polymers. These bonds could 
not be reduced by PPh3 as this would cause reduction of the azide formed upon the 
polymer. Controlled NaBH4 reduction of the RAFT end group to a free thiol and 
clicking of a maleimide through thiol-ene reaction to the terminus thiol, could be a 
method to remove the end group and then inhibit the shoulder formation. The 
formation of disulphide bonds at the omega terminus of two polymers could in 
principle be used to form large polymers by linking them together (doubling the Mw), 
since the polymerisation showed lack of control at higher DPs. In Chapter 4, chain 
extension showed a promising route to form larger polymer backbones and this could 
be investigated to produce > 100 kDa polymers with Ð < 1.3.  
 
“Engineering HA-binding peptides for self-Assembly with HA” 
In chapter 3, several HA-binding peptides, derived by phage display (Pep-1) and taken 
from natural hyaladherins (CD44 and link protein), were exploited to create defined 
and controlled self-assembling nanostructures. It was shown that HABPep-3 formed 
stable complexes with HA, as the peptide formed elongated nanofibers. By contrast, 
the sequences derived from the HABPep-1 and HABPep-2 did not form stable 
complexes, due to their high-water solubility. Using a PA design, the HA-binding 
sequence could be displayed on the surface of spherical (micelle) or cylindrical (fibre-
like) nanostructures, depending on the pH. The incorporation of HABPep-3 in a PA 
design (HABPA-3) led to the formation of shorter nanofibers compared to the 
elongated fibres before modification. HABPA-3 lacks the self-assembly structure of 
long elongated fibres in order to produce gel structures. The next steps in the design 
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of self-assembling versions of Pep-1 would be to include V3A3 domain close to the 
alkyl tail to promote the formation of elongated fibres able to interact with HA in a 
controlled manner. Other possibilities to explore would be to use other sequences from 
HA-binding proteins (Table 1.7), as the variations in peptide sequence could lead to 
unique self-assemblies.  
 
“Comparing the properties of HA synthetic analogues with natural HA” 
The results presented in chapter 4 showed that the glycopolymers produced do not 
exhibit physical properties similar to those of natural HA. The differences arise mainly 
from the lack of a glycosidic bond and shorter polymer length. The polymer backbone 
does not give the rigidity of the glycosidic bond between the monosaccharides, 
compare to HA. These will lead to different internal hydrogen bonding interaction 
causing changes in the HA properties in solution. The glycopolymers showed the 
ability to aggregate as seen through the CAC measurements and TEM imaging. The 
low cytotoxicity towards different cell types suggest their potential use in biomedical 
applications, such as a drug delivery vehicle. Hydrophobic drugs can be incorporated 
within the core of the glycopolymer aggregates, similarly to the CAC assay using the 
hydrophobic nile red dye.   
 
“HA glycopolymers as probes to elucidate HA binding processes” 
In the later section of chapter 4, the ability of HA glycopolymers to interact with the 
HA-binding Pep-1 (HABPep-1), described in chapter 4, was investigated by SPR with 
the binding results showing patterns and trends in the structure of the saccharide and 
the sequence of the glycopolymer (Table 5.1). This allowed us to probe which HA 
sugar might be involved in the binding process. These studies were extended to HA-
binding proteins (CD44) as well as to other (non-specific) carbohydrate-binding 
proteins (lectins: Dectin-1 and DEC-205).  
Table 5.1. Summary table of binding hits (blue) of the glycopolymers and the lectins. 
Lectin 
Glycopolymers 
Monosaccharide to test 
HA P3 P4 P5 P6 P7 P8 P12 
DC-SIGN         ManNAc, ManA 
MBL         ManNAc, IdoA 
SP-D         6-deoxy-D-glucose & 2-deoxy-D-glucose 
Dectin-1         Swap GlcNAc in P8 and P12 
DEC-205         Swap GlcNAc in P8 and P12 
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In the SPR measurements, the HABPep-3 was attached to the chip surface rather than 
the glycopolymer. The peptide used is at most 12 mers away of the gold surface 
whereas the glycopolymers are roughly 50 repeats (Figure 5.1). Through the RAFT 
end group of the trithioester, the glycopolymers could bind to the gold surface. Whilst 
the glycopolymer have shown to aggregate in solution, the gold surface will restrict to 
a degree this aggregation to display the monosaccharides across the surface of the 
gold.   
 
Figure 5.1. Schematic representation showing the potential limitation of the peptide bound onto the gold surface 
(left) compared to the glycopolymers (right) due to the distance from the surface. 
QCM showed the binding of P7 to the surface of the gold crystal followed by the 
binding of HABPep-3 to the glycopolymer as seen by the positive mass increase upon 
every addition. The QCM will provide further validation of the SPR results. From the 
binding results of this first generation of HA glycopolymers, a second generation can 
be obtained as different combinations of statistical and alternating glycopolymers 
could provide a key insight the binding to lectins. By building up a large library of 
glycopolymers with the binding to the lectins, structural similarities can be determined 
to find glycopolymers that produce a strong KD as either potential inhibitors or 
agonists for the lectins. 
An alternative method to measure the binding affinity is isothermal titration 
calorimetry (ITC). By measuring small heat changes between a reference cell and the 
reaction cell in which the ligand is being titrated into the cell the heat of binding can 
be quantified. Preliminary ITC experiments with HA and HABPep-3 showed that the 
interactions were masked by the heat of dilution of HABPep-3 in water rather than as 
heat of binding between HABPep-3 and HA (Figure 5.2). HABPep-3 was shown to 
have a low CAC of 6.7 ´ 10-5 M and dilution of HABPep-3 below the CAC, generates 
Conclusion and Future Work 
 254 
heat that is entropic rather than enthalpic. Based on these results, SPR and QCM were 
considered more adequate methods. 
 
Figure 5.2. ITC graph of Pep-1 (30 μM) titrated with HA 20 kDa (300 μM) (red) and against water (black) showing 
the overlay between the two graphs. 
The ability of the glycopolymers to bind to a gold surface opens the possibility to 
explore their attachment to gold nanoparticles (NPs). The RAFT group possess at C16 
tail which would help the stabilization of the gold NPs with the monosaccharides 
displayed from the central gold core. This method will allow to exploit of their 
biological effects of the glycopolymers were shown to be non-toxic. The gold can be 
imaged by TEM to track the glycopolymers in vitro. 
Since the acrylate polymers did not show any CAC, compared to the styrene-based 
glycopolymers, it can be concluded that the polymer backbone affects the 
conformation of the glycopolymers in water. By completing the synthesis of the dual 
acrylate glycopolymer synthesis, (Scheme 4.4) as well as the statistical, a complete 
comparison can be undertaken for the styrenic and acrylate-based glycopolymers. 
This work has shown for the first time the synthesis of alternating glycopolymers 
based on the structure of HA. The same polymer backbone can be used as an 
interchangeable platform to create glycopolymers of sulfonated GAGs. If the 
biological properties of these new GAG glycopolymers are comparable to other 
sulfonated glycomimetics reported in the literature, the synthetic route to obtain GAG-
based glycopolymers can be greatly simplified. 
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